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For further details, see ‘What is a Witness Seminar’, in Tansey E M, Catterall P P, Christie D A, Willhoft S V,
Reynolds L A. (1997) Wellcome Witnesses to Twentieth Century Medicine, vol. 1. London: Wellcome Trust, i–v.
The extensive published record of modern medicine and medical science raises
particular problems for historians: it is often presented in a piecemeal but formal
fashion, sometimes seemingly designed to conceal rather than reveal the processes by
which scientific medicine is conducted. Study of unpublished archives may provide
helpful insights but there are difficulties. Official archives may be limited in range and
depth and in the UK public records are subject to a restriction that keeps papers hidden
for at least 30 years. The survival of personal papers can be patchy. Many are lost during
the lifetime of an individual, as space constraints or relocation demand the jettisoning
of material without proper regard for its significance. Probably even more papers are
wrongly discarded as worthless and uninteresting by their owners, or by relatives acting
immediately after a bereavement. Thus historians of contemporary medicine and
science are increasingly turning, or returning, to the traditional technique of oral
history to supplement, or extend, existing records, and to create new resources.1
This volume is a departure from the standard Wellcome Witnesses to Twentieth Century
Medicine format of a single Witness Seminar transcript per volume. The complete
transcript of the witness seminar in 1999 entitled ‘The MRC Epidemiology Unit (South
Wales)’ follows (page 15). But this is preceded by a selection of relevant material from a
partly unpublished Witness seminar in 1994 ‘Pneumoconiosis in Coal Workers’. This is
included to provide details of the origins of the work of the MRC Pneumoconiosis
Research Unit, from which the Epidemiological Research Unit (later Epidemiology
Unit) emerged in 1960. Quotations taken from interviews conducted by Dr Andy Ness
between March 2000 and August 2001 with former members of both units follow the
four chronological sections. These quotations provide additional information on matters
discussed at the two Witness Seminars and topics not covered at the seminars.
A small project grant from the Wellcome Trust to Dr Andy Ness, Professor George
Davey Smith and Dr Tilli Tansey made these further interviews possible (listed on page
2). These interviews were undertaken to explore the rich varieties of experience of those
who had been at the cutting edge of epidemiology over more than five decades. It also
enabled us to hear from those who had been unable to attend the original meetings and
to follow up in detail some of the views and opinions expressed there. This approach
has also allowed us, inter alia, to preserve records of early fieldwork practice, and to
record accounts of the problems associated with the subsequent analysis, and storage,
of the vast quantities of data generated in the Unit over many years. 
In planning the Witness Seminar (and subsequent interviews), we identified
appropriate participants with the help of the meeting’s chairman and external adviser,
in this case Sir Richard Doll, and our co-editor, Dr Andy Ness. Invitations inevitably
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lead to further suggestions of people to invite, and we relied heavily on such
recommendations. Despite this process some individuals were overlooked, and the
records of the meeting include correspondence and recollections offered to us at a late
stage in the production process. No Witness Seminar claims to offer a definitive history
of a subject, as, naturally, the discussion and reminiscences flow only from those who
contribute on the day. Often key people are unable to attend, a constant problem when
many we invite are elderly. For example, the late Professor Charles Fletcher suffered a
bad and incapacitating fall just days before he was due to join Dr Philip D’Arcy Hart
as one of the two principal witnesses at the ‘Pneumoconiosis’ meeting in 1994.
Balance and purpose
Our aim has been to trace the development of field epidemiology and epidemiological
methods in South Wales from the late 1940s onwards and to assess the contribution
of this work to methodological advances and to medical knowledge. We have tried to
include the voices of epidemiologists, statisticians and fieldworkers who worked in
South Wales during this period, including those who worked there for a long time and
others who worked there for only a brief period.
In focusing on the work of the Epidemiology Unit, we have also tried to recognize and
acknowledge the work of the MRC Pneumoconiosis Unit, from which it evolved. Mrs
Sheila Wright and Mrs Margery McDermott have argued that the important
contributions made by the Pneumoconiosis Research Unit, particularly those of non-
medical scientists in physics, chemistry, petrology, and electronics, should not be
neglected.2 Their comments arrived after the text had been finalized and will be deposited
in Archives and Manuscripts of the Wellcome Library for consultation by interested
researchers, along with all other correspondence, tapes and other records from the seminar.
The other group that is not well represented is those who were enrolled in these
epidemiological studies. As our primary intention was to study the scientific process
from the perspective of those running the studies we did not attempt to contact study
subjects. Though it was beyond the scope of this project, others have written about the
mining communities, and their attempts to get compensation3, the impact of the
unions,4 and the working conditions they endured.5 We believe that more information
2
See note 31, 180–184. For example, see Timbrell V. (1965) Human exposure to asbestos: dust controls and
standards. The inhalation of fibrous dusts. Annals of the New York Academy of Sciences 132: 255–273. Wagner J C,
Gilson J C, Berry G, Timbrell V. (1971) Epidemiology of asbestos cancers. British Medical Bulletin 27: 71–76.
Glover J R, Bevan C, Cotes J E, Elwood P C, Hodges N G, Kell R L, Lowe C R, McDermott M, Oldham P D.
(1980) Effects of exposure to slate dust in north Wales. British Journal of Industrial Medicine 37: 152–162. Oldham
H G, Bevan M M, McDermott M. (1979) Comparison of the new miniature Wright peak flow meter with the
standard Wright peak flow meter. Thorax 34: 807–809. Clark R L, Bugler J, McDermott M, Hill I D, Allport D
C, Chamberlain J D. (1998) An epidemiology study of lung function changes of toluene diisocyanate foam
workers in the United Kingdom. International Archives of Occupational and Environmental Health 81: 169–179.
3
Bartrip P W J, Burnam S. (1983) The Wounded Soldiers of Industry: Compensation policy, 1833 to 1897. Oxford:
Clarendeon Press. Bartrip P W J. (1983) Workmen’s Compensation in the Twentieth Century: Law, history and social
policy. Avebury: Gower Publishing Co. Ltd. Our thanks to Mark Bufton for bringing these to our attention.
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Bloor M. (2000) The South Wales Miners Federation, Miners’ Lung and the instrumental use of expertise,
1900–1950. Social Studies of Science 30: 125–140.
5
Howells G, Rees C. (1999) Pneumoconiosis: a study of its effect on miners’ health in South Wales, 1900–1980. Nursing
Standard 13: 39-41. Coggon D, Inskip H, Winter P, Pannett B. (1995) Contrasting geographical distribution of mortality
from pneumoconiosis and chronic bronchitis and emphysema in British coal miners. Occupational and Environmental
Medicine 52: 554–555. Carpenter R G, Cochrane A L, Clarke W G, Jonathan G, Moore F. (1993) Death rates of miners
and ex-miners with and without coalworkers’ pneumoconiosis in south Wales, 1955. British Journal of Industrial Medicine
50: 578–585. Woodward N. (2000) Why did south Wales miners have high mortality? Evidence from the mid-twentieth
century. Welsh History Review 20: 116–141.
on the study subjects and their communities, and the impact of the studies, would create
a richer picture of the historical place of this epidemiological work in South Wales.
Have the interviews enhanced and extended our understanding?
The additional reminiscences and contributions have allowed us to expand an
individual’s contributions, enlarged upon subjects mentioned in passing in the
seminar, and introduced new topics. The interviews have filled several gaps in our
knowledge of the evolution of the subject and revealed other lacunae. For example, the
interviews with Peter Sweetnam, a statistician at the unit from 1966 until its closure
in 1999, revealed how important technical developments in computing had been. He
described how statistical analyses that take only a few seconds on a modern computer
were only feasible on small samples and would require hours (or even days) of hand
calculations or calculations using an electromechanical calculator. 
Voices not well represented at the witness seminar had an opportunity to be heard. Dr
Philip Hugh-Jones described contributions by physiologists in the early years at the
PRU. Mrs Janie Hughes told of an earlier, less regulated way of life when recruiting
samples in the valleys, or ‘cold calling’, involved knocking on front doors that were not
locked, and using Post Offices as authoritative sources of local information on those
who had moved away or died.
The excerpts from interviews also illuminate several perspectives, as distinctly different
views emerge on a variety of subjects. By interviewing subjects about the whole of
their lives we can begin to trace the paths that led people into epidemiology. For
example, the interest in (and experiences of ) studying birds described by Professor
Estlin Waters (collecting data on the wrens of St Kilda in the Outer Hebrides) perhaps
provided an ideal grounding for a future in epidemiological research. 
The selected quotes represent only a small part of the material available and reflect a
range and diversity of views and experiences – memories, anecdotes, opinions – that
can only be hinted at in the published text. The tapes of seminars and interviews and
the corrected transcripts along with accompanying correspondence have all been
placed in the Wellcome Library and are available for further historical study. We hope
that these records will add to the resources available to historians of present and future
generations who wish to study the development of medical research and ideas over the
second half of the twentieth century. 
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The following text also appears in the ‘Introduction’ to recent volumes of Wellcome Witnesses to Twentieth Century
Medicine published by the Wellcome Trust and the Wellcome Trust Centre for the History of Medicine at
University College London.
WITNESS SEMINARS: MEETINGS AND PUBLICATIONS
1
In 1990 the Wellcome Trust created a History of Twentieth Century Medicine Group,
as part of the Academic Unit of the Wellcome Institute for the History of Medicine,
to bring together clinicians, scientists, historians and others interested in
contemporary medical history. Among a number of other initiatives the format of
Witness Seminars, used by the Institute of Contemporary British History to address
issues of recent political history, was adopted, to promote interaction between these
different groups, to emphasize the potential of working jointly, and to encourage the
creation and deposit of archival sources for present and future use. In June 1999 the
Governors of the Wellcome Trust decided that it would be appropriate for the
Academic Unit to enjoy a more formal academic affiliation and turned the Unit into
the Wellcome Trust Centre for the History of Medicine at University College London
from 1 October 2000. The Wellcome Trust continues to fund the Witness Seminar
programme via its support for the Centre.
The Witness Seminar is a particularly specialized form of oral history where several
people associated with a particular set of circumstances or events are invited to meet
together to discuss, debate, and agree or disagree about their memories. To date, the
History of Twentieth Century Medicine Group has held over 30 such meetings, most
of which have been published, as listed in the table on pages xi–xiii.
Subjects for such meetings are usually proposed by, or through, members of the
Programme Committee of the Group, and once an appropriate topic has been agreed,
suitable participants are identified and invited. These inevitably lead to further contacts,
and more suggestions of people to invite. As the organization of the meeting progresses,
a flexible outline plan for the meeting is devised, usually with assistance from the
meeting’s chairman, and some participants are invited to ‘set the ball rolling’ on particular
themes, by speaking for a short period of time to initiate and stimulate further discussion. 
Each meeting is fully recorded, the tapes are transcribed and the unedited transcript
is immediately sent to every participant. Each is asked to check their own
contributions and to provide brief biographical details. The editors turn the transcript
into readable text, and participants’ minor corrections and comments are
incorporated into that text, while biographical and bibliographical details are added
as footnotes, as are more substantial comments and additional material provided by
participants. The final scripts are then sent to every contributor, accompanied by
forms assigning copyright to the Wellcome Trust. Copies of all additional
correspondence received during the editorial process are deposited with the records of
each meeting in Archives and Manuscripts, Wellcome Library, London. 
xAs with all our meetings, we hope that even if the precise details of some of the
technical sections are not clear to the nonspecialist, the sense and significance of the
events are understandable. Our aim is for the volumes that emerge from these meetings
to inform those with a general interest in the history of modern medicine and medical
science; to provide historians with new insights, fresh material for study, and further
themes for research; and to emphasize to the participants that events of the recent past,
of their own working lives, are of proper and necessary concern to historians.
Members of the Programme Committee of the 
History of Twentieth Century Medicine Group
The Group’s activities are overseen by the Programme Committee, which includes
professional historians of medicine, practising scientists and clinicians. The Programme
Committee during 2001–02 comprised:
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Sir Christopher Booth – Wellcome Trust Centre at UCL, former Director, Clinical Research
Centre, Northwick Park Hospital, London
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Dr Daphne Christie – Senior Research Assistant, Wellcome Trust Centre at UCL and
Organizing Secretary
Professor Hal Cook – Director,Wellcome Trust Centre at UCL
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Professor Ian McDonald – Harveian Librarian, Royal College of Physicians, London
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INTRODUCTION
Field epidemiology in south Wales: from tuberculosis to non-communicable disease
In 1952 a history of American epidemiology appeared, documenting the development
of the discipline up until the mid-twentieth century.1 It was almost exclusively
concerned with infectious disease, although it contained hints that the chronic
diseases then rapidly taking over from the declining infections as the leading cause of
death would become the focus of future epidemiological work. The book is frequently
used as a benchmark for considering the development of epidemiology in the second
part of the twentieth century.2 In Britain the population-based research in south Wales
from 1937 onwards provides a window into the emergence of what has come to be
termed ‘modern epidemiology’. The armament of case-control studies,3,4,5 prospective
cohort studies2,6 and randomized controlled trials 7 all have pre-histories stretching
back over the twentieth century, and even before, but a moment of particular
importance for all three was the appearance of a series of case-control studies on
smoking and lung cancer,8,9,10,11 the establishment of the Framingham heart disease
study12 and the MRC streptomycin trial for treatment of pulmonary tuberculosis.13 ,14
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Tuberculosis was, as the US epidemiologist George Comstock has pointed out, a
bridge to chronic disease epidemiology.15 While tuberculosis was clearly an infectious
disease, it was not one that was tractable by the standard methods of infectious disease
epidemiology. It re-established the importance of host susceptibility after the apparent
triumph of simple germ theories of disease and had no clear incubation period (with
many cases of late adulthood clinical tuberculosis being recrudescence of infection
acquired decades earlier16 ). As the pioneering US epidemiologist Wade Hampton
Frost wrote in 1933 for TB,
we cannot assume that the risk with which we are concerned is concentrated
within the year or even the decade following the establishment of the known
exposure. It may, perhaps, be manifested by excessive morbidity or mortality
in any subsequent period of life. Hence, observation of the exposed group
must extend over a sufficient number of years to define the rates of morbidity
and mortality prevailing in successive periods throughout the usual in span of
life. To keep a sufficiently large group of people under systematic, exact
observation for such length of time is a difficult task which has, indeed, been
undertaken in various places, but to the best of my knowledge has not been
carried much beyond a decade. However, such simple facts as lie within the
knowledge and memory of the average householder may be obtained by
retrospective investigation, tracing familial histories backward into the past.17
Frost emphasised the need for careful retrospective data collection, although clearly
prospective study was preferable. In fact, a prospective investigation of tuberculosis
had been established in Framingham, USA, during the First World War,6 and the
existence of this study was one factor leading to the establishment of the seminal
Framingham heart disease study three decades later.
Prospective epidemiological studies of chronic (believed to be non-infectious) diseases
can be seen as a development of the methods applied to the study of tuberculosis.
Although Frost established retrospective studies of tuberculosis and investigated the
biases, which could be introduced into these18 formal case-control studies do not seem
to have been used in investigating tuberculosis. However the rise of lung cancer
stimulated investigations of the possible role of old tuberculosis scars as a source of
the disease, early studies generally concluded that this was not the case.19
Investigators of this issue considered that smoking was an important cause of lung
15
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cancer by 1931,20 well before the first formal case-control studies in Germany in 1939
and 1943.21 Several of the early case-control studies of lung cancer investigated
tuberculosis as a possible cause or co-factor. With respect to randomised controlled
trials, while others had been carried out before the landmark streptomycin for
tuberculosis trial,22 it is the latter study, which established the methodology as central
to evaluating the effectiveness of medical treatments. 
The initial population-based research in south Wales was chronic pulmonary disease
research. Here there is a link between the old and new epidemiology. Dr Philip
D’Arcy Hart, who had worked on tuberculosis, directed surveys of south Wales coal
miners in the late 1930s and early 1940s.23 He was also involved in the MRC
streptomycin trial,13 as well as an earlier and largely forgotten randomized controlled
trial of treatment of the common cold. Archie Cochrane returned from a Rockefeller
fellowship in the USA to Britain in 1948 and hoped to obtain work from his friend
D’Arcy Hart, who was then engaged in the streptomycin trial.24 Cochrane intended
to investigate the impact of BCG immunisation and mass X-ray surveillance on
tuberculosis rates in Scottish border towns, and only when that project proved
unfeasible did he take up the offer to join the MRC’s recently established
Pneumoconiosis Research Unit (PRU) in Cardiff. The radiographical and other
similarities between tuberculosis and progressive massive fibrosis (PMF) of the lungs
led to a belief that there could be an interaction between dust exposure and
tuberculosis in generating the disease. A major study was set up by Cochrane and
others in the PRU to examine this by reducing the level of tuberculosis infection in
one of two comparable mining valleys and establishing the effect of this on the
subsequent risk of PMF in the two valleys.25 The continuing general decline in
tuberculosis prevented any definitive results from the study, although the effort put
into it was considerable. However, a major part of the output of the PRU until the
early 1960s dealt with tuberculosis. 
The subsequent development of the work of the unit built on both the methods
developed for these earlier studies and on the contact established with populations
that were well defined, relatively stable and willing to participate in research. In 1959
Archie Cochrane applied for and secured the David Davies Chair of Tuberculosis at
the medical school at Cardiff University [then the Welsh National School of
Medicine]. When he was moving to Cardiff the idea was mooted that a separate unit
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for epidemiological studies under his direction should be set up. In a memo circulated
in the MRC toward the end of 1959,26 presumably written by Dr Dick Cohen27 at the
MRC, it was suggested that the techniques which had been developed in the
pneumoconiosis work – of surveying whole populations and using standardised
methods – could be applied to many other fields, including rheumatoid arthritis,
asthma, blood pressure, coronary heart disease, diabetes and bronchitis. 
The epidemiological studies of the south Wales Unit produced a wide range of
important findings with respect to specific health outcomes. These are discussed at
length in this volume, but an important principle of the studies is the generalizability
of the findings. Direct clinical or health policy relevance of the findings is also evident,
something which is often not seen in epidemiological research. For example, the
studies on iron deficiency anaemia had important implications for clinical practice
(and in this sense the distinction between population and clinical epidemiology is
sometimes hard to maintain, with the most robust evidence for clinical practice
coming from population studies), as did the trials of nutritional influences on asthma,
child growth and myocardial reinfarction. 
The south Wales work is perhaps best remembered in the epidemiological community
for two aspects of its work. First, the high response rates that were obtained,
something that has slipped somewhat in more recent epidemiological studies, perhaps
because of reduced engagement with the studied communities.28 Second, the
promotion of randomised trial evidence, most famously in Archie Cochrane’s
Effectiveness and Efficiency 29 published in 1972. While the unit did carry out trials –
in particular two important early trials of aspirin following myocardial infarction –
more of its resources were devoted to observational epidemiology. The Cochrane
Collaboration, however, will make certain that this contribution continues to be
widely recognised.30
Perhaps less widely appreciated by epidemiologists in the second part of the twentieth
century was the importance of large sample sizes in randomised controlled trials with
regard to producing robust evidence for clinical practice.31 In observational
epidemiology the situation is in some ways different, and more precise or repeated
measurements on smaller sample sizes have value, particularly in the situation where
26
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there is substantial confounding.32 Several of the prospective studies from the unit,
particularly the Caerphilly cohort study, are unusual in terms of having repeated data
to allow the investigation of this issue. 
Epidemiology in the twenty-first century is certain to be more concerned with genetic
contributions to disease than was twentieth century epidemiology. Exciting advances
in technology that allow for such studies should not take away from the importance
of good study design and relating study findings to biological reality.33 The
developments in ‘population laboratory’ research pioneered in the south Wales valleys
will continue to inform epidemiological practice as long as epidemiology continues to
have anything to offer to health sciences and public health.
George Davey Smith
Department of Social Medicine, University of Bristol
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Dr Philip D’Arcy Hart:1 First of all, pneumoconiosis,
in case anybody doesn’t know, is really only dust disease
of the lungs, that’s all, and could cover asbestosis. But
here we are confined to coal dust. I am going to try to
rescue from threatened oblivion the initiative of the
MRC some 50 years ago. This was the investigation on
coal miners’ pneumoconiosis in south Wales and it took
place in what I think I can call two medical phases. The
first was phase 1, with which I am concerned, from
1937 to 1940. That is, just before the War and just after
it started, when things were rather tense out in Wales.
The second part was after Charles Fletcher’s unit started
in 1945. 
For a long time, and before X-rays of the chest existed,
it was reported by many people that inhalation of coal
dust produced chronic disabling disease. You have
probably heard of the term ‘miners’ phthisis’ which was
one of the terms. And in Great Britain it was
particularly rife in south Wales, and in south Wales it
was particularly prevalent in the west, where the
anthracite pits were. There was no opportunity for
systematic study of coal miners’ diseases, but it was
generally believed they existed. It wasn’t until 1929 that
there was any compensation for these people and then
it was for the minority of coal miners who worked in
hard rock, for example tunnelling, who would develop
a classical silicosis which is due to quartz inhalation. In
1934, four or five years later, the compensation scheme
was extended to all underground workers. But they had
to conform to the definition of classical silicosis. The
great majority of workers had not worked in hard rock.
* The following text is a contribution by Dr Philip D’Arcy Hart to the Witness Seminar, ‘Pneumoconiosis in Coal
Workers’ held on 9 November 1994 at the Wellcome Institute for the History of Medicine (WIHM), London, and
has been partly included in P D’Arcy Hart, edited and annotated by E M Tansey. (1998) Chronic pulmonary
disease in South Wales coalmines: An eye-witness account of the MRC surveys (1937–1942). Social History of
Medicine 11: 459–468. The transcript of the ‘MRC Epidemiology Unit (South Wales)’, held at WIHM on 23
March 1999, follows on page 15.
1 
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MRC PNEUMOCONIOSIS RESEARCH,* 1937– 60
The Medical Research Council
(MRC) was asked by the
Home Office and the Mines
Department in 1936 to
investigate chronic pulmonary
disease among coalminers,
particularly the conditions in
the south Wales coalfield. The
MRC referred the problem to
its Committee on Industrial
Pulmonary Disease, chaired by
C G Douglas. Dr P D’Arcy
Hart was appointed to
undertake the medical work,
along with Dr E A Aslett, who
was seconded from the Welsh
National Memorial Association.
Dr T H Belt did the
pathological work, assisted by
Dr A A Ferris.2
Figure 1: Dr Philip D’Arcy Hart in the 1950s.
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The local doctors and the men themselves complained
that there were conditions in coalface workers, who had
never worked in hard rock, which produced disability,
but because their X-rays and post mortems did not look
like ordinary silicosis, they did not get compensation. So
while the compensation cases granted went up rapidly
during the next few years after the scheme came in, so
also did the refusals, and there was great discontent. 
This was the position in the mid-1930s, when the
Government, through the Home Office and the Mines
Department, asked the MRC to sort things out, make
recommendations and to do it urgently.4 Now looking
back, I ask myself why did the Government, which
doesn’t usually act urgently in this sort of thing, why did
they act urgently in this case? I can think of three reasons.
One is that the compensation costs were going up
rapidly. Secondly, there was a war round the corner and
they certainly did not want a dissatisfied coal-producing
force. And, thirdly, I like to believe that there was some
concern for the health and welfare of the miners. 
The MRC, through the Industrial Pulmonary Diseases
Committee, recruited a large contingent of people from
inside Wales and outside to work on the project: medical
staff, Edward Aslett, a chest physician from Wales, and
myself, MRC scientific staff. And then there were
environmentalists, dust experts, mineralogists, geologists,
inspectors of mines, and pathologists. We obtained the
cooperation of the South Wales Miners Federation, that’s
the miners’ trade union and the local miners’ Lodges and
the cooperation of the coal owners. There were individual
coal owners then, before nationalization, privatization
‘Mark 1’. You are going to have ‘Mark 2’ now.
Why did I join the MRC? Well it’s rather confessional,
but I wanted to get out of consultant medicine, because
I found that I wanted to do research, with a small ‘r’,
3
See discussion in House of Lords. (1998) Hansard, Columns 1102–1113 (16 November 1998).
4
Meeting of MRC, 14 February 1936, Minute 28.  ‘Industrial Pulmonary Disease’; MRC Minute Book 3,
1927–36, MRC Archives, Public Record Office FD1/5256. Meeting of MRC, 27 November 1936, Minute 181
(a), ‘Alumina Dust’; Minute 191 ‘Pulmonary Disease Among Coalminers’, Minute Book 4, 1936–39, MRC
Archives, Public Record Office FD1/5257. Meeting of MRC, 22 October 1937, Minute 119 ‘Pulmonary Disease
Among Coalminers’; MRC Archives, Public Record Office FD1/5257.
The Workmen’s Compen-
sation Act of 1943 took account
of the Committee’s findings that
the key factor was prolonged
exposure to airborne dust,
particularly quartz mixed with
coal and other materials.
A ‘no fault scheme’ for
compensation was introduced
by the British Coal Board in
1974. In 1993 the Board was
privatized as British Coal. The
Government assumed British
Coal’s liabilities on privatization
and miners could claim
industrial injury benefit for
bronchitis and emphysema
within strict limits. Chronic
emphysema and bronchitis
were prescribed as dangerous
diseases in 1993 following
American and Belgian studies
that demonstated that they
were an endemic risk to mining
workers.The High Court ruled
in 1998 that the failures 
of British Coal and its
predecessors to control the
levels of coal dust in mines from
1949 to 1970 and to a lesser
extent thereafter, was the cause
of emphysema, bronchitis and
other respiratory illnesses in
former miners. A year later
vibration white finger was
added to the list. It was
estimated in 1999 that up to
105 500 former miners in
England, Wales and Scotland
would be eligible to receive
£2.1 billion in compensation.3
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5  
MRC Special Reports Series 243, 244 and 250, were published between 1942 and 1945, as Chronic Pulmonary
Disease in South Wales Coalminers. I–III, illustrated above in Figures 2–4. See also note 2.
6
A coal trimmer was a skilled worker in the hold of a coal ship, who balanced the coal by hand. As the coal poured
from the rail wagons on the staiths above the ship, the trimmers levelled the coal with specialized shovels. Colliers
at the coalface, trimmers and surface workers on the screens were exposed to coal dust. Trimmers were not eligible
for compensation. See MRC Special Report 243, note 2, 40–41 and Gough (1940), note 173. 
and I found I couldn’t do it, because I had to earn my
living. And therefore I was looking for ways of getting
out. Out of the blue, Sir Thomas Lewis on the Council,
heard about this demand from the Home Office or the
Government to do something about pneumoconiosis,
and they were looking for somebody to do it. And he
knew me (he was at University College Hospital and I
was first assistant to T R Elliot’s unit there, the medical
unit, and I used to see Thomas Lewis and he must have
gauged that I wasn’t happy) and so he suggested me and
they asked me. 
I might say that at first I was offered a three-year job
and that got to the ears of Thomas Lewis, who was very
influential, and he apparently told the MRC (somehow
or other I saw the letter), ‘You can’t ask this man to give
up a career of consultant medicine for three years. You
have got to speculate and give him a life’s appointment.’
And so that is how I got in those days a permanent
appointment from the beginning. That’s how I joined.
The medical phase, which I am calling phase 1, started
work in 1937 and finished in 1940, and produced three
Green reports.5 I might say to some of you who are very
keen historians, as a core of people here are, earlier history
of pneumoconiosis right back, there’s a lot more of that in
the medical report. We started on the three stages of this
phase. The first stage in 1937 was six months at one
particular anthracite colliery in Ammanford, not far from
Swansea. The second stage was 15 representative mines
distributed throughout Wales, to be representative. The
third stage was the examination of the people who load
ships with coal, called coal trimmers,6 at four south Wales
docks. Meantime, a lot of work was going on with our
dust experts and any autopsies were examined at
Hammersmith Hospital by Dr Thomas Belt. 
The work at Ammanford was very intensive – we
worked from a schoolroom which was lent to us and
Figure 2:
Report 243,
1942.
Figure 3:
Report 244,
1943.
Figure 4:
Report 250,
1945.
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did clinical examination of the miners, X-rays, some sort
of respiratory disability tests, rather crude ones I have to
say in retrospect, was all we could do, and history taking.
There was no X-ray set-up there and we used a mobile
van, Portable X-rays Limited, which trundled round the
valleys, and it is amazing what beautiful X-rays they took
for the period. Our history taking was important, due to
the remarkable memories of the miners. We wanted to
know how long they worked in certain seams, when they
moved, and they were quite remarkable. And also it was
due to the equally remarkable facility and ability of my
clerical assistant, J I T Jones, whom I have failed to trace,
who spoke Welsh and got the confidence of the miners,
who started by being, as you can imagine in private
ownership, extremely suspicious of any ‘oddbod’ that
came in from outside. The second stage was much less
intensive and limited to prevalences in these 15 other
pits, 16 pits in all. We had no base in Wales. It was an
expeditionary force, people descended and came from
all over the place to work. 
I lodged in Swansea and went up every day by car. I might
say that the car I had was presented by Lord Nuffield, the
manufacturer. Cars of that vintage had a windscreen with
a hinge so you could open it. If there was an enormous
amount of fog, snow and rain, you just had to push it
open in order to see and put on your goggles and peer out
in front. Later on I had as my base a desk at the London
School of Hygiene and Tropical Medicine.
I am going to mention several achievements. The first
and most important was that we confirmed by X-rays
and by post mortems that coalface workers who had not
worked in hard rock did have serious, disabling lesions.
And they did not look like classical silicosis. So this
confirmed the suspicions that had been around.
Secondly, we were also able to trace the progression of
these lesions according to the length of exposure to
their work in the coal-seams. We were able to do that,
not by following people along, of course, but by taking
people who had been for different periods at
Ammanford colliery, and matching them against the
7
Additional comment by Dr Philip D’Arcy Hart in the published version, see note on page 3.
Philip D’Arcy Hart
1. Compensation. Our MRC
surveys (1936–42) as described
above promoted, in the 
early 1950s, a widening of
compensation to include coalface
workers under a general 
heading of ‘pneumoconiosis of
coalworkers’. But even in this
change of the regulations,
bronchitis and emphysema were
not considered integral; they were
only considered to confer
additional disability to that
caused by the pneumoconiosis,
simple or complicated, which
was present also, and the worker
had to have been 20 years
underground. In 1992 the
regulations were widened to
regard bronchitis as causable by
coal mine dust, but, for
compensation purposes, at least
simple pneumoconiosis must also
be present. In 1998 the causative
effect of coal mine dust 
to produce bronchitis was
emphatically reaffirmed, and the
necessity for accompanying
pneumoconiosis was dropped;
although underground service for
20 years was still required. A
late, but radical, advance.
2. Dust control was improved
following the first MRC reports
in the early 1950s but later, and
in the 1960s, faded as coal
production and accidents became
priorities. Only since about
1970 did dust control again
become of serious importance,
and dust is now considered to
have been causative of bronchitis
as well as pneumoconiosis. The
improvement was especially
evident in south Wales.
Addenda, July 19987
MRC Pneumoconiosis Research
7
lesions they showed in their X-rays. And we were able
to describe the character of the lesions, as it appeared on
X-ray, starting with a reticular appearance, then a
nodular appearance, and then big masses, with
increasing disability. In contrast to silicosis we didn’t
find tuberculosis to be a leading feature of
pneumoconiosis of colliers.
Our nomenclature and results were not always treated
with acclamation. But, what I have just said was very
much the subject, of course, of Charles Fletcher’s unit
which came afterwards, and they had to look into all this
and we were criticized for making our descriptions and
classifications only by X-ray. Afterwards he would
probably have said that his unit modified the categories,
improved them and linked them with the pathology more
than we had, and produced a more basic classification,
rather on the same lines, but suitable and accepted by
international classification. Thus, the classification started
with ours, but became different as regards names. I think
the essentials of our findings still hold up, and the term
‘pneumoconiosis of coal workers’ stands today. 
There was also an argument about disability. And that
was quite acute. We thought there was some disability,
very early changes, which we called reticulation, when
people were beyond middle age. That was disputed later
on by a number of people who said that it was not
pneumoconiosis. Whatever it was, maybe it was due to
smoking or something like that. And I think that the
whole thing now has recently been cleared up and I will
come back to it when I talk about compensation. So I
think that what we said stands as the beginning anyway. 
The third achievement needs the map. [See Figures 5
and 6] We introduced a hypothesis, we called it ‘the
rank of coal hypothesis’. We had noticed that the
prevalence of pneumoconiosis was highest in the west
and lowest in the east and intermediate in the middle.
But we found a closer correlation if we compared the
prevalences of pneumoconiosis in different collieries,
with the rank of coal mined. Now the rank of coal, put
simply, is the carbonaceous content, and that’s highest
in anthracite, lowest in bituminous, (which is what
house coal is), and intermediate in steam coal (which is
Population-based Research in South Wales
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what factories tended to use). The question is: is the
rank of coal hypothesis any use? Well, it was found, by
environmentalists,8 that the rank and the amount of dust
go in parallel and the highest amount of dust was in the
anthracite and the lowest in the bituminous. It was
hoped that there might be salient things in the quality of
the coal too, but that has not been actually proved.
The fourth achievement was by our environmental
colleagues who did an enormous amount of work and
they pinpointed the areas in which they thought that
coal dust could be reduced, and they introduced new
techniques for measuring it. It seems, however, that
their techniques were not fully adopted until later.
8 
The environmental studies were conduced by T Bedford and C G Warner, members of the scientific staff of the
Industrial Health Research Board, along with Major J G C Leech, Professor H V A Briscoe, J Ivon Graham, 
D F Runnicles, D Hicks, G Nagelschmidt, J Thewlis and Major R Yates. See Figure 3, MRC Special Report 244,
note 5.
Figure 5: Map of the
south Wales coalfield,
showing the relative
incidence of X-ray
abnormalities at each 
of the 16 collieries.
Figure 6: Relationship
between the rank of coal
and relative incidence of
X-ray abnormalities at
the 16 collieries.
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See page 15. See also C M Fletcher in a Royal College of Physicians video interview, RCP-OP/VTR3/1985. A
collection of his papers, PP/CMF, are held by Archives and Manuscripts, Wellcome Library.  Booth C. (1995)
Obituary of Professor Charles Fletcher. Independent (23 December 1995).
10 
The National Joint Pneumoconiosis Committee of the Ministry of Power appointed a field research
subcommittee in 1951. The following year it recommended that the National Coal Board should undertake
research to establish how much and what kinds of dust caused pneumoconiosis and the environmental conditions
that could reduce disablement in mine workers breathing dust at work. A Steering Committee was established with
representatives from the Ministries of Power, Pensions and National Insurance, the MRC and others. Fieldwork
started in 1953. See Hicks D, Fay J W J, Ashford J R, Rae S. (1961) The Relation between Pneumoconiosis and
Environmental Conditions: An analysis of the results of the first series of X-ray surveys in the National Coal Board’s
pneumoconiosis field research. London: National Coal Board.
11 
Sir Christopher Booth, speaking at the Witness Seminar, ‘Pneumoconiosis in Coal Workers’, 9 November 1994,
unpublished.
And the fifth achievement was compensation. The
compensation rules were, that people had to have
‘silicosis’. So, many with pneumoconiosis were refused
compensation. We considered this was too restrictive
and we recommended that the word silicosis should be
dropped and instead the scheme should be called
‘pneumoconiosis of coal workers’, so it would include
coal miners at the face, rock workers and the coal
trimmers at the docks. And we also widened the
categories that were covered. New regulations
embodied our recommendations. The terms of the
compensation scheme since have remained practically
unaltered down to 1983. But there’s been one
important change, that in 1992 emphysema and
chronic bronchitis were included provided that the 
X-rays showed some evidence of pneumoconiosis.
What therefore, in summary, did we think we achieved?
I think that we uncovered the natural history of this
rather bastard sort of disease in phase 1, which was not
really silicosis, and not really understood much before.
We paved the way for things to happen and we also
drew the attention of the informed public to this being
a very important and widespread condition, and out of
this came quite a large number of organized efforts.
Then there was Charles Fletcher’s unit of course, which
I can’t really talk about.9 Then there was the National
Coal Board, which started doing studies by X-raying
the miners periodically 10 and in 1963 they covered all of
the miners of Great Britain and there was a very, very
good turnout, and they could see what the prevalence
of disease was. Then there was the Institute of
Sir Christopher Booth
The MRC appointed Charles
Fletcher as head of this unit and
Charles was, in my view, I am
sure you would agree, a most
unlikely choice. I mean an Old
Etonian, Trinity College, rowed
in the boat race in 1933, won
against Oxford. One of the last
social occasions his father
attended was seeing that boat
rowing to victory from Duke’s
Meadows in April 1933. You’d
think that that was really a man
with quite extraordinarily
wrong qualifications to go to
talk to coal miners in south
Wales. Nothing could have been
farther from the truth, because
there was nobody who really
managed to get people eating out
of his hand in south Wales better
than Charles Fletcher. He was
incredibly successful in his
relationships with all the people
there and he deserves very great
credit for that.11
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Occupational Medicine in Edinburgh which took a
great interest, and they did a lot of work on the
cytotoxicity of dusts, the analysis of mine dusts. They,
particularly Professor Anthony Seaton, pushed for
emphysema to be included, because he and his
colleagues found that emphysema could occur in the
fairly early stages of pneumoconiosis.12
Another thing I want to say is, looking back now, can
we say that we know what the actual cause of the
pneumoconiosis was? We know that quartz and silica
are causes, but at first we thought that there might be
some other silicate, some specific substance in the coal
dust that does it. There has been no evidence that that
really is so. And what one can say is that there is no
doubt whatever that the prime suspect is the quantity of
mine dust. Whether the quartz – there’s always some
quartz mixed in with the dust, however small – whether
that plays a part is still not known, but I think there is
a great suspicion that it does and that that’s what makes
it so peculiar. But it has not been absolutely proved,
because it never seems to come out quite right
quantitatively. However, I think one can say that a little
quartz doesn’t do you any good. 
There has been a dramatic fall in the prevalence of
pneumoconiosis. In 1963, the Coal Board instituted
periodic X-raying and that has gone on, eventually
under British Coal, right up to 1993 and the last lot of
figures were in the British Coal Report (1993–94). And
it shows that there was one-thirtieth in 1993 of the level
in 1963. Why did this happen? It’s thought primarily
because after 1975 the dust concentration was radically
reduced. The other minor thing may have been shorter
hours. People who have been detected with lesions have
been switched perhaps to less risky parts of the mine,
and also, one has to say, redundancy and retirement
have played their parts.
12
Morgan W K, Lapp L, Seaton A. (1972) Respiratory impairment in simple coal workers’ pneumoconiosis.
Journal of Occupational Medicine 14: 839–844. See also Mossman B T, Bignon J, Corn M, Seaton A, Gee J B.
(1990) Asbestos: scientific developments and implications for public policy. Science 247: 294–301. Seaton A.
(1990) Coalmining, emphysema, and compensation. British Journal of Industrial Medicine 47: 433–435. 
Figure 7: Swiss miner, 1930s, using a power drill.
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I am now going to ask you all to go from underground
up into the fresh air and to the light. I want to deal with
the lighter aspect of social history, and to give you the
flavour of what it was like just before, and at the
beginning of the Second World War, doing work in the
coal mines. Surprising as it may seem nowadays, we
were really well funded by the MRC. I give you two
examples. First, there is the story of the half-crowns
(2s.6d., 121/2p).Some of you may have heard this before,
it was published in a Welsh local paper, but as it was in
Welsh maybe I can say it again, it is so highly topical.
As part of our work we wanted to see whether
tuberculosis was a factor in the progression of this
pneumoconiosis. There was a lot of tuberculosis around
there then, much more than now. So as part of our
approach we decided to do tuberculin tests on a sample
of men in order to see whether we could show any
relationship between the lesions that they had and the
tuberculin sensitivity. They were stratified according to
their lesions. We selected a lot of miners and, after a lot
of consultations, they agreed to have the skin test,
which meant an injection of tuberculin into the skin
itself. All went off well and each one collected half-a-
crown reward and we were very pleased at that. Now
this test, if people were negative, they required a second
test exactly two days after and we assumed that that
would be OK. But it wasn’t, because the men grumbled
and said, ‘We’ve had one jab, we really don’t know why
some of us should have another one’. And there was a
crisis and into the breach stepped Sir John McMichael,
who happened to be down there studying some
physiological aspect of respiration in miners. He made
the most remarkable speech and won them all over. He
told them that the job was only half done and if they
gave up we should have no results at all (which was
absolutely true). And so they decided to do it and we
were very pleased. But then came the second crisis,
‘Half-a-crown again, please’. Well, we had no half-
crowns. Time was ticking over, and the second day was
approaching. I rushed to the telephone in Ammanford,
telephoned Westminster and told the MRC of our
predicament, and I am glad to say that when I met the
local train that same evening, the guard handed me a
sack of half-crowns marked ‘Medical Research
Julian Tudor Hart
What was said at that meeting
[Witness Seminar, 23 March
1999] about the half-a-crown for
participating miners, was actually
true. I didn’t know it was true
then, but I have looked it all up
since then, but the inference he
drew from it was not true. The
argument of the miners’ union
was that if any men were paid to
participate, then all men should
be paid to participate, because
that was always the attitude of the
union, and in fact this half crown
was something to do with
defrayment of expenses and so on.
But the principle that for
participants in research, it should
be a voluntary act and should be
unpaid, is very, very important. I
think the moment people start
doing something for a living,
whether it is giving blood, or
taking part in research or
whatever, you introduce yet
another source of corruption of
data, it is unpredictable and
destructive. I don’t have
documentation on it, but
apparently in America it is now
very difficult to get research
subjects without paying them. It
has certainly become very difficult
to get students to participate in
research without paying them.
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Council’, so we were able to carry out the tests and they
did not show any relationship between the tuberculin
sensitivity and the type of lesion, and that work was
confirmed later on by Professor Archie Cochrane and
his colleagues.13 That’s the first story.
The second one is more personal. This work was my
first job with the MRC and in my briefing they said,
‘Oh, by the way, you’ll be travelling by train, I’m sure,
in Wales. Travel first class’. So I said, ‘That’s very nice,
why?’ So they said, ‘Well, we don’t want you to have too
many conversations with the miners’. We didn’t carry
out that rule, we saved a bit of money and we had some
quite interesting conversations. But in any case,
travelling by train wasn’t very easy, because you never
knew where you were. The stations were all wrong.
They were all mixed up. You thought you were at one
place and you were at another. That was because they
thought this would confuse the Germans if they
invaded. I travelled mostly by the Morris Nuffield car
and one day I was in the middle of the country and it
inactivated itself, so I decided that I must walk to the
nearest railway station and I hoped to thumb a lift.
Well, there were very few cars on the road and
eventually I got a lift in a car with two big men and I
asked if they would take me to the nearest railway
station. As we went along they started asking me an
enormous number of questions, and I couldn’t make
out why and I said, ‘What station are you dropping
me at and why are you asking me all these questions?’
They said, ‘We are taking you to the police station, we
think you are a German parachutist.’ So I said, ‘Oh
no, you are making a great mistake, I work for the
British Government’ and so we had a long
conversation and eventually I convinced them and
they took me to the railway station and on saying
goodbye they gave me a bar of chocolate, which was a
very rare treat, I can tell you. 
13
Hart J T, Cochrane A L, Higgins T T. (1963) Tuberculin sensitivity in coal workers’ pneumoconiosis. Tubercle
44: 141–152. For a more detailed historical view, see Meiklejohn A. (1951) History of lung diseases of coal miners
in Great Britain. I. 1800–1875. British Journal of Industrial Medicine 8: 127–137. idem (1952) ibid. II.
1875–1920. ibid 9: 93–98. idem ibid. III. 1920–1952. ibid.: 209–222.
Julian Tudor Hart
I went down to south Wales and
spent a year there. Archie gave
me a project where I had got to
look at tuberculin sensitivity in
relation to progression of
progressive massive fibrosis, as a
final validation or invalidation
of Gough’s hypothesis that the
cause of progression from simple
pneumoconiosis to progressive
massive fibrosis (PMF, also
known as complicated pneumo-
coniosis) was tuberculosis. It is an
interesting thing historically, but
we now know beyond question
that tuberculosis has nothing to
do with it. But it was an
extremely attractive hypothesis, a
hypothesis that seems so self-
evidently true that you can
hardly believe that you need
evidence to prove it. I have seen
so many people crash through
having a religious belief in their
hypothesis and bend data to
confirm what they feel is already
proven, believing that it’s only for
the doltish multitude that you
have to produce more evidence,
because otherwise they won’t
understand it.
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Now back to the serious matter. It’s a real anticlimax.
Who would have dreamt in those days and even until
recently that people who knew no science, no medicine,
would solve the problem of pneumoconiosis in Great
Britain, by removing a large body of highly skilled
craftsmen both from their work and from their risk of
pneumoconiosis. But so it is. But of course this problem
is still present in countries that supply us with coal –
Colombia, China, Poland, and so on. 
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Figure 8: Dust Diseases:Their cause and care. This pamphlet was published by the National Association for the Prevention of
Tuberculosis, 1950.
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Sir Richard Doll: I am particularly glad that we are
having the meeting today to discuss the work of this
unit, because Archie Cochrane expressed his concern to
me before he died that he was becoming better known
because of his work on controlled clinical trials and his
book, Effectiveness and Efficiency,14 which of course
reached almost religious qualities throughout the world
after he died, and it wouldn’t be much of an
exaggeration to many people that one should be
referring to Saint Cochrane. But he thought his
epidemiological work was the major part of his
scientific work, not his work in controlled trials. I must
say that he and I agreed on that and it is particularly
nice that it is therefore being recognized today. 
I am going to claim a lot of credit for the very early
work that he did in Cardiff, for the simple reason that
Charles Fletcher asked me to apply for the job of
epidemiologist to work with him in 1947 and for
various personal reasons I refused to do so, with the
result that Archie Cochrane was appointed and really
excellent work was done, which I would never have had
the imagination or the energy to carry out. So I claim
responsibility for the origin of his work. Now we have
people here, I think, who were members of the unit in
those early days, late 1940s and early 1950s, and I
wonder if any of them would like to start by telling us
a bit about the work that was going on then.
Professor Owen Wade: I was a junior member of the
Pneumoconiosis Research Unit (PRU). I joined in April
1948 and left in April 1951. The unit was set up in
1946. At that time there were 800 000 coal miners
working in the UK, of whom 120 000 were employed
in south Wales. There were 20 000 men certified as
suffering from pneumoconiosis, most of them from the
south Wales coalfield. 
14 
Cochrane A L. (1972) Effectiveness and Efficiency: Random reflections on health services. The Rock Carling
Fellowship 1971. London: Nuffield Provincial Hospitals Trust. See also Maynard A, Chalmers I. (eds) (1997) Non-
random Reflections on Health Services Research: On the 25th anniversary of Archie Cochrane’s ‘Effectiveness and
Efficiency’. London: British Medical Journal Publishing Group.
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Figure 9: Professor Charles Fletcher
(1911–95), 1971. © Keystone Press.
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Hart P D, Aslett E A. (1942) Chronic Pulmonary Disease in South Wales Coalminers. A. Report by the Committee
on Industrial Pulmonary Disease. B. Medical survey by P D’Arcy Hart and E A Aslett; C. Pathological report by
T H Belt with assistance from A A Ferris. Medical Research Council Special Report 243. London: HMSO. See
also note 5 and Figures 2 to 4 on page 5. Mining practices are explained in the Medical Survey, 2–31.
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Professor Owen Wade wrote: ‘Stalls about 20 feet wide were cut into the coalface with headings about 3 feet
wide between each stall to hold up the roof. With this work there would have been low concentrations of coal dust.
But when power-driven drills and coal cutters were introduced the dust produced in the confined area of a mine
corridor was such that it was hard to see anyone more than a few feet away.’ Note on draft transcript, 2 April 2002. 
The study made by Philip D’Arcy Hart and Dr Aslett15
between 1937 and 1941 suggested that the incidence of
pneumoconiosis was related to the rank of coal,
anthracite being more dangerous than steam coal,
which was more dangerous than bituminous coal in the
east of the coalfield. [See Figure 5 and 6, page 8] Soon
after Archie Cochrane started the PRU’s more extensive
surveys, it became clear that the incidence was more
closely related to the coal workers’ exposure to dust,
than to the rank of coal that they were mining. The
miners’ exposure to dust had been greatly increased
when compressed air drills and coal cutting machinery
were introduced in the late 1920s in the deep and
difficult mines in the anthracite areas in the west of the
coalfield and only later in the steam coal mines of the
Rhondda and the bituminous mines further east. Before
air drills, men had worked with pickaxes and shovels in
traditional ‘stall and heading’ work.16 When a power drill
hits the coalface there’s dust. I have been underground
when there were chaps working at the stall with the
pickaxe. As soon as you put in a mechanized coal cutter,
it’s very difficult to see them due to the dust. So I think
the first thing that became clear was that the prevalence
and incidence of pneumoconiosis was related to the
amount of dust and that the differences were really
related more to the introduction of the power drilling
than to the grade of coal.
The second thing that was very important to me was
the relationship between the severity of the X-ray
changes of dust disease and the degree of disability in
the patients we were seeing. I was engaged with Philip
Hugh-Jones and [John] Gilson on the physiology side
of things. When I first arrived in 1948 you could have
two men, both of them with very severe-looking
pulmonary changes in their X-rays, and one would be
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Figure 10: Dr Philip Hugh-Jones,
c. 1980.
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very modestly disabled and the other would be very
profoundly disabled. One study looked at men in three
age groups: those around the age of 35, around the age
of 45, and around the age of 55. Each age group had
ten men with no evidence of pneumoconiosis and ten
men divided among four groups of increasingly severe
X-ray changes of pneumoconiosis, the worst group
having progressive massive fibrosis (PMF). As age
increased, the disability related to any given degree of
X-ray change increased, even in normal subjects with
no evidence of pneumoconiosis the lung function tests
deteriorated and disability increased. Some young
people with very severe X-ray changes are not as
disabled as some of the older people with less severe-
looking pulmonary disease.17
It was Archie Cochrane’s conviction that the total
population of any colliery be identified and when we
went to visit a mine, whether it was in the Rhondda or
Gwaun-cae-gurwen, or the Monmouthshire field, we
should interview and X-ray every man who was there.
An enormous amount of work went into preparation
beforehand. All of us in the unit were made to visit the
colliery and meet the miners. A series of lectures was
arranged. Any ability I have as a lecturer was, I am sure,
because I had to go and speak in pubs, or clubs as they
call them, because the pubs were shut on Sunday. 
Sir Christopher Booth: In Welsh?
Wade: Yes. Pubs shut on Sunday in Wales, therefore all
miners belong to clubs, which opened on Sunday. But
it didn’t matter which day of the week, the procedure
was always the same. The presiding chairman would
introduce you, and you went up and explained to them
what pneumoconiosis was, how it affected them, and
why it was necessary for us to see every man in that
colliery – 80 per cent wasn’t good enough, 90 per cent
wasn’t good enough, 95 per cent wasn’t good enough.
We wanted to see every man. As a consequence of this,
Figure 11: Advertisement in 1949
Postgraduate Medical Journal.
Reproduced with permission 
of the BMJ Publishing Group.
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when we did do the survey, you’d see big heavy miners
carrying the youngsters out in order to get them 
X-rayed. They were so insistent that everybody should
be X-rayed. I think it was part of Archie [Cochrane]’s
genius that he saw this was very important.18
It was pretty arduous. You used to go out to a pub,
usually there were chaps wandering up and down and
beer coming in from the hatches, and I’d give my talk.
As soon as I had finished, there would be men leaping
up saying, ‘How is it, Dr Wade, that me and my brother
always worked at the same coalface, and when we went
for chest X-ray, both of us went together on the same
test, and he gets certified by the Silicosis Medical Board
and I didn’t?’ You had to use language that was
understood by the miners. I said, ‘Well, it’s like this, it
isn’t the amount of dust in your lung, it’s the amount of
scarring that’s caused by that dust. You all know that if
your hand is burnt badly, how the scars restricts the
movement of the hand, well, it is the same with the dust
scarring in the lung. It is the scarring that matters and
you can’t use a scarred lung as well as a normal lung,
you see.’ Questions like this would go on for about
three-quarters of an hour, and the chairman would
close the meeting, to my great relief. He would then
invite the lecturer into his office and give him a pint of
beer. Inevitably there were some men who wanted to
consult you privately, another half-hour to three-
quarters of an hour of a sort of out-patients clinic. You
didn’t get any more than a glass of beer, of course, but
it was added interest. For me, it was a wonderful
introduction to epidemiological research.
The final comment that I would like to make is the
enormous contribution to the work of the unit that was
made by the late Peter Oldham. At this time, in the
1940s, very few doctors and very few people outside the
MRC and a few research units knew very much about
statistics. Peter Oldham made a tremendous impact on
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all members of the PRU – certainly on me. I learnt
about means, standard deviations, coefficients of
correlation, and analyses of variance. I wasn’t the only
one. There were many others working at the unit and
were influenced by Peter, and this must have had a wide
effect on teaching and medical students and others, in
our profession and related fields – another example of
the influence of the work of the Pneumoconiosis
Research Unit.
Doll: Thank you very much for that wonderful
introductory account of conditions at that time. Now
who else? Have we got anyone else here who remembers
that early period?
Professor Stewart Kilpatrick: I shall be brief because I
am neither an epidemiologist nor a physiologist. I went
first of all to the PRU in 1952 in the days of Charles
Fletcher and John Gilson. It was a very stimulating
environment, and I enjoyed it very much. I then
realized that of all the other fields in medicine I hadn’t
recognized there was epidemiology with Archie
Cochrane. We used to go out in the evenings as Owen
[Wade] has said, up into the valleys, to talk in the pubs,
to go down the mines, to do all sorts of things. It was
interesting, it was exciting and for me entirely different.
Archie was an incredible character. I was privileged to
live in his house at Rhoose and those of you who visited
him there will probably remember a very elegant house
and a very beautiful garden, with servants and people
who washed your car in the morning and all that sort of
thing. I remember very clearly my engagement party
was held in Archie’s house and Bill Foreman, who was a
physician superintendent at Sully [Hospital], came up
to me and said, ‘I really can’t see why you are leaving all
this to get married’.
I learnt a great deal from Archie. I think one of Archie’s
great strengths was, as Owen [Wade] was saying too,
that he introduced the concept of defined populations
that has never been surpassed. The other incredible
thing about Archie I think was that he had no personal
ambition. He was a scientist, he was interested in
finding things out, but he hated working things out. I
Figure 14: Residents of Rhoose Farm House, 1958.
L to R: Peter Oldham, Joan Kilpatrick, Martin Wright
holding his son, Sheila Wright, Stewart Kilpatrick,
Archie Cochrane, Mrs and Mr Barlow
(housekeeper and butler), and non residents,
Bill Briscoe and Mrs Briscoe. Seated: Pauline
Oldham with Harriet and Rosemary Barlow.
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was concerned at various levels with Archie over the
years in the studies of dust disease, anaemia,
hypertension, and all the other things that were done
both in the Vale of Glamorgan and in Leigh and in
Staveley.19 It was an exciting, interesting and pleasant
time. And, like Owen too, I learnt a great deal about
statistics from Peter Oldham, who was an incredible
chap who thoroughly enjoyed statistical work and all
that sort of thing. 
Archie, as you heard, became David Davies Professor of
Tuberculosis, but in 1969 he couldn’t stand academic
working and left. For my sins, I succeeded him in the
chair. I am afraid that I enjoyed it, but then I was a
clinician and a teacher, rather than an epidemiologist,
but I am entirely and sincerely grateful for all the
training and experience that I had at the
Pneumoconiosis Research Unit (PRU) and at the
Epidemiological Research Unit (ERU). They were
never to be forgotten and I am very grateful. 
Booth: But why Cochrane? What was his background
before he went to Wales?
Kilpatrick: Who’s the most recent reader of his
autobiography?20 I think the background essentially was
that he was a radical person, he was a thinker, he was a
double-first at Cambridge, and therefore was
intellectually very bright, he had experience of
tuberculosis, particularly in the prisoner of war camps
where he did a great deal of very good work and even
did some primitive controlled trials at that time. He
then went to America for a year to study tuberculosis. I
think it was the background of that and the fact that he
was a very wide-ranged thinking person that attracted
him to the PRU. I hope that answers your question. 
Professor George Davey Smith: I was just going to say
it shows the open mindedness of the [selection]
Population-based Research in South Wales
20
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Seminar Room at 4 Richmond Road, c. 1980.
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procedures, because the only publication on his CV at
that time was a paper in the International Journal of
Psychoanalysis in 1934 on the death instinct.21 One
wonders today what the MRC would make of
someone who turned up with a 16-year-old paper on
the death instinct.
Dr Peter Elwood: Can I comment on this high
response that Archie achieved? Some of it we used to
call Cochrane units and a survey with a 96 per cent
response rate would be one Cochrane unit and we
would try to increase the number of Cochrane units.
One of the ways that Archie used to stimulate and
challenge us was he would come up to a survey towards
the end in his Jaguar car and he would go to the
reception desk and he would ask for the bundle of cards
for refusals, the visiting cards for refusals. He would
take the bundle and he would say, ‘I’ll do some of
them’. He’d go out and he’d park his Jaguar car very
prominently outside the house of the first, or the
second, or the third, persuade one man to come. He
would drive that man into the survey, see him through
the procedure or whatever it was, and then say to the
rest of us, ‘I’ll run this man home, but I have got to go,
you finish off the rest.’ This was one of the ways that he
used to challenge us, ‘No difficulty, I’ll drop this man
off without any difficulty’. No matter how many he had
tried, he always brought in one.
Doll: Perhaps we ought to record how they did get the
last 5 per cent in one mine, and that was after having
discussed with the trade union representative and being
told that the only way to ensure it was by payment, and
I think he said it was 2s.6d. [121/2p] per man, I can
produce them for you. I think that was the sum and
Archie had to ask the MRC for that small sum of
money, and he brought in the last few per cent by
paying the trade union.22
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Figure 16: Professor Archie Cochrane,
aged  51, 1960.
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Wade: Archie never admitted that. I can never
remember any payments of that sort in any of the
collieries we visited when I was at the unit. Because of
the preliminary work, which Archie insisted that we do,
we had no difficulty in getting full cooperation from
the miners.
One of the problems in our surveys was that we never
knew the names of the men working underground.
When you went to a pit to X-ray the miners when they
finished work, we had the lamp number. When a miner
went underground he picked up his lamp from the
lamp room and the person in charge of the lamp room
knew which lamps were underground.23
Dr Julian Tudor Hart: I do want to come in because of
this question about the high response rate and the
miners and the unions. It really is quite important. I am
very surprised about the 2s.6d. story. Perhaps it’s true,
although it doesn’t fit in with anything that I have ever
seen or heard. I am very surprised at that story, but
certainly what was much more important was not the
last 3 per cent, but the first 97 per cent, and the reason
we had the first 97 per cent was certainly because
Archie had got round the National Union of Miners
(NUM), which was a very important force in south
Wales at that time, and if Dai Dan Evans had not been
persuaded that this was in the interests of the miners,
and that it wasn’t only for the cause of humanity –
which he actually cared quite a lot about – but also that
it also met the immediate needs of the miners and their
families, nothing ever would have happened. You
would have had a 3 per cent response rate, instead of a
97 per cent response, or whatever it was. I think this is
very important, because the fact that in the descendants
of the original Caerphilly population originating from
those days,24 you are still getting 85 per cent response
rates now in heroin-ridden valleys that are completely
demoralized compared with those days and the NUM
now doesn’t exist. That is an extraordinary feat and I
don’t think will be very easily sustained or repeated. 
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Figure 17: (above) A thermal precipitator used for
sampling the concentration of airborne dust,
designed by the National Coal Board, being 
checked by members of the PRU, 1940s,
(below) Sampling head.
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Elwood: Can I comment on Archie and the
randomized controlled trial, because I think Archie
had an enormous international effect in stimulating
people to do randomized controlled trials and of course
he later stimulated Iain Chalmers to set up the first
Cochrane Centre based on the overviews of
randomized controlled trials.25 Archie was very quick
to confess that he had never done a randomized
controlled trial but he stimulated everyone in the unit
to think in those terms, it was almost a religion at the
unit, and many, many others did randomized
controlled trials. But Archie did publish a delightful
paper that I am sure most people are aware of. ‘My
first, worst, and most successful clinical trial’26
described his experience in the prisoner of war camp
with famine oedema. His output measurement was the
buckets of urine that were carried out from the
different wards. I would just like to tell a little fact
about that. Archie talked about it occasionally to us in
the unit, but I asked him if he would address a
meeting. I had arranged a conference on some topic,
and I invited all the speakers and a few key people to a
dinner the evening before, and when I did this I
usually asked somebody to give a talk on something to
entertain the guests after their dinner. I asked Archie
on one occasion would he tell us about his experiences
in the prisoner of war camp and about this controlled
trial, and he agreed with very great reluctance. As he
told the story and spoke about the horrific conditions
in the prisoner of war camp he almost broke down
emotionally. He had very great difficulty in finishing
the story, but afterwards he came and thanked me. He
said, ‘You have helped me to get over that difficulty
and I am glad you did it’. Very shortly after that he
wrote it up and it was published in the British Medical
Journal,27 but that was the only controlled trial that he
did and he was very quick to confess he never himself
did a randomized controlled trial. 
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Tudor Hart: Could I just add something to that? I first
met Archie in 1946 – I think I had just got out of the
Army. I don’t know when he got back from the war, as
it was very difficult, people got held up for a long time.
On the whole, prisoners of war got back quicker, but I
imagine he got back in 1945. This was really quite close
to his coming home and I went as a student to a meeting
of the Socialist Health Association, which was the
Socialist Medical Association28 in those days, somewhere
in west London, and Archie was the speaker. He was
telling us all about his experiences as a prisoner of war,
and what was striking about this, it made a tremendous
impression on me, I really remember it very well and I
have forgotten most things from that time, but he
described it in a quite different way than he ever did in
anything that he has written, although perhaps not quite
so differently from what Peter is remembering. And I
had the same impression that this was a cathartic
experience for him to talk about it. The biggest messages
out of it were first of all the degradation that the
prisoners were subjected to as soon as they were taken
from Crete to Salonica, where they were systematically
terrorized by the Germans, everyone had diarrhoea and
so they were going all the time to the latrines to shit and
the Germans would toss in hand grenades, just
randomly, from time to time. They had a hospital of
some sort, with a staircase with windows along the
staircase, and as health personnel and patients were
taken up and down these Salonica stairs, again randomly
from time to time they were sniped at and shot as they
went up and down these stairs. This was happening in
this reception area in Salonica before the prisoners were
dispersed to their destinations.29 The big point that
Archie made was how every nationality and racial group
was given a place in a hierarchy, a pecking order with the
Americans at the top and the British immediately after
the Americans, and then all the way down to Poles and
then finally Russians. This also is a perception of order
and Archie was interested in the ordering of things. I
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think he eventually was glad to forget about all this or at
least never to bring it up again. At that time he really did
want to talk about it. I think it is difficult for people
now to grasp really how different our view of the world
is now than it was in the 1950s and the 1960s, and that’s
part of the whole bundle that we are talking about.
Booth: I just have a comment and a question that
relates to Archie Cochrane and his reaction to his very
painful experiences during the war. There’s a very
interesting interview which some of you may have seen
with Archie Cochrane at the Royal College of
Physicians collection of videotapes of individuals.30
There’s no question he just broke down completely on
that videotape and cried when he talked about these
awful experiences in Macedonia, I think it was. It
certainly made an enormous impression upon him.
My question was who were the people at the MRC who
supported this unit? Because no unit survives within the
MRC unless it’s got good referees who are saying, ‘This
is good work’ and so on and have made quinquennial
reviews, obviously there are some very important
people. My question really is to try to see if there was
any link between Bradford Hill’s position in
epidemiology in the country at that time and what the
unit was doing, because I know he had a very close
relationship with Sir Harold Himsworth, in fact
Himsworth got him elected as the first non-medical
Fellow of the Royal College of Physicians [1963], so
one wonders the extent to which other people in this
field were in fact influencing the MRC at that time?
Dr Joan Faulkner: I am really not sure. Certainly Sir
Austin Bradford Hill supported this unit and others in
similar field, but going back before Himsworth, Sir
Edward Mellanby was very interested in setting up the
units with a social aspect and I think Sir Harold
envisaged that. A lot of the units, like toxicology,
pneumoconiosis, social medicine, were set up during
Figure 19: Sir Austin Bradford Hill (1897–1991).
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Mellanby’s time31 and I think Sir Harold had the same
sympathetic attitude towards research that was going to
be of immediate value to people as well as to themselves.
Booth: Let me just add one other point. I entirely agree
with that point about the MRC and Mellanby. Mellanby
tried to set up this unit following negotiations with the
MRC and the government of the day, particularly the
Department of Mines, I forget what it was, but it was a
government department much interested in the question
of what was going on in the mines. And Mellanby set up
a subcommittee under the chairmanship of Richard
Schilling,32 to identify a chairman or a director of a unit
in pneumoconiosis, and Richard Schilling told me that
he went back to Mellanby and said, ‘I am terribly sorry
we cannot identify anybody’. The following week he was
called to see Mellanby, who said ‘I’ve got the very 
chap, Morley Fletcher’s boy, he knows nothing 
about pneumoconiosis’. 
Faulkner: I am extremely grateful for what Chris has
just said, because I recall sitting in the tea place at the
London School of Hygiene where the MRC was housed
at that time,33 because its building had been blitzed, it
wasn’t bombed, but it was blown up, and a colleague
said to me, ‘Mellanby is interviewing Charles Fletcher.
You want to watch when he comes out, he’s the most
beautiful thing you have ever seen in your life’. Because
he was interviewing people in those days and at that
time, as I have said before, Mellanby was asking,
‘Would you like to do so and so?’
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Figure 20: Dr Stewart Kilpatrick, late 1960s.
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Doll: Of course, there was a social medicine unit set up
at that time too, under Jerry Morris.34
Booth: At the Central Middlesex.35
Kilpatrick: Again, Charles Fletcher, when he was
appointed, he felt he had been posted to some
outlandish part of Wales, had never really been there,
didn’t really understand it, and would only accept the
job provided he could have unlimited visits back to
London to the various scientific societies.
Doll: Unfortunately we haven’t got Bill Miall here, but
I would like to read something that he has written. It’s
quite a long account of his work at the unit and his
association with Archie.36
I think that brings us into the phase in which the
epidemiological group had broken away and developed
into a new unit.
34
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Figure 22: Dr Bill Miall, 1958.
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Booth: I think Charles Fletcher always used to make
the case that it was the unit work that showed the
importance of observer error37 and that was something
that was not accepted in clinical medicine. I mean the
average chap would tap out the heart and that was it. I
remember meeting Evan Bedford on one occasion and
telling him about some famous man and he said, ‘Yes, I
once examined his heart, absolutely true’. But, that’s all
he had examined. 
Wade: There is another member of the unit that no one
has mentioned and that’s Chris Wagner. He came from
South Africa and was a big influence. He was the
pathologist and certainly influenced both Peter Elmes
and me, because a lot of the work on asbestos troubles
with the shipyards that we did in Belfast was stimulated
by Chris Wagner. I never worked with him, because I
left long before he came. I don’t know whether anybody
else remembers him.
Doll: Chris Wagner was invited to this meeting, but
unfortunately couldn’t come.38 Would anyone like to
comment on Chris Wagner’s work? His initial work had
been done outside the unit, but he did develop it to a
very great extent in the unit.
Kilpatrick: I can say a little bit about Chris Wagner,
because I knew him well, I did some work with him. He
was instrumental really in the discovery of the
relationship between asbestos and mesothelioma.39 This
work was done originally in South Africa and he
continued it in the Pneumoconiosis Unit at Llandough
Hospital. He did a great deal of other dust work,
particularly in relation to asbestos, and he is and was a
contributor. I think he probably isn’t here today because
he hasn’t been very well recently.
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Figure 23: Miner working in 
a cramped position, 1940s.
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Doll: He was not actually a member of the
Epidemiology Unit.
Kilpatrick: No, he was a member of the
Pneumoconiosis Unit, not the Epidemiology Unit.
Dr Sheila Howarth: There was another lady down in
south Wales. I don’t know whether she impinged on 
the activities of the Epidemiology Unit, namely one
Alice Stewart.40
Elwood: We all know Alice Stewart and know her work,
and have a tremendous admiration for it. The only
contact I had was when she was very critical of one of
my studies, but otherwise to my knowledge she never
had any direct contact. 
Doll: She went to Oxford very early, after the war.
Tudor Hart: She [Alice Stewart] preceded the PRU.
She came down with the first sort of scouting forays in
south Wales with Philip D’Arcy Hart. She worked on
what happened to miners and so on.
Howarth: She was actually there when Charles Fletcher
was the Director of PRU.
Dr Hugh Thomas: Yes, we have actually got a list of all
the reprints of PRU from when it started in 1945, and
then of publications from about 1948 onwards,41 and
she was involved in some of the early publications,
partly linked to dust disease, but also to tuberculosis,
which was her interest there.
Wade: There are three other members of the PRU 
no one else has spoken very much about. Philip 
Hugh-Jones played a big part in the physiological work
of the unit. During the war he worked with the
40 
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Ministry of Defence. He almost died in a tank carrier in
Lulworth Cove, where had been testing the carbon
monoxide concentrations in the air in the tank-carrying
vessels when all the tank engines were started, as would
be the case when the vessel approach the landing beach
in Normandy. In the vessel he was inspecting the big
fans to carry away the tank exhaust which had been
installed the wrong way round so that the carbon
monoxide was routed back into the tank carrier. Philip
developed methods of measuring the transfer of gas
from alveoli of the lung to the blood in the pulmonary
capillaries using carbon monoxide in very dilute
concentration. Philip was a very enthusiastic if rather
excitable man who contributed a lot to the unit.
John Gilson had worked at Farnborough for the RAF
during the war on a number of physiological problems
and was older than most of the rest of us. He gave
enormous support to Charles Fletcher in dealing with
mine owners, trades union officers and later on with the
Coal Board. You will remember when Charles Fletcher
left the unit to return to London, it was John Gilson
who became the Director of the unit.
One other comment that is relevant to our survey work
was a problem with chest X-rays. Now I forget the
name of our radiographer [Mr Clarke], but two chest
X-rays could be taken of the same patient and one
would look hazy showing evidence of early
pneumoconiosis and the other would be much clearer
and normal. The reason for this was that the definition
of a radiograph is related to the number of peaks of
alternating voltage that occur during the very short
exposure time. Our radiographer modified the X-ray
machines so that the current always switched in at
exactly the same phase of the alternating current, so
that in identical exposure times there would be the
same number of peaks of current voltage. This was
important because so much of the work of the unit
depended on an accurate assessment of the degree of
radiological change caused by pneumoconiosis.42
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Figure 24: Dr John Gilson (1912–89).
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Philip Hugh-Jones
After the war I decided, having
got that far in medicine, I ought
to do the Membership [of the
Royal College of Physicians], the
MRCP, and to go back and do
some house jobs. I had only done
one house job. And I went to Sir
Edward Mellanby, who was the
Secretary of the Medical Research
Council, and I said that I would
like now to stop doing this sort of
research and do some other
junior hospital doctors jobs 
and so do the Membership
examination. Mellanby’s reaction
was extraordinary. It was as if I
had said something obscene. He
jumped in the air and banged
the desk and said, ‘Wasting your
time as a good researcher doing
these stupid exams, no.’ And he
opened a drawer and flung
medals across the desk and said,
‘You will get things like that if
you get on and do some research,
you just go down to Cardiff, we
have got a big problem on there’.
I think I just said, ‘Yes, sir’. This
was how I first met Charles
Fletcher and went to the
Pneumoconiosis Research Unit.
One thing Charles Fletcher
did was to keep everybody keen.
He was a wonderful PR man
with the miners; he couldn’t have
been better, and he was very
concerned, as a clinician, for
their welfare, as his subsequent
work with relationships between
doctors and patients showed.43
He was a very warm human sort
of person, very bright and very
competent. I don’t think Charles
was a scientist as such, I don’t
think I ever think of him as that,
but he was a very surprising
person because, as you know, he
had been up at Eton and was a
Cambridge rowing blue at
Trinity, was to have been the
great consultant, and the last
person one would think would
ever have gone down to south
Wales. He packed up all that and
took on this job on Mellanby’s
recommendation. But he did it
with superb skill and created a
very, very good team. He was a
delightful person and he
acquired very good people
working around him. Everybody
had a great loyalty to Charles.
Charles Fletcher employed
John Gilson and me as combined
clinicians and physiologists. John
Gilson had been doing similar
work to mine, but with the RAF.
Similarly I think as a civilian in
the RAF, but doing physiological
work on the design of clothing
and all sorts of odds and ends.
John Gilson and I were faced
with the problem of assessing the
breathlessness of the south Wales
coal miners. The generally
accepted and only lung function
test then available was essentially
the ‘vital capacity’, which had
been going since 1875, that sort
of time. I have forgotten when
Hutchinson published his
paper,44 but it was in general use
in medicine. We set about trying
to do other things. First of all, we
looked at the possibility of
measuring the total volume of gas
in the lungs, which at that time
the Americans were doing by
getting patients to breathe oxygen
in and out of their lungs and
measuring the rate at which the
nitrogen originally in the air in
the lungs was washed out. From
that you could calculate what the
volume in the air must have been
by the serial dilution of the
nitrogen. It was a cumbersome
and tedious method and we
decided to use a closed-circuit
method instead. In this patients
re-breathed round a close-circuit
spirometer with their carbon
dioxide being removed by a
cylinder containing caustic soda.
Oxygen, with a small amount 
of helium, was in the gas
apparatus. We then measured the
change in concentration of
helium using a catherometer
which did the measurement by
the cooling ability of the helium.
John Gilson made the
catherometer himself, which I
thought was very impressive. He
coiled up a fine platinum wire
and put it into a metal block so
that the helium concentration
was then measured by its cooling.
We did publish that method
separately, as a way of measuring
lung capacity.45 I don’t know
whether we were the first to do
that or not, but it was an early
way of doing it, and has since
become one standard method. 
Having done that, we then
decided that we would like to
know how much miners could
pant as one way of assessing their
breathlessness relative to their
chest X-ray. We used a rather
cumbersome method, which was
the only way we knew, of getting
them to pant in and out of one of
those big Douglas bags,46 but
using a valve just to catch only
the expired gas. Thus, we
measured how much air they got
out of their lungs when they were
panting as hard as they could
over 15 seconds (maximum
voluntary ventilation). We used
to say, ‘Go on pant, pant’. It was
43
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almost as tiring for us as for the
miners. We suddenly realized
that one breath was very like
another and if we measured one
breath and multiplied it by a
rate factor, we ought to be able
to get the right answer for their
maximum possible ventilation
more easily, but it never
correlated well with the Douglas
bag results. It was left to a very
bright Frenchman called Robert
Tiffeneau,47 who realized that
the actual stroke volume of the
breath is not the vital capacity,
it’s much less than that, and is 
a fixed proportion of about 
70 per cent of the vital capacity
in normal subjects (he called 
his test the Tiffeneau index, 
I think). We subsequently
renamed it the forced 
expired  volume.48 It is most
extraordinary that this has
become such a universal test,
though it was Tiffeneau’s bright
idea and not ours. It was rather
like when I worked in the army,
I went to a textbook, thinking I
could find out how much a man
could push on a pedal, for
example at maximum effort,
and finding no information, but
had to set about finding out.49 
But, we did not think of a
good way of measuring gas
transfer into the lungs until
Professor F J W Roughton, the
grand old man of physiology,
came to visit us, and said, ‘Oh,
you want to use carbon
monoxide’. That was a very
bright idea, because Marie
Krogh had done it for measuring
the diffusion capacity or
diffusion constant of the lungs.50
In fact, various people came to
see us and thought it a wonderful
idea so published it before us,
which was rather irritating.
That too has become a standard
method of measuring the gas
transfer in the lungs.
Stemming from the applied
work we did, three essential
parameters of lung function were
developed in the PRU at that
time and have all been in use
subsequently – the measurement
of the total lung volume and its
subdivisions, maximum breath-
ing capacity, and carbon
monoxide transfer. The Medical
Research Council published the
results of our research over about
five years in a Green book,51 so
called because official HMSO
reports had green covers at that
time. We realized during the
preparation of that report that if
you measure vital capacity you
were measuring partly what 
was measured as maximum
breathing capacity now derived
from the FEV [forced expiratory
volume]. None of these tests were
pure tests, but they interacted
with the others. We couldn’t
think how to sort out this
difficulty, but Peter Oldham,
who was the unit statistician
then, produced a model of a
factor analysis which appears in
the Green book. This analysis
showed the extent these different
tests of lung function measured
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Figure 25: Douglas bag, c. 1930.
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the same thing, and to what
extent each was unique.
Computers weren’t around at
that time and I remember sitting
for hours in front of a Friedman
electric calculator, doing multiple
correlation coefficients, between
all the tests on all the subjects. It
took me days on end, not just
hours. At the end of the war I
wrote to the Medical Research
Council asking for a Friedman
calculator because of the research
work I was going to do. I had to
put in a special grant for it before
it was approved. Now I could 
go to Woolworths and buy an
equivalent calculator for about
£3. It’s staggering what has
changed in electronics.
Charles Fletcher and I, and
John Gilson, also had charge of
the ward for the miners, and
although I didn’t have my
Membership [of the Royal College
of Physicians] at that time, I was
promoted to somebody of clinical
competence, but then went to
Oxford and by incredible good
fortune got the Membership from
a junior  registrar job. 
Stewart Kilpatrick
John Gilson, a very able director
who succeeded Charles Fletcher,
was more mechanically
interested at that time, I
suppose, in as much as he
constructed and made a
dishwasher machine for his
invalid wife from first
principles, a very able person.
His wife had been ill, but she got
better and is still surviving,
living in Devon. He was
interested in research,
particularly in respiratory
function, and published a
number of papers on that. He
was a very stimulating person
with whom to work, and the
combination of Charles Fletcher,
John Gilson, Archie Cochrane
and Peter Oldham, was an
environment in which I was
involved for some three or four
years and I learned a great deal.
I hope I contributed to a certain
extent as well, but I learnt a lot. 
I first met Peter Oldham,
funnily enough, with Kingsley
Amis, the author, in a pub in
Cowbridge. And then I went to
stay with Archie Cochrane and
Peter Oldham was a resident
there at that time. He was an
extremely able statistician, a
very pleasant person, and a very
interesting one, tried to help
people to do research and did,
but was quite prepared to put
people off if he didn’t think it
was a reasonable thing to do. A
very pleasant companion, he
died about ten years ago now.
These trials were instigated by
Bradford Hill, who was one of
Peter Oldham’s mentors.
Jeffrey Chapman
I joined the Pneumoconiosis
Unit in the early days of the field
surveys, and the first field survey
we did up at Haig Colliery,
Whitehaven, Cumberland, in
1949. My introduction to
pneumoconiosis was late on a
spring evening when it was
hissing down with rain and I’d
waited at the station at
Whitehaven for a very long time
to contact two people whom I
didn’t know but had heard
about. One was John Gilson and
the other was Archie Cochrane
and after waiting there for hours
the most decrepid prewar
Vauxhall came along and in it
there were two immense figures.
John Gilson you may recall was
an absolutely huge man. They
were both drenched in the
prewar car, the hood had broken
down and the rain was hissing
in. We then drove at what I can
only describe as a rate of knots
out to St Bees, near the Sellafield
Nuclear Station, where they were
staying. I had just come back
from Australia and then we
started the work up at
Whitehaven where, I think, that
wonderful thing, observer error,
tended to be born. And out of
that came a paper by Archie
Cochrane which showed that if
you were a smoker, as many of us
were in those days, then of the
people that you were
interviewing to take histories
from, you saw more smokers if
you were a smoker, whereas if
you weren’t a smoker, you didn’t
see as many smokers. I think that
was the sort of beginnings of
observer error.52 I think the first
British demonstration of it was
somebody who asked a series of
distinguished cardiologists in
London to percuss with their
fingers the left-hand border of
the heart, which is something
that all good cardiologists count
as one of their great skills. I think
ten were selected and it was
marked on the chest and there
were ten different left borders of
the heart.53
Bill Miall
So in 1951, ten years after
meeting Archie Cochrane in
Salonica [in the prison
hospital],54 I became his assistant
in the early days of epidemiology
in south Wales. The
Pneumoconiosis Research Unit
(PRU) was a very impressive
place in terms of its staff. Charles
Fletcher was its first Director
52
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[from 1945 to 1952] and had
collected together a team of
people covering a wide 
spectrum of interests – physicians,
phy s i o l o g i s t s , p a tho l o g i s t s ,
physicists, bioengineers, and
statisticians. John Gilson was
Deputy Director. John had been
at Cambridge with Charles and
during the war had been
investigating respiratory problems
of flying at Farnborough. When
Charles resigned the Directorship
and went on to be Reader and
later Professor of Clinical
Epidemiology at the Postgraduate
Medical School (later Royal
Postgraduate Medical School,
Hammersmith Hospital, London)
John Gilson took over the unit
[until 1976] and was an
excellent choice for a post, which
required someone with a wide
range of interests and expertise.
Archie Cochrane came third in
the hierarchy at that time. He
had also been at Cambridge and
may have overlapped with
Charles there. Two others playing
leading roles were Peter Oldham,
an excellent statistician, and
Martin Wright, an equally bright
pathologist, who was always more
interested in bioengineering than
in pathology.55
Stewart Kilpatrick
Archie was a very interesting
person. He was an atheist. He
was a heavy consumer of
cigarettes, he enjoyed a drink,
though not in any way
excessively, he was very fond of
foreign travel, he had a sister,
(Helen Stalker, d. 2002), in
Galashiels in Scotland. She
developed porphyria and Archie
Cochrane went up when he
heard his sister was ill, and when
they made the diagnosis of
porphyria he decided he would
like to know a bit more about it,
so he bought all the books he
could on the subject, looked up
all the articles on it, and then
did a study of his family tree in
relation to porphyria,56 which
took him all over the world, and
he got specimens from all over the
world. He was a great reader, he
was a great thinker, he was a
very good and meticulous
research worker – he enjoyed
doing research, but didn’t like
writing up the research work that
he did, he couldn’t really be
bothered about that. He was
fortunate in being of independent
financial means. I think that he
suddenly realized when his
grandfather’s will was read out
that he never need again fill in
the stub of any cheque that he ever
issued. Independent financial
means, not extravagant, except
perhaps in cars: he used to drive
a large Jaguar car which he
enjoyed very much, and I always
remember the second Jaguar he
got, he was in Llandough
hospital and a girl said, ‘I have
come to deliver your Jaguar, here
are the keys’. He said, ‘Thank
you very much’. She said, ‘Well,
aren’t you going to go and look at
it?’ And he said, ‘I will see it
when I go home’. Completely off-
hand in relation to that sort of
thing. His house in Rhoose was
very pleasant and had a very
lovely garden. He didn’t know
very much about gardening, but
was prepared to take advice,
some of which he got from my
wife. He had a servant and his
wife, who looked after them, and
looked after the house and
garden and the swimming pool,
where we used to go and see him.
[See Figure 14] On occasions he
was a slightly selfish man, very
critical and could be rude and
abrasive if necessary. It didn’t
worry him. But in some ways he
was, I won’t say undependable,
but slightly problematical. I got
on with him very well, because I
think we were on the same sort of
wavelength, possibly because we
were both Scots.
Sheila Wright
I was terribly disillusioned
when I actually met Archie
Cochrane. I had heard about
this beautiful boy, this very
handsome man who went off to
the Spanish Civil War, when I
worked for Dick Cohen, who
had known him as a young man
at Cambridge, along with C P
Snow, there was a whole lot of
them there at the same time. I
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Figure 27: Archie Cochrane, 1940s.
Figure 26: Dr Martin Wright
(1912–2001).
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had this image, then when I met
him, his face had fallen in and
he’d lost all his teeth as a
prisoner of war, though of course
they had been replaced. He was
terribly haggard, and he looked
about 50, though of course he
wasn’t. Of course, he was
tremendously lively. 
Philip Hugh-Jones
Just after the 1955 report 57 on
lung function, Dr Martin
Wright was appointed to the
unit. He almost eclipsed John
Gilson in his engineering ability
and ideas. He decided that even
the measurement of FEV could
be improved if one could measure
the actual peak gas flow during
exhalation instead of a volume
related to time. With this idea in
mind he designed the peak flow
meter.58That test too has become
of almost universal clinical use
and later developed into the
breathalyser.59
Stewart Kilpatrick
Archie Cochrane’s relationship
with the miners was particularly
good. He was very particular. 
He worked fairly closely with 
the National Union of
Mineworkers, who were initially
a little suspicious of it 
all, but eventually Archie
persuaded about 99 per cent of
the people to get X-rayed, history
taken, and all the rest of it. And
the relationship with Charles
Fletcher and the miners was very
good. My only regret at that time
and subsequently was that the
PRU wasn’t more closely
associated with the Cardiff
Medical School, University of
Wales College of Medicine. Why
this was so, I don’t know. I think
partly, a lot of the PRU people
lived on the west side of Cardiff,
whereas the medical school was
in the centre of Cardiff, and they
didn’t particularly want to go
into Cardiff, and they had a
loyalty to Llandough Hospital,
which was perfectly
understandable. The other
problem that Archie and
Charles Fletcher had was
that the relationship with
Professor Gough was not
necessarily very good. He was
the Professor of Pathology, an
opinionated, very able man,
but not an easy man, and he
and Archie Cochrane and
Charles Fletcher didn’t get on
very well together, which was a
pity. This relationship with
Cardiff and local researchers got
a little closer when Archie
Cochrane and Harold
Scarborough, who was Professor
of Medicine then, and myself as a
research fellow, did some work on
anaemia and hypertension and
coronary artery disease. So there
was a closer relationship at that
time.60
Bill Miall
I came in when the Little
Rhondda [Rhondda Fach, the
smaller of the two valleys] had
been X-rayed for the first time
and the X-raying of the miners
and ex-miners in Aberdare valley
was still to be done. Archie 
had recruited a team to help
with the survey work. Some, like
Gwilym Jonathan, Hugh Bates, 
57
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Figure 28: Using a spirometer to
measure lung function in the 1950s.
Figure 29: Hollerith card (left) and
sorting machine (right), 1940s.
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and Tom Benjamin,61 were ex-
miners living in and well known
in the valleys; their role was
particularly to persuade folk to
collaborate, usually by visiting
them at home. Response rates of
less than 90 per cent were not
acceptable. Others were chosen
for different skills. Fred Moore,
for example, was a male 
nurse who was obsessionally
accurate and meticulous about
keeping orderly records. At that
time Archie and I were the 
only medics. 
From the early 1950s we
recognized the potential of the
Rhondda Fach as a field for
epidemiology research into 
other conditions which could 
be accurately defined and
reproducibly measured. Having
the Rhondda Fach population
defined by private census and on
Hollerith cards – the nearest
approach to computerization in
those days – we were in a
position to obtain representative
samples of the general population
and become involved with
research into other conditions.
This was in the very earliest days
of chronic disease epidemiology
as it is currently known.
Philip Hugh-Jones
Dr Archie Cochrane joined the
team shortly after Alice Stewart
had left. Cochrane had a very
penetrating mind and was
meticulous in his work and, as
an epidemiologist, he pointed out
that it was important to study
not only those who came up 
to hospital complaining of
breathlessness and had an X-ray
taken (when it was assumed that
their breathlessness was related to
the spots on the X-ray, if present),
but also those still working in the
mines, as some of them might
well have the same spots on their
X-rays, but had no breathlessness.
This was found to be the case.62
Bill Miall
It was very non-medical work in
a way. I was busy learning how
to read pneumoconiosis in chest
X-rays, interviewing miners,
Welsh miners, and my job largely
was, apart from the X-ray
reading, going round the houses,
interviewing those who had
abnormal X-rays, or who ought
to be recommended to go for
compensation. I was doing that
sort of thing for a year or two
and then we were increasingly
realizing that the facility of
having a general population all
censused [counted and their data
recorded] on what were then
Hollerith cards, or punch cards.
It was an opportunity to look at
other diseases apart from miners’
chest diseases.
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Bill Miall
I was keen to start studies of the
factors influencing blood
pressure, and we consulted with
George Pickering and Fraser
Roberts about them. It was about
this time that a heated debate
was starting between Robert
Platt and George Pickering
about the nature of essential
hypertension.64 Platt took the
view that essential hypertension
was a discrete entity transmitted
by a single gene and therefore due
to one specific biochemical
disorder which you either had or
you didn’t have. Pickering
believed it represented no more
than the upper end of a
continuous distribution of blood
pressure and was influenced by
many factors, of which one was
polygenic inheritance. One of the
difficulties faced by both Platt
and Pickering was that they had
to start their studies with
hospital populations and chose to
study patients selected as having
blood pressures above some
arbitrarily selected threshold. We,
with access to more representative
populations, were in a position to
study people, and their families,
who were not selected in that sort
of way. This is not the place to
describe the findings in details,
but in general this and later
studies strongly supported
Pickering rather than Platt.65
Julian Tudor Hart
I think for archive there was also
an element that was political
and social, also to do with the
1945 election and postwar
expectations in Britain, which
were very different from
America. In America the Cold
War was already going on. Very
early on, the Cold War stopped
the liberal social programme in
America, which never since has
managed to get round to
providing a health service for the
whole of the American people. It
all got tied up with hostility to
social ways of doing things,
collective ways of doing things.
Already collectivism was equated
with communism, and they were
looking for individual solutions
for everything. We weren’t like
that. So I think that had an
effect early on. It is of course true
that if you focus on
pneumoconiosis as a topic, then
you are going to go to an
industrial working class area
with a militant political
tradition. For me, I saw in
Pickering’s work an opportunity
to apply my political ideas to
clinical medicine as a medical
student; my politics was more
important than medicine, and it
still is. Politics, in the sense of
changing the world, is an overall
context within which medicine
operates, so in that sense it is
more important. I had wanted a
way to be a useful person,
politically changing the world
while actually doing something
useful with my hands. I always
wanted to be a GP. I assumed I
could never get to be a consultant
anyway, because I assumed that
you would get shut out from that
area of work if you were
political. Quite correctly too,
people like me who did try to
become consultants, for example
Ian Gilliland and Michael
Tempest, had a terrible time
getting jobs. I had very primitive
ideas about being a kind of
tribune of the people.
Stewart Kilpatrick
I think again one of Archie’s
strengths was that he had
carefully defined populations
which he used. These have not
been quite so strictly viewed
recently, but by and large people
in Wales have got to know about
studies and surveys, and I think
that on the whole are prepared to
take part in them. At one time
somebody said look can you
extrapolate from the studies in
Wales to the rest of England, the
rest of the country, and I think
the answer is yes.We did studies
in hypertension, anaemia, and
other things in the Rhondda, in
the Vale of Glamorgan, in
Wensleydale, in Annan, in the
south of Scotland, and in parts of
the Midlands, Staveley, and on
the whole these were reasonably
comparable, so I think the
studies should continue in Wales,
and I would like to think that
they would.
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1954–58 Blood pressure and respiratory surveys63
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Chart 1: Studies done by the MRC Epidemiology Unit (South Wales), 1954–1990
1954–58 Respiratory surveys  – Rhondda; Leigh, Lancashire; Annandale,
Vale of Glamorgan, Staveley, including the first ECG surveys
1954–56 Blood pressure surveys – Rhondda and Vale of Glamorgan
1963–65 Glaucoma surveys
1964 Industrial workers’ studies – flax, asbestos, steel 
and slate workers
1964–69 Iron deficiency anaemia studies – observational 
and intervention studies
1965–70 Headache and migraine studies
1965–70 Renal disease
1966 Respiratory survey: Staveley follow-up
1969–79 Aspirin trials
1972–79 Barry–Caerphilly child growth study
1973 Asthma studies
1976–78 School milk supplementation study
1976–82 Environmental lead studies
1979–ongoing Caerphilly cohort study
1983–89 Diet and reinfarction trial (DART)
Table circulated at the Witness Seminar, 23 March 1999
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Doll: I think it’s about time we moved on to the second
phase of epidemiological work there and this was when
Archie broke away and had his own epidemiological
research unit.
Dr Jean Weddell: I joined, well I didn’t join, but I
started working at the unit in 1964. It was when I was
[a patient] in the Orthopaedic Hospital, Cardiff. I was
asked to help to code the Vale of Glamorgan blood
pressure study. I then joined the unit, working as a
junior research assistant on cervical cytology, the whole
city survey, which at that time was really making
history.66 I then got involved in the randomized
controlled trial of treatment for moderately raised
blood pressure. Then David Bainton and I did pilot
surveys of medical care given to stroke patients, and I
did some work on varicose veins.67 The unit was great
fun. By then its reputation was established. We had a lot
of visitors from all over the world, it was really exciting,
very stimulating and great fun.
Booth: One can understand why they wanted to recruit
you [Jean Weddell], because you had a pretty good
reputation by then.
Doll: There was quite a lot of discussion with the MRC as
to whether or not he should have a epidemiological unit.
I think Dr Faulkner will remember a good deal about how
this happened if I might ask her to contribute?
THE MRC EPIDEMIOLOGICAL RESEARCH UNIT 
(SOUTH WALES), 1960–74
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The city of Cardiff had a population of 350 000 and was considered by Hubert Campbell, Archie’s statistician
and later Professor of Medical Statistics at the Welsh National School of Medicine, to be a suitable sample for the
cervical cytology survey, funded by the MRC and the Department of Health, and headed by Dr Joyce Landsman
in 1965. See note 20, 202–204.  Dr Jean Weddell wrote: ‘I worked on the cervical cytology study, then on anaemia
in Wales, followed by a randomized controlled trial of two treatments for varicose veins, surgery and injection
compression treatment. This included comparative costing of the two methods by David Piachaud. I also carried
out a pilot study of care given to stroke patients. I worked first in Cardiff and then at St Thomas’ Hospital,
London, on the two-centre study of control of moderately raised blood pressure.’ Letter to Mrs Lois Reynolds, 
15 March 2000.
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See page 51 for details of moderately raised blood pressure. See also, for example, Piachaud D, Weddell J M.
(1972)  The economics of treating varicose veins.  International Journal of Epidemiology 1: 287–294. Chant A D H,
Jones H O, Weddell J M. (1972) Varicose veins: a comparison of surgery and injection/compression sclerotherapy.
Lancet ii: 1188–1191. Piachaud D, Weddell J M.  (1972) Cost of treating varicose veins.  ibid: 1191–1192.
Figure 30: Number 4 Richmond Road,
Cardiff, the home of the Epidemiology
Unit from 1962 until it returned to 
Llandough Hospital, Penarth, Cardiff, in
1990. Archie Cochrane’s epidemiology 
course run for the Welsh National School 
of Medicine had vacated the house in favour 
of more appropriate space at Sully Hospital.
68 
Separate unit proposed in MRC 59/786 above, confirmed by the Council on 22 April 1960, having considered
‘Proposed Epidemiological Research Unit’, MRC 60/541, 13 April 1960. See also Minute from Dr J Faulkner to Sir
Harold Himsworth, 18 November 1959, PRO FD7/1046. The unit’s proposed staffing was for two scientific and
technical staff, five administrators, including one health visitor. See note 20, 176–178; 187–189. See also Jones H.
(1989) Industrial health research under the MRC, in Austoker J, Bryder L. (eds) Historical Perspectives on the Role of
the MRC: Essays in the history of the Medical Research Council of the United Kingdom and its predecessor, the Medical
Research Committee, 1913–1953. Oxford: Oxford University Press, 137–161.
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See extracts, notes 107 and 108, on page 66.
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The Council of the MRC
agreed in April 1960 that the
epidemiological work of the
Pneumoconiosis Research
Unit (PRU) should be
developed in a separate unit
under the direction of
Professor A L Cochrane.
The PRU remained at
Llandough Hospital, Penarth,
Cardiff, and the Epidemiological
Research Unit (ERU, later EU)
was expected to move to a
new £25 000 building at the
Sully Chest Hospital, Penarth,
but remained temporarily at
Llandough until 1962 when it
moved to 4 Richmond 
Road, Cardiff. On the scientific
staff were Archie Cochrane,
Ian Higgins and Bill Miall, with a
seven-member survey team
and clerical staff. Additional
staff included an epidemiologist,
a sociologist, a statistician, a
chemist, a photographer, and
two clerical staff, sharing the
Administrative Officer, the
radiographic and mobile
equipment and staff with 
the PRU.68
Faulkner: I remember going down [to south Wales] after
Archie had got the chair and this was a good enough
reason for separating off a unit to cover the
epidemiological aspects of what was going on in the PRU
then. There was also a certain amount of friction
between Archie and John Gilson. They were very, very
different people – equivocal mercurial Archie, and a
rather staid John Gilson. I loved them both dearly, but
the move took a certain amount of organizing, because
of Archie’s nature and the demands he made when the
Council agreed to do it. First of all, he wanted a huge
building put up and I forget how many staff, 33 or 40 or
something like that, and it was eventually whittled down.
He thought Dick Cohen and I were particularly mean
administrators. But I think that’s really all I have to say
about that time when the change was taking place.69
Wade: Can I just ask how many staff did he finish 
up with?
Figure 31: MRC 59,
16 October 1959.
PRO FD7/1046.
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Faulkner: I think it was about 15, I am not sure, but it
is in one of the MRC annual reports. Ian Higgins,
Archie himself, and Bill Miall were the three medically-
qualified people,70 and then there were a whole group of
interviewers and secretarial staff. There was a lot of
discussion about a pathologist, because there were
things like blood lipids to be done and Archie wanted a
first-class research biochemist and when we asked him
why he wanted this – because it wasn’t really a job for
such a person; what kind of stimulus was this chap
going to get? – he replied, ‘Well, it will be much nicer
for me to have someone like that to talk to’.
Doll: Good enough reason. It actually did need in those
days a pretty good biochemist to get reliable results
which were repeatable on a separate occasion. Well, I
think, Julian Tudor Hart, you were in a pretty early part
of that period, I wonder whether you would like to give
us some more reminiscences?
Tudor Hart: Well I got there just before they moved to
Richmond Road and they were still at the PRU. I wasn’t
aware of these frictions, they all seemed absolutely weird
people to me. That was 1961. Rationing ended as far as
I remember in 1951 something like that,71 but they still
weren’t having any butter on their bread or jam for tea.
You just had this dry choice of white or brown stale bread
and some red stuff that you could put on it. All the rest
of the staff, this terrific team that Archie gathered round
(who ought to be better represented here today I think)
all those people ate proper human food, post-rationing
food in another room, or another part of the library. But
all these mean doctors, because that’s what it was, it was
just meanness, sat there eating their bread and ‘jam’, they
wouldn’t even have marge, and I asked John Gilson,
because he seemed the most approachable and normal
person, why this was so and he said, ‘I don’t know. Ian,
70
Bill Miall and Ian Higgins were Honorary Assistant Directors to Archie Cochrane, before Miall went to direct
the Epidemiological Research Unit (Jamaica). See Committee of Privy Council for Medical Research. (1962)
Report of the Medical Research Council for the Year 1960–1961. Cmnd 1783. London: HMSO, 12. By 1965, the
Annual Report listed eight scientific staff and one part-time administrator as senior staff, with A L Cochrane as
Honorary Director and W E Miall as Honorary Assistant Director. The Epidemiological Research Unit (Jamaica)
had six scientific staff, one of which was honorary part-time and the other a visiting worker. idem (1965) Report of
the Medical Research Council, October 1963 – March 1965. Cmnd 2787. London: HMSO, 159–160.
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why don’t we have butter?’ and Ian Higgins said, ‘Oh, I
don’t know.  Archie, why don’t we have butter?’ So they
all muttered like this, ‘Why didn’t they have butter?’
None of them could actually bring themselves to say that
it was because they had to pay for it. They had to pay for
it themselves, it wasn’t provided by the National Health
Service. I can’t remember what the upshot of it was. I
suppose eventually somebody must have bought butter.
So it was that kind of odd place and an awful lot of time
was wasted, a lot of it by me, but because of Archie’s
demands to be talked to and to have entertaining people
around. He did do an awful lot of that and I must admit
I felt that there was an atmosphere, there was a certain
amount of aristocratic dilettantism about research
altogether in those days. 
In fact, how I got the job seemed to be
rather like that. There weren’t any
interviews or anything like that, so I
remained rather an onlooker and a
bystander, not being terribly good at the
job anyway and finding it a great
disappointment, until I could work on my
own hypotheses later on. It was a very
good school, I think, for people entering
epidemiology because it was at that time
such early days of the discipline and nearly
all the people associated with it there
ended up being very important people
and very interesting people. But I didn’t
actually find the work enormously stimulating if you still
had a big interest in clinical medicine. I think it’s much
more interesting nowadays. There are much better
chances now for people genuinely to have both interests,
really to be clinical epidemiologists, than at that time.
There was within the unit quite a lot of reciprocated
hostility to clinicians, I think that was part of the
problem between John Gilson and Archie. I don’t think
it was just personalities, I think it was that the PRU
people were becoming more clinical and actually had
people on the wards and so on. Archie could be very
scathing about clinicians. Sometimes I think excessively
so. That was one of the reasons I left. They were a good
gang of people that Archie recruited, but they weren’t all
Figure 32: Receptionist during
an anaemia survey, c. 1968.
72
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miners. Tom Benjamin had never been a miner, I am not
sure whether Gwilym [Jonathan]72 had ever been a miner,
and certainly Fred Moore had never been a miner, but
they were all very plebian folk, they were very streetwise.
Doctors in general were extremely ignorant of the real
reasons that prompt people to do things or not do things
in those days, much more so than now. And Archie was
very cunning in employing people who were right at the
centre of gossip machines and had a really streetwise
approach to getting cooperation. He wasn’t a terribly
good team leader because he was often rather divisive in
his approach to managing a team, but he was very, very
good at perceiving talent in people without qualifications
or education. Other people who ought to be here are Bill
Clarke, whom Owen [Wade] was trying to remember in
the X-ray department, and Sheila Wright. Archie got a
lot of very high-quality supporting staff of all kinds. He
did infect everybody with obsessional attitudes to high-
quality data. You couldn’t live with yourself if you didn’t
do things very, very well for Archie. Some of that was
Figure 33: Gwilym Jonathan in full voice in the
Rhondda in the late 1960s.
Figure 34: Fieldwork team for a survey of anaemia, migraine and urinary tract infections led by Peter Elwood and Estlin Waters
(both standing, back row, far right), c. 1968.
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Fred Moore too. A terrible old woman, but exactly what
you needed in an epidemiology unit.
Doll: Well, I think Peter Elwood came in about then.
Would you like to say something?
Elwood: I joined Archie Cochrane in 1963. I would
like to pay tribute to John Pemberton. I learnt much of
my epidemiology from John Pemberton and I gained a
tremendous enthusiasm for epidemiology from him. I
had been in general practice, I did a diploma in public
health and was exposed to epidemiology during that,
and a name that came up very frequently was Archie
Cochrane. I joined a research team with John
Pemberton and worked on flax byssinosis74 and we did
what I think was a very fine survey and then we
followed it up 20 years later. But John Pemberton
suggested I should go over and see Archie Cochrane,
and see if there was a chance of working with him. 
I had also done, as a separate study from the main task,
a survey of anaemia in women in Belfast.75 I picked a
random sample from the electoral roll and I achieved 97
per cent in that survey and I know that that was one of
the things that endeared me to Archie Cochrane. We
differed on many things, particularly on religious
beliefs. We had a delightful two or three days. He took
me round everywhere. I stayed in his home and I had a
delightful time and I know it was because of the work
that I’d done with John Pemberton and this high
response rate that we had had, both in the flax survey,
which was an industrial population, but perhaps more
particularly in the random sample, a representative
73
See, for example, Graham P A. (1966) Screening for chronic glaucoma. Proceedings of the Royal Society of
Medicine 59: 1215–1220. idem (1969) The definition of pre-glaucoma. A prospective study. Transactions of the
Ophthalmological Society UK 88: 153–165. idem (1972) Epidemiology of simple glaucoma and ocular
hypertension. British Journal of Ophthalmology 56: 223–229.
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Elwood P C, Pemberton J, Merrett J D, Carey G C R, McAulay I R. (1965) Byssinosis and other respiratory
symptoms in flax workers in Northern Ireland. British Journal of Industrial Medicine 22: 27–37. McAulay I R,
Carey G C, Merrett J D, McClarin R H, Elwood P C, Pemberton J. (1965) A survey of dust concentrations in
flax mills in Northern Ireland. ibid. 22: 305–310. See also note 111, and Elwood P C, McAuley I R, McLarin R
H, Pemberton J, Carey G C R, Merrett J D. (1966) Prevalence of byssinosis and dust levels in flax preparers in
Northern Ireland. ibid. 23: 188–193. 
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Elwood P C. (1964) Distribution of haemoglobin level, packed cell volume, and mean corpuscular haemoglobin
concentration in women in the community.  British Journal of Preventive and Social Medicine 18: 81–87.
1963–1965 
Glaucoma surveys73
Estlin Waters
Peter Graham was the consulant
ophthalmologist. I was very much
a field worker. The survey
involved measuring intraocular
pressures and the detection of
glaucoma. I wasn’t really very
involved in that study and I
wasn’t involved in the writing up.
This survey was one of the many
Archie Cochrane was involved
with to establish whether
screening for various diseases was
scientifically justified.
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Hollows F C, Graham P A. (1966) The Ferndale glaucoma survey. In Hunt L B. (ed.) Glaucoma: Epidemiology, early
diagnosis and some aspects of treatment. Proceedings of a symposium held at the Royal College of Surgeons of England,
London, June 1965. Edinburgh: Livingstone, 24–44. idem A critical review of methods of detecting glaucoma. ibid.
103–115. See also Graham P A, Hollows F C. (1964) Sources of variation in tonometry. Transactions of the
Ophthalmological Society of the UK 84: 597–613.
sample, of the women in Belfast. So I came over to
Archie Cochrane shortly after that three-day interview
and one of the tasks I was asked to pursue was looking
at iron deficiency anaemia. I arrived at the unit when
the glaucoma survey was at its height [1963–65] and I
think we should talk about that a little, because Archie
was immensely proud of the way he was able to
stimulate the ophthalmic people in Cardiff to do a
survey. He did a magnificent survey, the Ferndale
glaucoma survey,76 which is still talked about, still
quoted by ophthalmologists. I think that Archie was
tremendously proud of it and rightly so, because it was
one of the first very big excursions out of the ivory
tower into clinical practice and they looked at a number
of conditions, but chiefly glaucoma and they then went
on with a randomized controlled trial. This got into
various difficulties, but was a very fine effort and Archie
was immensely proud of it. One of the things that I
valued Archie for was he allowed us to do our thing and
get on with it and he never seemed to have much team
work within the unit, he was very happy with me doing
work on anaemia and later on other things and with the
glaucoma team upstairs in the attic. We rarely met, even
when on survey in the Rhondda, I was seeing women in
connection with anaemia, and the other team was
Figure 35: Fieldwork team for a
large survey of more than 5000
women in the Rhondda Fach
conducted by Peter Elwood 
(far right), Ferndale Clinic,
c. 1965, with Fred Moore
(second row, far left), Estlin
Waters (back row, middle), and
Janie Hughes (front row, third
from right). See note 75.
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working on glaucoma. We termed the glaucoma team
the ‘B’ team, which rather irritated Archie. 
Professor Estlin Waters: After I completed my house
jobs in February 1960 my next job was as a Senior
House Officer at the Pneumoconiosis Unit. I took that
job because there was supposed to be, by reputation,
lots of time to read and work for other things; it wasn’t
a very busy clinical job. My job was to clinically care for
the patients in the pneumoconiosis ward, although I
was employed by the Medical Research Council. The
thing I remember most from that seven months is the
tea breaks. I can’t remember whether there was butter
on the menu or not, but I can remember the very
stimulating conversations between John Gilson, Archie
Cochrane, and Peter Oldham, particularly between
Archie Cochrane and Peter Oldham. Those tea breaks,
I suppose, changed my career, because I hadn’t planned
to go into research, but five years later I was offered a
post in the Epidemiology Research Unit by Archie
Cochrane. My credentials for that were probably even
less than Archie’s credentials for his job. At least he had
had a paper published in a medical or a psychological
journal.77 My only publications were on seals and birds;
I think Archie Cochrane was quite impressed that I got
up at dawn for a whole week to count the number of
wrens on St Kilda in the Outer Hebrides. I had hardly
any experience in medical research when I started at the
Epidemiology Unit in July 1965. I found the unit very
friendly and was given responsibility at a very early stage,
especially considering my lack of research experience. I
started off right from the beginning working on a
number of different topics with a number of different
people. I worked on chest disease with Archie Cochrane
himself.78 Most of my time, especially in the first few
years, was spent working with Peter Elwood on all the
various aspects of iron deficiency anaemia. I also started
some work with the people at the Cardiff Royal
Infirmary, particularly Max Sussman and Bill
77 
See note 21.
78 
Professor Estlin Waters wrote: ‘Ian Higgins flew over from the USA to supervise the 1966 follow-up study at
Staveley, Derbyshire, but I was largely responsible for the day-to-day organization of this survey.’ Note on draft
transcript, 26 May 2000.
Figure 36: The south-west coast of Hirta,
the main island in the St Kilda group, where
cliffs tower to over 1100 feet and many
wrens (Troglodytes troglodytes hirtensis)
nest among the boulders.
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Asscher 79on urinary tract disease, especially bacteriuria.
Peter Elwood suggested that I should develop a subject
of my own and very kindly handed over a study that he
had just started on headache and migraine. 
I worked on migraine throughout my time in the
Epidemiological Research Unit until September 1970
and for about the next ten years after I left for
Southampton University, but I am very grateful to
Peter for all that he did during the time that I was at
the unit, but particularly for giving me the
encouragement to start this topic on my own. I think
this shows that there was no fixed pattern as to how the
unit was working at that time. Some of the work was
done in cooperation with clinicians and my work on
urinary tract disease would be an example of that.
Other work was almost entirely confined to people in
Figure 37: Fieldwork team 
for another anaemia study
conducted by Peter Elwood 
(far left), Ferndale Clinic,
May 1968, with Marion Jones 
(white top, front row) next 
to Fred Moore, Janie Hughes 
(in front row), next to Estlin
Waters (far right).
Population-based Research in South Wales
48
the unit and, as Peter [Elwood] has mentioned, to
particular people in the unit.
A number of distinguished visitors came to the unit at
about that time.80  I can remember many of these people
and it was an honour and thrill to take them up to the
Rhondda to show them around. One of the things I
remember was taking them to lunch in a café in the
Rhondda Fach called Myrtles. At that time pit-head
baths were not universal and when these eminent
scientists from around the world came to sit in Myrtles
very often they would be joined by miners up from
their shift underground, their hands, face and clothes
still covered in coal dust. It probably wasn’t the sort of
visit that they had anywhere else.
Mrs Janie Hughes: I joined the MRC Epidemiological
Research Unit in 1964 and, surprising to say, I must have
enjoyed the time because I am still working for Dr Elwood
now, even though I retired from MRC two years ago.
Professor Cochrane was the Director when I joined, but I
had very little to do with him. He was popular as an
overseas speaker and he entertained us with the things that
happened. I must say more things happened to Prof.
Cochrane when he was abroad than to anybody else since.
He got his passport stolen, he was accosted in lifts, he lost
his luggage every single time he went abroad. I have always
worked for Dr Elwood and we probably will be working
together when we are both on our Zimmers. But we were
a very happy unit. I think people are astonished when I say
we were like a family, we were really very happily working
together. Very recently I have been working part-time for
a local health authority and apparently one of their criteria
when they asked me to join them was that I was
epidemiologically trained (whatever that might mean),
and as Dr Tudor Hart said, I did have an interview when
I joined, but I wonder now how I ever got the job. I had
no training whatsoever in epidemiology or anything to do
with medicine, but Dr Elwood was a great encourager as
he likes to call it. I didn’t call it that at the time, when just
80
Professor Estlin Waters wrote: ‘When travelling, there was a paradox between how little was known about the
Epidemiology Unit in Britain and the mention of the unit or Archie Cochrane abroad – at least in the late 1960s
and 1970s – was a passport to recognition, even envy. Abroad, it was amazing how many people one met had
stayed in Archie’s Rhoose home. But I met a selected sample of people!’ Note on draft transcript, 26 May 2000.
Figure 38: Janie Hughes (left) 
as receptionist in an anaemia
survey, c. 1966.
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after I had passed my driving test, I had to drive 40 miles
along the coast road to this obscure little place to join a
survey team, but I must say I have thanked him every day
since. He ‘encouraged me’ to administer some horrible
questionnaires to people, he encouraged me to knock on
doors late at night. In those days though people still left
their keys in the door – something that doesn’t happen
these days – and you’d knock on the doors in the Rhondda
valleys and they’d just shout, ‘Come in’. They all have
burglar alarm systems attached to them now. I have had a
very, very enjoyable work time and I think I can thank Dr
Elwood for most of that.
Professor John Pemberton: We did perhaps benefit in
those days from there being an absence of ethical
committees. [From the floor: We were perfectly
ethical.] In another study when we were getting
interested in anaemia, Peter [Elwood] and I thought we
were going to eliminate hypochromic anaemia from the
world by adding iron to bread.81 We started by
persuading the director of the mental hospital to allow
us to add iron to the bread of patients in various wards.
So some got extra iron and the others who didn’t were
controls. We went on increasing this iron in the bread
until it tasted so bad that we ourselves couldn’t eat it. 
Wade: One of the interesting differences between survey
work with the byssinosis and other asbestosis work that
Figure 39: L to R: Ann Chapman,
a haematology technician from
the local hospital, Janie Hughes
and Estlin Waters above the
Rhondda valley during the
anaemia study in Rhondda 
Fawr, 1967.
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Peter Elmes and I did in south Wales,82  and my later work
in Belfast was the names. I don’t think we realized how
difficult it was going to be when surveying miners in
south Wales where so many men had names like Jenkins,
Jones, Thomas or Williams. Archie solved this by
ensuring that every man X-rayed was also photographed
holding a board with his X-ray number and his name.
When the unit returned four or five years later to re-X-
ray that pit, it was possible to identify and radiograph the
right Mr Jones. Of course the miners all know each other
by Jones ‘longtuff ’ or Jones ‘big nose’ or some phrase of
that sort, but that wasn’t very useful to the survey team. 
Kilpatrick: I think probably one of Archie’s few failings
was that he wasn’t remotely interested in the career of
epidemiology or epidemiologists. He wasn’t interested in
administration, he wasn’t interested in academic
medicine, he didn’t enjoy the professorship as I told you,
he didn’t particularly enjoy being president of the Faculty
of Community Medicine, and I think this is a great
tragedy in a way, he could attract people to his unit, but
he didn’t see further than giving them any opportunity
for further training. This I think was a pity and that was
one of his few failings as far as I was concerned.
Doll: Dr Howarth, have you got any comments from
the MRC side at all about this work?
Howarth: I don’t think really I can contribute on this
one, because I had very little to do with the unit during
my time in the headquarters office. There is one
question that I would like to ask, and that is whether
the studies on hypertension in this unit led to
controlled trials in the 1960s, just when the new drugs
became available for the treatment of hypertension,
because it was very strong letters from Archie Cochrane
in the unit and from Colin Dollery at Hammersmith,
which persuaded the Council to set up the working
party, under the Chairmanship of Professor Peart, which
carried out the mammoth treatment trial of mild to
moderate hypertension, which Bill Miall in his spare
82  
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time is probably still analysing.83 But I really don’t know,
and it’s a question that I would ask from people in the
unit, whether in fact there were any such trials, and
whether this is what persuaded Archie to write his letter.
Weddell: Yes, we carried out a randomized controlled
trial of the control of moderately raised blood pressure.84
It was a combined trial, combined between the Cardiff
unit and the medical unit at St Thomas’. Our numbers
were much too small, but the data collected during that
trial actually formed the basis of the calculation for the
sample size of Bill Miall’s subsequent MRC mammoth
trial. There was no way we were ever going to get any
results at all out of our tiny one, but it did pave the way.
Dr David Tyrrell: I wanted to ask a question and make
an observation about the international impact of the
unit. I came across the unit in a way first of all when I
was in the USA and I met Ed Kass85 who was starting to
become interested in infections of the renal tract and
possible relationships with hypertension. He had to base
much of his work on patients coming into the hospital in
Boston. He amused me really, because he assumed I
knew everybody in Great Britain. He said, ‘Do you know
these people in Wales? There’s a man called Bill Miall and
he’s looking at hypertension in a population’. Later, of
course, he actually met and worked with Miall when they
did the same sort of thing in Jamaica.86 I think it was that
people who couldn’t do them were impressed with the
power of studies done on whole populations, and that
seemed to me to be something which drew them to study
what was being done at the unit and the methods used
and so on. I wonder whether I am right in that, because
Figure 40: Stories of iron tablets
being fed to the Rhondda sheep
are without foundation, despite 
this offering from Estlin Waters 
in the late 1960s.
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it was just an impression that I got. The people who saw
the visitors and took them up the Rhondda might be the
people who would know what they were really most
interested in and about the way the unit ticked.
Doll: Can anyone answer Tyrrell’s question?
Wade: There weren’t quite so many visitors to the PRU
when I was there in the early days. The work that
attracted attention later was the system of grading chest
X-rays, jointly developed by Archie Cochrane, John
Gilson and Peter Oldham.87 Each chest X-ray was
graded by a team of at least three people against
‘standard films’. There were four grades: normal, grade
1 pneumoconiosis, grade 2 pneumoconiosis, and
progressive massive fibrosis (PMF). The standard films
were in demand from all around the world.
Elwood: The iron deficiency studies that John
Pemberton mentioned in Belfast88 led to some questions
about the government policy then of adding iron to
flour. We found no evidence that the iron was being
absorbed and that alarmed the Department of Health
(the Ministry of Health at that time), and Dr Bill
Berry89 flew over to Belfast and interviewed us and
87 
Fletcher C M, Oldham P D. (1949) The problem of consistent radiological diagnosis in coalminers’
pneumoconiosis. British Journal of Industrial Medicine 6: 168–183. idem (1951) The use of standard films in the
radiological diagnosis of coalworkers’ pneumoconiosis. ibid. 8: 138–149. Ministry of Health, Joint Committee.
(1952) Standardization of Radiological Terminology in Pulmonary Disease and Standardization of Technique in Chest
Radiography. Report of a joint committee of the Joint Tuberculosis Council, the Faculty of Radiologists and the
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Berry W T. (1968) Nutritional aspects of food policy. Proceedings of the Nutrition Society 27: 1–8. Berry W T, Darke
S J. (1968) Vitamins in health and disease. Practitioner 201: 305–313. Greaves J P, Berry W T. (1974) Medical, 
social and economic aspects of assessment of nutritional status. Bibliotheca Nutritio et Dieta 20: 1–9.
Dr Peter Elwood wrote: ‘Dr Bill Berry was a very good friend and enormously encouraging. He had an interest in all
the nutrition work of the unit and very much against the procedures in government departments at that time. He
obtained funding from the Ministry of Health for our two-year randomized controlled trial of iron added to bread, also
for the trial of the effect of milk on infant growth and nutrition, including bearing the costs of the daily milk tokens
given to half the mothers, their infants and their other children, and he provided funding for the school milk trial. The
iron-enriched bread randomized controlled trial involved daily deliveries of bread to 300 homes. In order to enhance
compliance we gave a 10 per cent discount to the women at intervals. This involved Janie Hughes and Marion Jones
visiting the women and giving each a postal order, some for quite sizeable sums of money. A few of the women got wise
to this and started purchasing extra bread for friends and neighbours, and keeping the refund themselves. Others got
even wiser and refused to pay the bread delivery man, knowing that we would not put in the huge effort into the trial
and just let them be lost to the trial. Sure enough, we told the bread firm and the delivery man that they must deliver
the bread to these women and we would pay whatever bad debts accrued. When I submitted the accounts and
explained this item to Bill Berry he was highly amused. However his accounts department was not amused at all. They
had never before handled the item “bad debts” before!’ Note on draft transcript, 27 March 2002. 
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visited various people involved and so on. He was very
anxious to find some flaw in our work, because it was
government policy to add iron to flour. Shortly after
that I left the Belfast unit, but I never lost the contact
with Bill Berry. He was head of nutrition within the
Ministry of Health and we did a series of studies, paid
for in part by the Ministry of Health. It was most
unusual in those days for the Department to admit that
they didn’t know something and to pay us to find the
answer, but the sad part was they never paid any
attention to the answers that we provided. We did a
series of studies, first of all on the absorption of
radioactive iron and then a feeding trial in the Rhondda
– one of the most ambitious studies I think that the
unit ever did – where for two years we had a special
bake of bread for 300 women and a little van went up
and down the valley supplying the daily bread to 300
homes and we monitored the change in haemoglobin
level over the two-year period.90
My interest in platelets is a long story, but it started in
the middle-to-late 1960s. I became interested in
ischaemic heart disease and one of the areas it seemed
to me should be opened up was haemostasis,
thrombosis, and within that I took a particular interest
in platelets. Pathologists, including Michael Davies and
others, were showing that in the vast majority of
infarcts the head of the thrombus was composed of
platelets,91 so I went to a number of meetings, and I
went round some haematology departments, talking to
haematologists about how to measure platelets, so that
we could set up an epidemiology study with tests of
platelet function and see whether those predict
ischaemic heart disease events. I couldn’t get any tests
that we could use in a large long-term study. The one
test that I remember discussing in great detail was
where one could take a glass slide, score it with emery
paper, put a film of blood on, wash the blood off after
a few minutes, stain it, and look at the platelets. If the
platelets were active, then they had a lot of pseudopodia
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going along these scores from the emery paper. If the
platelets were not very active, then they didn’t have
those pseudopodia. That’s not a test that you could do
in a field study, but it was many years before we actually
had a test that we could use there. I then became
interested in publications on aspirin and platelets, and
it occurred to me that as a second-best strategy, for an
epidemiologist, we could alter platelet function in a
number of people and see whether that altered the risk
of ischaemic heart disease. So we planned the first
aspirin trial and we started admitting patients, as far as
I remember in 1968, after their first infarct, to a
randomized controlled double-blind trial. Now if I can
just make a remark about what happened later. Many
years later in our Caerphilly study we did tests of
platelet function, and we borrowed a mobile laboratory
from Serge Renaud92 in France. He motored it across,
he brought it up to Caerphilly, and the hospital
provided hard-standing, and within that mobile
laboratory we did very detailed tests of platelet
function, using platelet-rich plasma. Ten years later we
evaluated those tests and we found that none of them
were predictive of ischaemic heart disease. Now we had
other tests which were done in a more recent phase of
Caerphilly, but I often think back that if I had had my
wish as an epidemiologist and I had got tests for platelet
function such as those tests done in the mobile caravan,
that whole area of research as far as we were concerned
would have come to nothing, because none of those
tests proved to be predictive of ischaemic heart disease.
But fortunately we took up this second-best as I say and
we set up a randomized controlled trial of aspirin. Our
interest at that time was platelet function, not aspirin.
We were using aspirin as a tool in an epidemiological
inquiry. The trial ran for, perhaps, a year or 18 months
and one day I had a phone call. Archie, by the way,
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Renaud S, Dumont E, Godsey F, Suplisson A, Thevenon C. (1979) Platelet functions in relation to dietary fats
in farmers from two regions of France. Thrombosis and Haemostasis 40: 518–531. For further work by the unit,
see, for example, Elwood P C, Renaud S, Sharp D S, Beswick A D, O’Brien J R, Yarnell J W G. (1991) Ischaemic
heart disease and platelet aggregation.  The Caerphilly Collaborative Heart Disease Study. Circulation 83: 38–44.
Elwood P C, Renaud S, Beswick A D, O’Brien J R, Sweetnam P M. (1998) Platelet aggregation and incident
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Figure 41: Serge Renaud’s mobile laboratory
at the Caerphilly Miners’ Hospital, 1984–88.
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always told the story that he took the phone call, but I
believe that it was me that took that call, one Saturday
morning. Martin Vessey, who had been working with
you, Sir Richard, had gone out to the USA to a
pharmacological unit with Hershel Jick.93 They had
been looking at unexpected effects of drugs and what
they were doing was questioning patients who had
come into hospital and on their third or fourth day after
admission they questioned them about the drugs they
had been taking during the week before coming in, to
see if they could spot any harmful associations between
drug taking in the week before coming in and
conditions they came in with and complications that
they developed having come in. In their first analysis,
the one thing that stood out like a sore thumb was a
negative effect of taking aspirin. The number of
patients with myocardial infarction [heart attack] who
had taken aspirin in the week before admission was
very, very low, their relative risk was about 0.3,
suggesting one of two things, and therein lay the
dilemma. Either patients who took aspirin in the week
before infarction died and didn’t get into hospital to be
questioned, so aspirin could actually be increasing
mortality, or patients who took aspirin didn’t get a
myocardial infarction to come into hospital. These two
alternatives were rather different, but they could both
explain the data that had been collected by Hershel Jick
and his team. So Martin Vessey told Hershel Jick that
there was a randomized controlled trial in south Wales
and I took this phone call on a Saturday morning, and
I immediately recognized that it was essential that we
break our code even though it was very early on in the
trial. It was such a dangerous situation to run on and
then perhaps find that our aspirin was increasing
mortality. We discussed it with a number of people and
I think it was then that you became involved, Sir
Richard. I think we saw you, or at any rate talked to
you, but we decided to break the code. My memory is
that there were 11 deaths on placebo and eight deaths
on aspirin, and those were trivial numbers, but they
Figure 42: Andrew Beswick doing platelet
aggregometry in the Caerphilly study, c. 1989.
Reproduced by permission of Dr Peter Elwood.
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gave us sufficient confidence to feel that we should
continue our trial. You [Doll] and others at MRC
headquarters were sufficiently excited by these
preliminary results and with the potential of aspirin,
that we were given extra resources, which was most
unusual in the MRC. We set up satellite trials, in
Oxford, Manchester, and Swansea. We had already set
1000 as the number to be randomized in that trial, but
we did go beyond that and actually randomized 1400
patients and about 18 months later we analysed the
results. And the results showed a 24 per cent reduction
by aspirin in the number of second infarcts or ischaemic
heart disease deaths, and we published that alongside a
paper from Hershel Jick’s unit in the USA, the
observational study showing the deficiency in aspirin
taking by myocardial infarction patients. We were
somewhat disappointed at the time, because the British
Medical Journal delayed and delayed before publishing
and they published our trial under the heading, ‘For
debate’,94  but looking back I think that was extremely
wise. We learnt, and Archie certainly emphasized, that
clinical practice should never be altered because of one
trial, however convincing, however exciting. There
should be a number of trials, trials should always be
replicated, and later of course we think in terms of
overviews. But those days were the most exciting.
After we broke the code, I was invited over to National
Institutes of Health (NIH), and I met a number of very
prominent people in America working on heart disease
and I presented the results of our trial, these 11 deaths
and eight deaths, and it was so exciting. The Americans
set up their trial on the survivors of their coronary drug
project, and that was published a few years later. We
then set up a second trial and within a few years six
trials had been published, and an overview of those by
Richard Peto in the Lancet was I think the first overview
and really paved the way for the tremendous growth of
94 
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interest in overviews.95 We went on to conduct two
more aspirin trials which perhaps I might talk about
later,96 but I think it is a very exciting situation now,
because there have been over 170 trials throughout the
world of aspirin and vascular disease and the
consistency of those trials is really quite remarkable. If I
might just add something of particular interest to me,
coronary heart disease is rising in incidence in the Far
East and in developing countries and I have been
invited out to the Far East and to India on a number of
occasions to lecture on heart disease and aspirin, and I
can honestly say that aspirin has enriched my career
enormously, even in retirement. I would like to pay
tribute to Nick Henderson, of the European Aspirin
Foundation,97 who has been enormously encouraging to
me personally, and, I think, to you [Doll] and Richard
[Peto] in your doctors’ trial,98 but also in spreading the
message in the Far East and other countries, that aspirin
is an exceedingly beneficial drug and highly cost
effective. The drug firms are not interested in it, it
makes no profit, and it takes the Aspirin Foundation
and a few enthusiasts to get this message across. It really
is marvellous to be associated with it.
Doll: This has been one of the major developments in
clinical medicine in the last 30 years and we do owe it
to a very large extent to the work of Peter Elwood and
that unit. The Medical Research Council had an
Epidemiological Committee at the time, which I was
chairing, and of course other people were aware of the
effects of aspirin on platelets and we were asked to
consider what we could do to test whether aspirin was
of any significant clinical value, and our committee in
its wisdom decided that myocardial infarction was too
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rare a condition to enable us to do a decent study, so we
thought we would have to test whether aspirin prevented
venous thrombosis. And we laid on a study to test if it
would prevent venous thrombosis and it didn’t seem to
have any material effect on that.99 It subsequently has
been shown to have an effect, but as Sir Richard Peto, if
he were here, would immediately leap up and say, ‘You
didn’t have anything like enough numbers’. But we were
frightened of trying to test its effects on the prevention of
myocardial infarction. When I say it was too rare, I mean
too rare a condition per 1000 people per year to be able
to lay on a prophylactic study, which Peter Elwood had
the courage to do. 
There’s one other comment I’d like to make. You talked
about people advising you after you had broken the
code, and found there was benefit in reducing the
morbidity, not just the mortality, not just your eight and
11 deaths, and that you really must enlarge the study,
and of course it so happened that the effects were much
greater in the grouping of centres that you had first
started with. I forget where that was, in Cardiff. Overall,
the 24 per cent reduction was exactly what subsequent
research has shown that aspirin does produce. But
Archie never forgave us for having said you must extend
to the other centres, because he said the other centres
didn’t ensure the treatment was carried out properly and
they didn’t get any significant reduction, when the
Cardiff centre was getting a 40 per cent reduction.
Elwood: It demonstrated what we all know, that Cardiff
is the place for good epidemiology!
Doll: Anyway he was very cross about it, but I believe
the combination of the four centres did in fact give you
the correct answer. There is Mr Henderson. He must
have some contribution to make on this, because many
of us have been grateful to him for the energy he has
had in persuading us to do research on aspirin.
Mr Nick Henderson: The Foundation has been going
for 25 years and most of you will also be aware, I am
99 
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sure, that this is the 100th anniversary of the
development and production of aspirin as a product for
treatment. I doubt if there are many products that have
lasted 100 years and have been so widely researched
and, if anything, it is gaining increasing interest. I want
to return the compliment, if I may, to Peter Elwood. He
is a tremendous enthusiast for aspirin and I think his
conviction is totally correct, but he’s too modest to say
that he has personally visited the Far East, Indonesia,
Hong Kong, Singapore, the Indian continent and
Pakistan, he has spoken about aspirin, and enthused an
awful lot of doctors about its use, and all from that very
early work he has described to us today and I think he
certainly should be remembered as the parent of aspirin
in myocardial infarction. The work goes on, and
shortly, I hope, he is going to South Africa. There is
now an American Aspirin Foundation, and Southern
African Aspirin Foundation, a Far East Foundation
based in Delhi, and perhaps as a sort of quid pro quo I
had a letter the other day from the Pakistan Aspirin
Foundation, so it’s growing and will continue to grow. 
Wade: Very interesting hearing about Hershel Jick. I
knew him quite well. After the thalidomide disaster,
that was 1962 [thalidomide was withdrawn in 1961],
Peter Elmes and I looked at what drugs people coming
into hospital had,100 because I think in Belfast at that
time 5 or 6 per cent of admissions were related in some
way or other to drug taking. I know that at this meeting
in 1966 at Geneva Jick was there and we discussed this,
and I don’t think I had published my paper at that time
but we were talking to him about it. He must have
started the study then, but I didn’t know that, and I lost
touch with him too.
Doll: Who else wants to contribute to the discussion of
aspirin? 
Elwood: Can I just add that aspirin, of course as
everyone will know, is of growing interest because of
growing evidence that habitual aspirin takers have a
very low risk of bowel cancer, gastric cancer,
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oesophageal cancer. It’s also been noticed that habitual
aspirin takers have a very low risk of cataract. But the
one that excites me and perhaps a few others in the
audience, is that there is growing evidence that aspirin
may delay cognitive decline and dementia. My
children, observing me taking an aspirin, or half an
aspirin a day, say, ‘Dad, it’s too late!’
Doll: There can be little doubt, I think, that the aspirin
work of this unit has been of outstanding importance,
but it’s so outstanding clearly that everybody recognizes
it and we know all about it. There is nothing to say
except that it is very much to the credit of the unit that
it had the imagination and energy to do this work.
Tyrrell: Did you do any work on the relation with
cerebrovascular events?
Elwood: We didn’t, but, of course, other units did and
the effect on stroke and on TIAs [transient ischaemic
attacks] is quite in keeping with its effect on other
vascular conditions and the evidence on that is every bit
as convincing as in myocardial infarction.
Tyrrell: Let me add a trivial point to fill this thing out.
I got a letter from the Chairman [Doll] some decades
ago asking if I would please take part in a trial of aspirin
and myocardial infarction, and I said I was already
taking regular aspirin, having had a TIA and he said,
‘Oh well, that lets you out of my trial then’.
Thomas: I remember the first scientific meeting I sat in
on, knowing Peter Elwood from church connections
and other people there. We sat very gentlemanly at the
table and ladies talking and so on, and I almost sat
forward at the end of the meeting, expecting them to
close in prayer, it’s a sort of Welsh tradition really, that
we were almost like that. It sounds like another
generation, which it was, we are talking 1972–73. But
there was a civility and a general enthusiasm. 
At the unit we had a wide range of students, some
dieticians from Guildford, the annual MSc students
down from the London School [of Hygiene and
Tropical Medicine], and applied biology students from
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Bristol. Students were taking part in projects and being
encouraged to do so and I think George [Davey Smith]
has indicated that he was in that category early in his
career. It’s that enthusiasm and the ability to get out and
change things [that makes epidemiology attractive]. I
think most of us come into medicine thinking that
people know the answers all the time, but the longer
you spend in medicine, clinically, you begin to realize
how uncertain are even the apparently firm foundations
of medicine. That’s what is good about the unit, it’s
been challenging them [accepted medical ideas], having
to define things [concepts].
I was just going to give some of my experiences of
working in the unit. It’s been said what encouragers
Peter Elwood and Archie Cochrane were. I went along
there in 1972, finishing a BSc project on air pollution
and chronic bronchitis, and I just happened to be very
enthusiastic reading the documentation that they had at
the Pneumoconiosis Unit. Archie was approaching
retirement but Peter Elwood mentioned to me it might
be worth reading Effectiveness and Efficiency, which I
did and I found it very interesting. I had a totally non-
medical background: I finished my public health degree
and was a health inspector for a few years and then did
an MSc in occupational safety and hygiene. Peter
Elwood and Archie, as I understand it, were thinking
about further research, a follow-up of the flax
workers,101 and they drew me in on that project, initially
with a research grant, and then working as a technical
officer, at the MRC Epidemiology Unit. I worked there
on a range of projects really. What impressed me was
the sheer range of projects that were going on for a
relatively small staff and medically trained staff. I was
looking at environmental aspects there. We did a fair bit
of work on lead, which Peter Elwood was very
enthusiastic about. We looked at water lead, we looked
at air lead, we travelled round and we really did field
epidemiology, which was the forte of the unit, high
response rates, hitting an area very intensively. I always
used to think from the early days when I would be
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collecting the water samples or whatever, and Peter
Elwood would be persuading the ladies that their children
ought to give a little blood sample for us and so on, that
maybe kissing the blarney stone was a thing that we all
ought to learn in epidemiology. There were respiratory
studies that we followed up, not only flax workers, but we
followed up the asbestos workers and in fact recently we
were also following up the slate workers that were seen in
the 1980s. Having been a public health inspector, I took
a little bit of interest in pesticides, and here I must thank
Sir Richard Doll for encouraging me in an early study I
did on following up pest control officers and their use of
a possible bladder carcinogen called ANTU (alpha-
naphthylthiourea).102
I do remember Peter Elwood’s encouraging role. I had
known him from church connections almost since I was
aged 14, and I remember even as a student he used to
say, ‘I am going to a meeting at such and such a town,
would you like to come along for the ride?’ Going from
Cardiff to have a look around Oxford was quite a day
out for a Welsh boy in those days. He got back in the
car, I remember, after the meeting with Sir Richard
[Doll], and he was obviously quite pleased with the
way that it had gone, and he said, I think in Sir
Richard’s summary of the meeting, that there was as
much evidence that aspirin was beneficial as there was
for half the drugs in the British Pharmacopoeia. 
Later on, I’d finished my research there and I was
always keen to study medicine and I applied every so
often – Peter Elwood must have got fed up writing me
references – but I was fortunate in 1981 to get a place
at Leicester and I went there. I was also able to come
back for my elective in about 1983–84, and from 1994
onwards to 1999 finishing the Caerphilly study. But in
my time at the unit as well I shared for several years the
attic with Archie Cochrane and I was really quite
unashamedly his tea boy. He was a bit shaky on his legs
as time went on, and we were at the top of the building
and to be honest, if Archie ever offered to make it,
102
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there was normally cigarette ash in it and various other
things, so we took it as a healthy way to make it
ourselves. But he used to be working away, he was
writing his obituary there,103 he used to let us read it,
which we young people all thought was a bit odd, but
he was working on his autobiography as well, and he
always said, ‘What shall I call it?’ I always said, ‘Why
don’t you call it ‘Archieology – The study of Archie
Cochrane’, because he was in a sense rather
unashamedly self-interested.104 Archie was always
interested in talking about the distinctions between
applied and pure research and, in his view, his job was
to educate people like myself and others in the attic.
He was very interested in the Rothschild report about
applied research then and I see things have gone full
circle now with the very great interest in applied and
commissioned research.105 At that time Archie had
implied that researchers were not under an obligation
to do applied research, and it had been said when he
was younger that ‘gentlemen’ did not do applied
research. I think Archie thought the truth was
somewhere in between, that there should be some
benefit to mankind from what he was doing. But my
own impression was, as the quinquennial reviews came
around, that the world of epidemiology was changing.
I got the impression that in Archie’s day you could be
like Indians, roving wherever you liked, attacking
whatever you liked, but as time went on people were
getting pinned down on reservations and they were
being told in strong terms not to stray off too widely,
that they had to develop programmes of research, and
that is why I could see that things like Caerphilly and
other projects coming on later, were trying to develop
more of a programme pattern. Archie was trying to
educate me about life and he showed me the
proposals for setting up the MRC Environmental
Figure 43: Archie Cochrane in
retirement with The Times 
crossword puzzle, c.1981.
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Epidemiology Unit106 on his desk and he said, ‘What
do you think about these?’ and I said, ‘This is very
interesting, Archie’, and Fred’s comment was, ‘It looks
like a great big fishing expidition, but it might catch
some big fish.’ Again, I think this is a fairly good
assessment of the situation. Fred Moore and he were
always discussing and arguing about things. People have
said that Fred was a bit of an old woman, really, and I
know on my leaving card he wrote in inverted commas,
‘Is there anything that I have forgotten?’ because I used
to be very paranoid. If Fred passed it [a paper], I knew
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Selwyn St Leger
There’s one anecdote that I can
repeat to you. This was told to me
by Archie, I wasn’t there at the
time. As you know there were
those with commissions during
the war, and then they were
reservists afterwards, and when
the Korean War came and the
Government decided that the
reserves would be called up, or at
least put on standby. At the time
two letters arrived at the PRU,
one addressed to Captain Archie
Cochrane, and the other to Major
Fred Moore. Archie used to tell
me that with relish. Fred, of
course, was a wonderful raconteur
about his experiences. He was
with the Desert Rats. Once,
explaining to me why he never
washed his mug – I supposed it
was a tin mug that he never
washed – other people washed
theirs and they all went down
with the Ds and Vs. He never
washed his, because they had
limited water supplies, therefore
there was contamination.
Figure 44: Captain Fred Moore (b. 1915), a member
of the Epidemiology Unit from 1950 to 1985.
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that most of the facts and figures were right and that
things were drawn correctly. Fred and Archie used to
argue, but Fred, rather like a good NCO in the services,
would have that polite way of saying ‘Professor’ or ‘Sir’
at the end of what he had said to him, which took away
the insult. I remember them coming back into the door
one day after they had been to a funeral, and he said ‘I
have said to Prof., the next funeral you go to, Archie, err
Professor, won’t be anybody else’s’. It was always a joke,
privately, in fact, as to who would be more wealthy when
he passed on, Fred or Professor Cochrane, because Fred
had investments and was, reputedly, part-owner of a
local brewery.
Figure 45: Archie Cochrane and Fred Moore at Richmond Road, Cardiff, c. 1981.
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Archie Cochrane
Your letter was about the first
thing that I saw when I got back
from a very pleasant holiday in
Davos. My immediate reaction
naturally was to return to Davos
at once, as there was little point
in my staying here! 107
Dr Joan Faulkner and 
Dr Dick Cohen 
Dr Cochrane’s attitude was very
much more reasonable than we
had anticipated. He was
prepared to discuss amicably and
rationally the staff he would need
in his new unit and the
accommodation that would be
necessary for them.108
Julian Tudor Hart
I realized that epidemiology is
really a democratic subject, high
response rates means one man one
vote, everybody in a community
is important. We need everybody’s
blood pressure, we don’t just need
the blood pressures of people who
have come along to see you about
their blood pressure or have
coronaries, we need the whole
distribution. This wonderful
discovery of Pickering’s, that
blood pressure was continuously
distributed, so we no longer had
to label people as having diseases
or not having them, but could
interest ourselves in how much
they had and whether it was
useful to call high blood pressure
a disease. So de-deifying disease,
getting distributions and
combinations of distributions,
was a new thing. I could see
straight away that the debate
between Pickering and Platt it
wasn’t a scientific debate, it was a
social debate.
Mary Thomas
I was only going to the unit as a
temporary worker in the
Rhondda Fach study, between
two other plans that I had. And I
stayed for probably two years – it
wasn’t that long. It was not a
happy place to work if you weren’t
in the scientific staff room. I don’t
know how happy it was in the
scientific staff room, but it was
terrible – infighting, backbiting
– you know, professional
jealousies. I presume they were
professional jealousies. I was very
much younger than I am now
and was an innocent in most of
that. It taught me a lot though.
Archie was very nice to me, good
to me. I was in the peace
movement at the time and he
defended me when I was arrested
in London, and was a couple of
days late back for work and the
personnel manager wanted to get
rid of me. Mr Cory109 was quite
ready to say that my services were
to be dispensed with, but Archie
said, ‘Oh, just leave it to me,
there’s no question’. And there was
no more heard of it. We were
extremely badly paid, very badly
paid, so badly paid that that’s the
real reason that I left, frankly. I
just was not making ends meet,
transport costs and living costs. I
was all right while we were
getting overnight subsistence out
on the Rhondda Fach survey, as
we were most of the time. But
when we were back in Llandough
or in Cardiff in Richmond Road,
then the money was absolutely
pitiful. I just couldn’t afford to
live. Archie was so generous,
because he was a rich man.
Rumours were going around all
the time that he was paying for
this and paying for that, and I
just didn’t want to be part of it. I
did tell him that I couldn’t afford
to stay there. I learnt all the skills
of field work in Rhondda with
Fred Moore and the team, the
obsessional nature of data
collection, I will be eternally
grateful for those skills that I
learnt and have never forgotten.
Peter Elwood
The unit then began, shortly
after I came [1963], to expand.
Archie was brilliant to work
under, but he had limitations.
He had the occasional brilliant
idea and will always be
remembered for these, but he
didn’t do an awful lot himself.
Now that’s not a criticism, he
operated at a very high level and
spent most of his time travelling,
meeting people, going to
meetings. He stimulated an
enormous amount of work, but
he left me to run the unit. There
was money available in those
days, and so the unit gradually
expanded. We took on an
assistant epidemiologist and then
another statistician, and then
another epidemiologist, and so
on. Archie of course had set up
the glaucoma survey with two
ophthalmologists and that was a
very, very fine piece of work, it
really set a lot benchmarks in
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Figure 46: Archie Cochrane.
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ophthalmology, but when that
came to an end there was very
little follow-up, and so I
inherited one or two people from
that team who joined the unit
and had no other work to do.
Peter Elwood
The Government had asked the
Department of Social Medicine
at Queen’s University, Belfast, to
investigate whether or not
byssinosis occurred in the flax
industry and if so, what
disablement did it cause? Richard
Schilling had established that
cotton workers’ byssinosis was
prevalent in the cotton mills,110 so
we did a survey of all the flax
mills in Northern Ireland, about
24 of them. Incidentally, the one
mill that would not give us
permission to do the survey was
owned and run by the then
Minister of Health from
1963–64, a man called Anthony
Barber. I interviewed all the
people, described this study that
we were doing, used the MRC
questionnaire on respiratory
symptoms, asked them for
employment history, and I think I
measured height and weight.
Another person did lung function
tests and someone else made dust
measurements in very great detail
throughout the mills. Eric
Cheeseman, the first professor of
medical statistics in the UK, was
in the department, a very prickly
character, but one who gave me
enormous encouragement, and I
owe a lot to him as well as to John
Pemberton. We saw about 2500
people in the flax industry, and
confirmed that byssinosis does
occur. I was left with some
questions, and I very nearly wrote
a minority report in the official
report of the study, because I felt
that there was doubt about
disablement from byssinosis.
When the men went in on the
Monday and the Tuesday, if they
were exposed to high levels of
dust, they got quite severe
symptoms. In my analysis I found
that it was really the smokers who
got the severe symptoms. Non-
smokers got very mild symptoms.
But I was very concerned whether
or not there was permanent
disability, and so I set up a little
study on my own, to follow up
some past workers, and I travelled
all over the north of Ireland
seeing these past workers, trying
to estimate whether or not they
had any continuing disability.111
Peter Elwood
John Pemberton was very good to
me. He offered me a job as ‘the
boy’, the junior member of a
small team of four people, to look
at flax byssinosis. I have always
said that somebody who was into
research should be fascinated by
the process, not by the answers,
and the process was absolutely
exhilarating, because we were
able to put limits on the degree 
of confidence. The statistical
estimate of the confidence
interval was the thing that 
really stimulated me. Clinical
medicine was just a fog about
this and dealt with single cases,
you never knew whether you had
any effect or whether any
association was real. Whereas
dealing with numbers, and with
pretty basic statistics in those
days, we were able to put levels of
confidence on our answers. I can
remember walking home reading
Moroney’s Facts from Figures,112
practically walking into
lampposts. It was such a
revelation to me that you could
have a degree of confidence
within medicine. This was way
back in the middle-to-late 1950s.
Estlin Waters
Certainly in my case there was
an overlap between counting
birds and epidemiology. I had
been interested in birds from a
very young age when I was in
Canada, but I was also interested
in the scientific side of
birdwatching, especially bird
migration and bird numbers.
When I was on St Kilda113 I
wrote about a dozen papers and
short notes for ornithological
journals and for the Proceedings
of the Zoological Society of
London on various aspects of
birds and on the grey seal. I was
interested as a naturalist. At that
time I didn’t have any real
knowledge of statistics. It was my
birdwatching that kept me
scientific during my medical
student days. I used to read some
of the bird journals, the medical
journals were too heavy to read as
a student. I don’t know how some
of our medical students now
manage, but they can and do. I
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felt the teaching we had at
London was not very scientific, it
was more of an apprenticeship: I
do this, so you do this. The
birdwatching kept me critical of
the scientific side of things. When
I joined the MRC it was very
much the other way round. It
was the epidemiology that was
the scientific side and I think I
have been able to apply a bit of it
to my birdwatching. The two
have run together, one perhaps
ahead of the other, but the two
are related. I think that someone
who wants to count wrens on St
Kilda has got something in
common with someone who
measures the haemoglobin level
in a population. My experience
of working alone on St Kilda and
writing papers on natural history
probably helped me when
starting in medical research.
Janie Hughes
When I first started in April
1964 the job was mostly office
based. I got to know what sort of
research the unit was involved in
and then I started to do some
fieldwork. My first field job was
Trehebert at the top of the
Rhondda valley, where Dr
Elwood had started some work
on anaemia and I started to
work in the clinics there and also
doing a bit of door-knocking, but
not very much to begin with.
After that I worked on studies of
lead pollution. Near motorways
we took blood from people who
lived there and swept pavements
in cul-de-sacs away from them. I
never took blood, Dr Elwood
did, but he always had to have a
chaperone and somebody to do
the admin. We’ve worked in
north Wales, taking blood from
very young children, looking at
blood leads. We worked on
studies of hard and soft water –
for example, a hard-water area
in Gloucester and perhaps a soft-
water area in south Wales
[Llanybydder, a big horse-
breeding area]. We collected
children’s teeth, cut their hair,
and took finger nail clippings.
Peter Elwood
It was my decision to withdraw
from the Rhondda, which was in
those days about an hour’s journey
away and it was really very
wasteful. The origin of course was
the studies of pneumoconiosis and
Archie actually got money to put
up a very nice clinic in Ferndale
in the middle of the little
Rhondda [see photographs on
pages 45 and 47], which we used
as a headquarters. We had about
four rooms and we could do a
certain amount of technical work
and did quite ambitious surveys
there. But it was an hour’s
journey away. I also felt that the
Rhondda was a selected
population and when we began to
study conditions other than those
of mine workers, it was quite
obvious that there was a social
class-biased movement out of the
valleys. So I made a conscious
decision to go somewhere else and
we chose Caerphilly, which we felt
was a fairly stable population,
relatively close, and the health
authority there and GPs and so on
seemed to be very cooperative and
have proved to be. I think the first
study that we set up was a study of
the elderly and Michael Burr
really took over that area of
research,114 but I did the study of
folate levels and B12 levels as well
as haemoglobin in Caerphilly.115
And we looked at a number of
things in relation to that. Then
Michael Burr arrived and he set
up studies on vitamin C and on
the health of the elderly and
respiratory symptoms. He then set
up studies on asthma and
Caerphilly proved to be very, very
suitable.
Figure 47:
Dust sample
taken from a
child’s hands
for lead
pollution
studies,
1970s.
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Julian Tudor Hart 
I was hoping to develop a practice
that was purpose built to be a
research department, and then I
thought Archie and Ian Higgins,
and Peter Elwood could come
along and they would use 
my population. So I went to
Glyncorrwg, which was an
isolated population easily defined.
I found gross pathology there, and
a shambolic state of the practice. I
couldn’t contemplate any kind of
research for at least five years.
About the third year I was there
Peter Elwood had been doing
haemoglobin studies on anaemia
prevalence and so on. I had been
very struck by each time I had
taken over a new practice, I found
a clutch of women with really
severe anaemia, haemoglobins of
3 or 4 grams, for whom it was a
deliverance, you topped them up
with iron and corrected it, 
and then the effect was fantastic.
So I bought myself a
haemoglobinometer and I started
systematically collecting data,
eventually aiming at 100 per
cent coverage. After I had got
about half way to that target, I
went down to Richmond Road
[to the EU] and talked to Peter
Elwood about it, hoping to get
some help from him. He was very
scathing about what I was doing,
he obviously thought it was
terrible half-arsed stuff, which it
was. But he didn’t seem to have
any idea of the circumstances I
was working in. He went on at
me about whether I had weighed
menstrual loss, whether I had
collected sanitary towels and
weighed them to assess their
menstrual flow (which we now
know to be a grossly inaccurate
way of measuring menstrual
loss). And then, he said, ‘Are you
sure that your measuring
instrument is accurate?’ Well, I
hadn’t done anything to it, I had
just assumed that it was. When I
did, I found that it was
absolutely awful, and I didn’t
know whether it had always
been awful from the beginning
or whether it had become awful.
So there was just no way I could
depend on it. I had to throw
away all the data. I lost
everything. But it was a good
elementary lesson, which I
needed. I had learnt all about
this before, but you don’t really
learn it if you are not doing it. It
has to be your own work.
Figure 48: Janie Hughes testing haemoglobin (Hb) levels on a haemoglobinometer, 1967.
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Peter Elwood
The study of the effect of iron in
bread on haemoglobin level in
the Rhondda Valley surveyed, as I
remember, about 8000 women.
We identified those who had
haemoglobin levels below 11
grams, I think it was. We gave
them a month’s treatment to
bring their haemoglobin level up
and then we put half of them on
bread fortified with an iron salt,
and half on ordinary bread, and
we watched the fall in
haemoglobin level over the next
two years. We wanted to look at
prevention, not treatment, with
iron in bread. So we raised their
haemoglobin levels, knowing that
they would slowly return to what
they had been over the next year
or so, and we gave half of them
bread. We estimated that the
absorption of iron from the bread
was only about 4 per cent. When
I submitted the paper to journals
they all refused it, and said, ‘This
cannot be right, we all know that
iron is absorbed from food at the
rate of about 30 per cent in
women with low haemoglobin
levels, this cannot be right’. I had
great difficulty publishing the
paper. In the end we did publish
it and over the next five, ten
years, it gradually became
apparent that iron absorption
from food stuffs is about 4 per
cent, so we were shown to be right
in the end 116But that was
another fascinating set of studies
and again I just valued the
opportunity to follow through an
idea and look at the distribution,
the association with indices of
morbidity, look at mortality, and
then to run randomized controlled
trials to look at prevention.
The iron studies with South
Asian women are perhaps the
most fascinating story of my life.
The studies of the absorption of
iron from bread were radioactive
studies, done immediately after I
came to the unit in 1963. I set
up these studies using radioactive
iron, because such precise
measurements of iron retention
could be made. I got friends and
colleagues to come to the medical
school (on Newport Road in
those days) and have a special
breakfast, in which we had two
forms of iron. One was given as
a control. We had baked some
iron 59, radioactive iron, into
bread and people received a slice
of bread with this, and then a
fortnight later, we asked them to
go to Harwell [the UK Atomic
Energy Authority, Harwell,
Didcot, Oxfordshire] and have
whole-body measurements of the
iron that had been absorbed
from the bread. The absorption
was almost nil. I got a bit of
publicity because of this, both in
this country and in the USA,
and I was asked to join the
WHO Committee on Iron
Deficiency. The Committee said
there was undoubtedly a real
problem where chapattis or
tortillas are eaten and bread is
not and wanted to know what
fermentation did to the iron and
would I repeat this study using
chapattis? So I set up a study 
to look at radioactive iron
absorption from chapattis. 
In order to mimic real life as
closely as possible, I got an
Indian woman to help make
about 200 chapattis. We
measured the amount of 
radioactive iron in each and
stored them in a deep freeze. I
went up to Coventry where there
was a fair-sized Asian
population with the help of the
health authority and one selected
GP. We did rough power
calculations (on the back of an
envelope in those days), and we
estimated that the method was so
precise that we could get very
accurate measurements from a
quite small number of women.
So we selected 20 women, all
over 50, not suffering from any
important disease, but no one
who might become pregnant.
Tom Benjamin, one of the
fieldworkers, and I took the
chapattis up to Coventry and we
asked the women to include one
chapatti with a meal each day
for one week. Each day Tom
Benjamin would deliver a
chapatti on dry ice to each of
these women, who would defrost
it and eat it as part of her meal.
A fortnight later they were
driven to Harwell, and Tom
Benjamin arranged a visit to
Oxford, took them round one of
the colleges, and took them for
tea, with breaks on the way there
and back, and really I think I
made 20 friends on that project,
they were so friendly to us. 
We found that iron was no
better absorbed or absorbed no
differently from bread .117 This
study was a seven-day wonder,
and everyone forgot about it.
Twenty, perhaps 25 years later, I
was telephoned by a reporter
making a television programme
on the uses of radioactive iron in
medical investigations. ‘Yes,’ I
said, ‘I did look at the absorption
1964–69 Iron deficiency anaemia studies
MRC Epidemiological Research Unit (South Wales)
71
118
See note 116. See also Elwood P C. (1968) Radio-active studies of the absorption by human subjects of various
iron preparations from bread. In Ministry of Health. Iron in Flour. Reports on Public Health and Medical Subjects
No. 117. London: HMSO, 1–30.
of iron from bread, and I was
also asked to look at it from
chapattis’. The television
programme blew up this story of
the radioactive chapattis in an
incredible way. They interviewed
one of the women and a relative
of another, who made
extraordinary claims that a
research worker from the MRC
(they didn’t name me) had given
them chapattis and they had
eaten a chapatti each day and
were then driven in secret to a
military establishment where
they had a whole lot of
measurements made. One
woman said, ‘My hair fell out, I
began to get pains and cramps, I
became arthritic, I am now
diabetic, and if only I hadn’t
touched those chapattis I am sure
I would be fit and healthy’. A
relative of the subject who had
died, said, ‘My mother’s health
failed from that day on and she
would be alive now were it not
for those chapattis’. 
The health authority set up an
enquiry at the request of the
Asian community and I went up
to Coventry. I had prepared over
the weekend a very full account
of what we had done and I had
clipped to it an account of the
original study published in the
American Journal of Clinical
Nutrition118 and I asked the
chairman of the meeting if I
could give an account of what I
had done before there were any
questions. Well, the meeting was
exceedingly hostile. The health
authority were obviously keeping
neutral, but one or two there
were not. Over the subsequent
weeks I was accused of all kinds
of things. For example, an Asian
health visitor had been with me
on this study and she could testify
to the fact that I had explained
all about the study to these
women, but she refused, saying
she had never met me, had never
had any part in the study of
chapattis, and knew nothing
about it. Janie spent a day or two
in the basement, going through
all the letters, and she dug out
one from the health visitor saying
how much she had enjoyed the
study, how well the people had
been handled, and how delighted
they were to take part, refuting
many of the things that had been
said. She also found a letter that
I had written to the son of one of
the women giving a complete
description of the study. Another
was from the physicist who had
prepared the radioactive iron,
which had been submitted
independently to a number of
experts, who said that it was an
extraordinarily low dose. That
was why we had used Harwell,
which had the most sensitive
counter in the whole country. So
the thing took a long time to die.
One little codicil to that. I was in
India a few years ago and one of
my contacts told me the
radioactive chapatti study had
been raised in the Indian Houses
of Parliament and in all the
Indian papers.
Another accusation was that I
had purposely chosen these
women because they were
illiterate. We found letters from
three of them thanking me for
the most interesting study,
written in perfect English.
Peter Elwood
I had an idea in the car about
the randomized control trial of
iron in bread [started in 1964].
I was chatting to somebody about
the problem of anaemia, as I
thought it was at that time, and
how we could do something that
was relevant to it. Giving tablets
through GPs was obviously
achieving very little, what could
we do? And so the fieldwork,
which lasted about ten years and
ended with the radioactive
chapattis, all started with an
idea in the car as I was chatting
to somebody about the work on
anaemia, which at that time had
only extended to symptoms and
realtionships with cholesterol
level and blood pressure. 
Figure 49: Special bread made from flour
containing iron labelled with a radioactive isotope.
Figure 50: The medical researcher as a baker’s
man, delivers bread from the Epidemiological
Research Unit.
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Estlin Waters
Although Archie Cochrane
suggested that urinary tract
infection would be a good subject
for me to get into, and I did
write a lot of papers and
attended conferences on that, I
was working in a team. It wasn’t
my own thing, so I wondered
what else I could do that really
would be mine, in the same way
that Peter Elwood had ‘got’
anaemia. I was helping him, but
it was his subject. Again I think
it was probably Archie Cochrane
who suggested headache and
migraine, because Archie himself
suffered from migraine. At that
time Peter Elwood had actually
started the first survey that the
Epidemiology Unit did on
headache and migraine.119 He
had just got to the stage of
collecting the questionnaires and
he very kindly said that if that
was the subject I wanted, it was
mine. He very generously handed
it all over to me, and really that
was the subject, headache and
migraine, that I did on my own
then. I did lots of surveys of
various sorts, including
randomized trials of treatment of
ergotamine tartrate.120 I spent a
long while on headache and
migraine, both at the
Epidemiology Unit and later
when I went to Southampton. 
One of the problems of
migraine is how you define it.
Definitions were not satisfactory
and varied widely. It quickly
became apparent to me that all
the definitions were really just
descriptions. Typically migraine
was usually unilateral,
sometimes accompanied by
nausea or vomiting, and
sometimes with a warning that it
was coming, but very few of the
definitions stressed how often this
had to happen, and whether it
had to happen in every attack or
whether all the features had to be
present. What I did was work
out the prevalence of headache,
and the prevalence of each of
these symptoms, without making
up my mind whether individuals
had migraine or not. So I would
say of all the headaches, what
proportion were unilateral or
sometimes unilateral? 
Archie Cochrane was very
keen, I am sure he was right, that
any questionnaire needs a
clinical validation. So we had
Paddy O’Connor (later Air Vice-
Marshall Patrick O’Connor
CB), who was in the RAF, to see
people who had completed our
questionnaires. His job, or one of
his jobs as the chief neurologist in
the RAF, was to decide if people
had migraine or not, and if they
had migraine they were not
allowed to be a pilot or a
navigator. So as far as he was
concerned they either had it, or
they didn’t have it. We got leave
of absence for him from the RAF
so he came down, and he lived in
my Cardiff house. He used to go
round houses in the Rhondda
seeing people who had completed
my questionnaires, and he did
this blindly, not knowing what
they had said on the
questionnaire, and he decided
whether they had migraine or
not. He more or less put them
into two camps, migraine or not
migraine. He did a little group of
GOK (God only knows), but I
think it was only a few cases in
120, where he couldn’t make up
his mind. Because I had given
him randomly selected people, I
was able to work out the
prevalence of migraine as if he
had seen everyone in the
Rhondda and this created quite a
stir, because it really hadn’t been
done in this way before. At that
time the Migraine Trust, with
Princess Margaret as patron, had
started up and was active,
having a symposium every year.
So I think I got quite well known
for the migraine studies.121I did
the randomized trial for
ergotamine tartrate on people
who had completed the headache
questionnaire, because one neat
definition was ‘migraine is a
headache that responds to
ergotamine’. It’s such an
unpleasant drug that if you
didn’t have migraine, you
wouldn’t take it. So I did this
randomized trial between
ergotamine and a placebo, and
found no benefit of ergotamine
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at all. At that time the only two
other randomized studies on oral
ergotamine had also shown that
it had no effect, but it was widely
used as the main drug for the
treatment of migraine. It was
supposed to be specific, if the
attack responded it was
migraine. For the trial we used
ergotamine only, which was
widely used, but a lot of
ergotamine was combined with
caffeine and other drugs. Of
course caffeine could have an
effect on ordinary headache as
well as migraine, so we didn’t use
it. But it has subsequently been
shown that caffeine increases the
absorption of ergotamine, so
maybe the pharmaceutical
industry was ahead of the
evidence at that time by putting
caffeine with ergotamine. For a
long time many headache
researchers never accepted the
finding of my ergotamine trial.
Then I tested various hypotheses
about migraine, whether it
occurs more often in higher social
classes, more intelligent people,
in people with higher blood
pressure, and whether it ran in
families. We did studies on all
these hypotheses, and almost all
were completely negative. For
example, when testing the
hypothesis that migraine people
were more intelligent, we found
that in the population as a whole
there was no link between
intelligence (nor social class) and
having migraine. But the higher
social classes, classes 1 and 2, and
the more intelligent people, were
much more likely to go to their
doctors with their symptoms.
Many people with migraine,
including many that Paddy
O’Connor had clinically
diagnosed, had never in their life
been to their doctor for their
headaches. So what really
interested me was that doctors
managed to pick out this
association between intelligence
and social class and those
attending for migraine. This was
true in patients who went to see
doctors. But they drew the wrong
conclusion in saying that
migraine was more common in
these groups than in the general
population. So I was quite
impressed how doctors could spot
a relatively small difference, but
nevertheless the material they
had was biased. 
Incidentally it is actually true
that after I wrote the paper
showing that migraine wasn’t
associated with intelligence and
higher social class,122 I left Archie
Cochrane’s unit. He was a well-
known sufferer from migraine,
and he often told the story: ‘Look
what happened to people who
don’t get the right answers!’ 
Figure 51: The Rhondda Valley in 1968.
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Peter Elwood
I remember one meeting in
America where I heard somebody
talking about the role of platelets
in heart disease, which was not
well established in the mid-
1960s. I came back and talked
to Professor G V Born and others
about methods of estimating
platelets. Really there was no
way. The literature had an
occasional letter from John
O’Brien, a haematologist in
Portsmouth, and Harvey Vice, a
haematologist in the USA. One
[letter] said that aspirin had a
very marked effect on platelets,
which were much more active
when the patient had taken
aspirin. John O’Brien showed
that aspirin was so active that
one tablet a day was enough to
reduce platelet activity.123 So I
felt, well, here is a way of testing
the role of platelets. One would
like to use a conventional
epidemiological model, measuring
platelets and following up the
cohort to see how it relates to
vascular disease. But I felt there
was another approach. We could
clobber the platelets of a group of
men and see what their
experience is. I got in touch with
one of the drug firms, Astra
Nicolas, long since absorbed by
another firm, and they were very
encouraging. So we set up a study
and in order to make it efficient,
we took patients who had had an
MI [myocardial infarction] and
thought we would give half of
them one aspirin a day and see
what the mortality was. And we
decided to use mortality, that the
identification of a second event
was too uncertain and there
could be bias in it, because
aspirin, even at one tablet a day,
might reduce their pain, and we
might not ascertain as many
infarcts in the group on aspirin
as on the placebo. We decided to
use an index of death or survival.
We had great difficulty
admitting patients, because the
consultants were very, very
reluctant – they thought this a
madcap scheme, absolutely daft.
I well remember some of the
patients saying to me after I had
explained it all, ‘Oh, of course,
doctor, I am all for research, I
will help you, but tell me what’s
really in these tablets? You are
not serious that it’s aspirin. Tell
me, what’s in it?’ I had great
difficulty in setting up the trial. 
Hershel Jick of Boston
University School of Medicine
had previously set up a fishing
expedition, where he asked every
patient what drugs they had
taken in the week before coming
into selected hospitals, eventually
about six hospitals in six
countries. He linked these 40 or
50 drugs with diagnoses, looking
for interactions, harmful side-
effects, that people taking a
rhubarb tablet came in with
liver disease, where this had
never been expected, that kind of
thing. He produced a whole
battery of tables with ten or 20
diagnoses, and 30 or 40 drugs,
and just risk ratios or some index
like that across for admission
with that drug compared with
all the other patients with that
diagnosis. The one thing that
stood out like a sore thumb on
this table was a risk ratio of
about 0.3, as I remember it, 
for aspirin and myocardial
infarction, an extraordinary
deficiency far greater than almost
any other. He was looking for the
unexpected, and this was
certainly unexpected. 
Peter Elwood
Doll was very, very worried
about one tablet a day. He said,
‘That’s homeopathy. Why don’t
you start giving a big dose?’ But I
stuck to my guns and said that
one tablet was enough, but I
gave in on the next trial. We set
up a second trial, and we gave
three tablets a day, but I
certainly wasn’t willing to
change the protocol for the first
trial, despite a lot of pressure.
And the MRC just said, ‘Ask for
whatever resources you want and
we will give you them, expand
the trial as much as you can.’ So,
looking back, I should have been
much more ambitious, but I
asked for three nurses, and I got
a nurse in Swansea and we
started admitting patients. We
got one in Manchester and one
in Oxford and we boosted the
number of patients in the trial. 
Peter Sweetnam
First, the aspirin study was
expanded greatly and in a hurry
because of Hershel Jick’s
findings.124 Because of Jick’s work
the study ended up with, I think,
1600 or 1700 individuals.
Whether it would really have
been much better if it had been
3000 or 4000 is a moot point,
because if you had looked at
aspirin and ischaemic heart
disease, say, in the late 1970s, I
think you would have found
1969–79 Aspirin trials
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something like five or six sizeable
randomized controlled trials, all
of which (bar one) showed really
quite similar sorts of results.
Typically there’s about a 25 per
cent benefit. None of these trials,
by and large, were statistically
significant in themselves, and
one, the AMIS (Aspirin
Myocardial Infarction Study),125
which showed next to nothing,
was by far the biggest of the lot. I
have always felt that I would
much rather have five separate,
disparate trials of 10 000
individuals rather than one of
50 000. Taking the aspirin
example, if AMIS had been the
only one that was done, the big
one, aspirin might have
disappeared forever from the face
of the medical earth, in terms of
thrombotic disease. There’s a
great advantage to having large
samples, but if it came down to a
choice between one large and
rather more medium ones, I
would go for the rather more
medium-sized ones every time,
with different people doing it,
slightly different designs or
different subjects. I think it is
much safer.
Janie Hughes
I think the most rewarding thing
of all that we have ever done is
the aspirin studies. I know it took
20 years to convince consultants
that this cheap little tablet could
be beneficial, but it really was
worth it. The first aspirin studies
were hard, hard work, trying to
recruit people by cold calling. I
think because we didn’t have a
reputation as yet. We were
visiting hospital wards and
taking names of men who had
been discharged after an MI. In
those days if you had had a heart
attack you were considered a real
invalid by your family and it was
hard to convince people that a
simple little aspirin tablet could
be of benefit to them. Whereas
now I think people have been
brainwashed and they know of
the benefits. Lots of papers have
been written, but those were real
pioneering days then in the early
1970s. Not that I was the
principal person who persuaded
them, but I usually chaperoned
somebody or other who was
doing it. 
Peter Sweetnam
Peter Elwood’s first aspirin trial
which was published I think in
the British Medical Journal in
1974.126 In the basement here
[in Canynge Hall, Whiteladies
Road, Bristol] you will find my
hand calculations for the life
tables and, literally, they were
done by hand. There are sheets
upon sheets of data, because we
still didn’t have access even then
to a computer on which you
could easily have done a life
table. It’s so difficult to try to get
things chronologically correct,
because I am sure that by then
the university had an ICL
System 4, and we used it for a
few years by going over to Park
Place in Cardiff, sitting down at
the punch-card machines and
punching out programmes and
control cards etc. We first started
doing that around about the
same time as I was doing the
analysis for the aspirin trial.
Writing a programme for a life
table analysis then was not the
easiest thing in the world to do.
[See also page 77]
Figure 52: John O’Brien, haematologist, St Mary’s
Hospital, Portsmouth, at a unit dinner following 
a scientific meeting for the Caerphilly study in 
the1970s. Seated on his left is Margaret Elwood,
and Ian Baker on his right.
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Peter Elwood
I had had a lot of contact with
the Department of Health, or
Ministry of Health as it was
then, following the work on iron
deficiency, and one of the
committees that I got on to was
on child nutrition and child
growth. So in collaboration with
the Department of Health, we set
up a study of child growth. We
selected 1000 pregnant women,
500 in Caerphilly and 500 in
Barry, a fairly stable town, not
too far from Cardiff. We followed
them during their pregnancy and
then we followed their infants to
the age of five. We made very
detailed measurements of growth
in the children and administered
questionnaires on nutrition, on
health generally, on their
psychological state, and a whole
lot of other things. Again the
point that I made earlier, the
ability in epidemiology and
particularly in an MRC unit, to
go back to a study or a cohort, is
unrivalled in a long-term unit
with secure funding. We went
back to those children and looked
at their school records and their
accidents when the children were
aged about seven and
administered a few questionnaires
to them to see if their early
growth and so on had affected
their situation later. We also
went back at 11 years and looked
at accidents in children, in
relation to a number of things we
had at baseline, but the real
value of that cohort is now being
shown by the Bristol group.127
Janie Hughes
In the early 1970s we worked in
Caerphilly on the child growth
and nutrition study. That was a
very popular study, because we
were giving out free milk to half
the women on the study and we
monitored their children until
they were five years of age, so we
were known. We weren’t known
terribly well, but we were
known, and when we started the
Caerphilly cohort studies in the
late 1970s – 1978, 1979, I
think – our reputation went
ahead of us and people seemed to
be very keen to join the study and
cooperate. We just worked from
there. And I mean these men,
now 20 years later, look on us as
friends. They have even been
known to ring up just to chat.
And we are still seeing them, still
monitoring their progress, still
doing tests on them, so I think we
have established a really good
rapport with these men. 
John Yarnell
Peter Elwood had started off
doing some work in the
Rhondda, both he and Michael
Burr had built up a relationship
with the Caerphilly general
practitioners and also
practitioners in Barry as well.
David Bainton had been at the
unit and he had done quite a lot
of work on the prevalence of gall
stones using the Barry
population.128
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Peter Sweetnam
It was mainly analysis of data.
The work was put in front of you
until one got a lot more
experienced when one got invited
along to join the discussions
about the design of the study in
the first place. The analysis in
those days was hard work,
because we only had
electromechanical calculators,
punch-card sorters (Hollerith
machines), so that even to do a
multiple linear regression with
two or three variables, if you had
200 individuals, was extremely
time consuming. If you looked at
the statisticians’ office then you
would have found mountains
and mountains of paper with
numbers on and sums of squares
on the ends of all the columns
and rows. And then one checked
them, double-checked them,
cross-checked them, trying to
make sure that you had actually
got it right, because of course it
was terribly easy to get them
wrong. There were also purely
practical things, such as the
electromechanical calculators,
which would jam regularly as
clockwork if you tried to be a bit
too quick with them. 
An electromechanical calculator
would be about 18 inches
square, with a moving carriage
on top. The keyboard had long
rows, of 0s, 1s, 2s, etc. You could
enter a two-, or perhaps three-
digit number at the left-hand
end of the keyboard and another
at the right-hand end. An
instruction to multiply that
number by itself would then
produce, on the moving carriage,
the square of the left-hand
number, the square of the right-
hand number and twice the
cross-product. These squares and
cross-products could be
accumulated. This could work
well, provided the original
numbers weren’t too large and
provided there weren’t too many
of them, when the sums could
overlap. But it was fairly easy to
get this wrong. The only
electrical assistance was to drive
the carriage up and down, the
rest of it was basically a
mechanical operation. Very, very
time consuming. I can’t actually
date this. Later we had what was
probably the very first purely
electrical calculator with a
programming capacity, called a
Monroe Epic. It consisted of a
box that was rather like the
electromechanical calculator,
and another larger box that
contained four large printed
circuits. There were two versions
of the Epic, one with 14
programming steps and another
with 42 steps. We, I think, had
the former. The machine had
four registers in which numbers
could be stored, but all
arithmetic operations were done
between registers 1 and 2.
Registers 3 and 4 were simply
non-accumulating stores. The
calculations that could be done
even with the 42 programming
step machine were thus very
limited as many programming
steps were used to switch
numbers between registers. These
Monroe Epic calculators would
have appeared around 1967–68.
Computers were beginning to
appear at about this time. I don’t
remember whether the unit sent
me, or whether I went of my own
volition to what was then
Newport Tech and did a
FORTRAN programming course
on an Elliot 803. That must
have been in the late 1960s. At
that time the only computer in
the university as far as I know
that was available for people like
me to use was a Stantec Zebra,
which was actually a valve
machine and where all the data
and the programmes were
inputed on paper tape, a real
nightmare of a problem to
handle. It was a very time-
consuming business and you were
really very restricted in the
analysis that you could do by the
sheer practical limitations. It
could take days to do a multiple
regression with this equipment,
unless there were very few
subjects, and just one or two
variables. 
Statisticians and technical preoccupations
Figure 53: Litton Monroe Epic 3000 keyboard 
and printing unit with free-standing calculating 
unit, introduced in 1967 as the first programmable
printing calculator. © Nigel Tout.
www.vintagecalculators.com/
Figure 54: Hollerith manual card punch, c. 1930.
Herman Hollerith patented a census machine in
1884, first used in the 1890 US census. He
established the Tabulating Machine Company in
1896, later part of the Computing,Tabulating and
Recording Company, the basis of the International
Business Machines Corporation formed in 1924.
© Computer Museum of America.
www.computer-museum.org/
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Peter Sweetnam
[Data arrived] usually on bits of
paper, sometimes it was decks of
[punch] cards. We had some
hand punches in the unit, the
nearest equivalent was the old
individual credit card machines,
with a block of metal and a little
keyboard, and you would just
slide the card in and type away
and the card came out punched
with the appropriate holes. There
was also another machine, a
verifier, whereby you’d put the
same card in and you would type
the same stuff in again, and it
would stop if you hit a key that
was different from the hole that
was actually punched in the
card. Staff like Janie [Hughes]
used to do that. Those machines
must have been available when I
started, because I am pretty sure
we would have used those on a
Hollerith counter-sorter machine.
The Hollerith could be set to look
at a particular column and it
would then run all the cards
through and sort them physically
into piles according to what was
punched in that column. It was
far from foolproof, although a
slick operator like Fred Moore,
the person who mainly used the
counter-sorter to sort the cards in
piles, would pack them all all
together and lift them up and
check that he could actually see
through the hole to make sure
that the machine hadn’t sorted
any into the wrong place. The
early machines just sorted the
card, they didn’t count. Having
counters on a machine was a
later addition. I think the one we
had when I first arrived would
have had counters on it as well. 
I didn’t do much of the actual
data punching. I don’t think 
that we ever had a large,
half-electronic card punch
machine like they used to have
over in the university, banks and
banks of them. I don’t know
whether Janie [Hughes] used to
go over to the university and
punch cards over there or up to
the Heath. At a later stage we
used the university department of
what was then called Medical
Statistics and Computing, of
which Hubert Campbell was
initially senior lecturer and later
professor, when they actually
appointed a professor, as there
wasn’t a professorship associated
with the department originally.
They had a sizeable department
of punch card operators and at
some later date and for most of
the Caerphilly data we would
actually pay them to enter the
data for us. In the early days it
would mean putting data onto
punch cards and later we used
direct entry, putting them onto
files on the computer and then
later on the floppy discs. People
like Janie were expert at it, she
was very, very fast. I got to the
stage where I was quite fast on
these machines, I could cope with
probably 7000 or 8000 key
depressions an hour. Janie would
probably be 50 per cent quicker
and the ones who were doing it
all the time probably double that
speed. A lot of data could be
punched in a short period of time. 
The counter-sorter could 
do cross-tabulations between
variables. You could also 
make cross-tabs between three
variables. If you imagine that
you have got three variables, each
with just three values each, then
you got 27 different possibilities,
which means you have got 27
different piles of punch cards. If
another variable is added with
four values, you are beginning to
get yourself in one hell of a mess.
Fred Moore was the obsessive one
who could do that, because it
really required somebody very
orderly, very meticulous, to do it.
Cross-tabs were about as far as
you could go on a counter-sorter.
Then you would do the
analysis – electromechanical
calculator, pencil and paper. And
it would be up as far as doing
multiple linear regressions with
two or three variables. If you look
at the papers from that date, that’s
very much the limit, because that
was the limit of what was do-
able. Correlation coefficients
weren’t not too bad if you had 50
subjects, but by the time you had
200 to enter and to calculate the
correlation coefficient, my
memory is that you could put on
the electromechanical calculator
you could put the x value down
the left-hand end of the keyboard,
the right-hand value down the
right-hand end and if you
multiplied that number by itself,
looking it as a whole number, you
could get on the moving carriage
the sum of squares of x at one end,
the sum of squares of y at the other
end and twice the cross product in
the middle. Provided the numbers
weren’t too large and provided
there weren’t too many numbers,
because eventually they would
start overlapping each other.
There was enough distance
separating the numbers, providing
the numbers weren’t too large or
too many. But by the time that
you get to 200, 300 or 400
numbers, you not only had the
problem of overlap on the
carriage, but to enter all those
numbers correctly, is a tedious task
to put it mildly. Again one has to
be a bit of an obsessive really.
Figure 55: Peter Sweetnam during
the Caerphilly–Speedwell study,
c. 1990.
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Elwood: I intend to talk about the community studies.
There were a number of strands in our thinking about
the Caerphilly study. One was our increasing contact
with John O’Brien,129 a very, very bright and active
platelet expert at Portsmouth, who is still working and
publishing on platelets well into his eighties. Another
strand was that David Bainton, who unfortunately isn’t
here, left the unit after working on gall bladder disease
and went to Bristol to set up the Speedwell study. You
will notice in our publications, it is very often
Caerphilly and Speedwell.130 He set up the Speedwell
study and the initial hypothesis was to look at HDL
(high density lipoprotein) cholesterol and the incidence
of ischaemic heart disease. Very shortly after that we set
up the Caerphilly study and they were set up as twin
studies. I often call them that and people ask, ‘Where
did you get 2500 twins living in Bristol and in
Caerphilly?’ Well, of course, that’s not what I mean. We
set up these two studies in parallel, with the same
methodology, the same laboratories, with the aim of
comparing variables between the two areas, one with a
high incidence of ischaemic heart disease, the other
with a slightly lower than average ischaemic heart
disease, or of combining the two cohorts and having
almost 5000 subjects. I think the success of the
Caerphilly studies, and they have been enormously
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successful, depends on a number of factors. One was the
teams that we had, and I would like again to pay tribute
to Janie Hughes and Marion Jones, who were meticulous
in getting a high response rate and in the quality of the
data that were collected, and then Peter Sweetnam, in the
meticulous analyses that he performed. They were set up
20 years ago and we are still seeing the men. The men in
the Speedwell study are being seen currently and no
doubt plans will shortly be formulated to see the
Caerphilly men again. We published some 120 papers on
ischaemic heart disease131 and we’ve looked at a whole
range of things from homocysteine, to haemostasis, to
lipids, to lifestyle factors, to psychological factors with
John Gallacher and Stephen Stansfeld.132 A tremendous
range of data was collected and looked at in a predictive
way. Then in the last two to three years Janie Hughes and
I have identified every stroke and TIA (transient
ischaemic attacks) as completely as possible in the
Caerphilly study and with help from people in Bristol,
we have done the same in the Speedwell study. We now
have a complete list of strokes and TIAs and we will be
able to examine prediction by all of these risk factors
which were originally collected in relation to heart
disease. We will be able to look at them as predictors of
stroke and TIA. I see this study as making a tremendous
contribution over and above what we have already
published on ischaemic heart disease. I mentioned one of
the reasons for its success and that was the team that we
had and their dedication to these studies, but in addition
we set out to enlist collaboration as widely as possible,
and there is a tremendous number of people in this room
and elsewhere, who have received either data from the
studies, or who have given us ideas to work on, in
collaboration with them, or have actually come down
and collected data with us, like Stephen Stansfeld.
131  
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See, for example, Gallacher J E, Yarnell J W, Sweetnam P M, Elwood P C, Stansfeld S A. (1999) Anger and
incident heart disease in the Caerphilly study. Psychosomatic Medicine 61: 446–453. Stansfeld S A, Sharp D S,
Gallacher J E, Yarnell J W. (1992) A population survey of ischaemic heart disease and minor psychiatric disorder in
men. Psychological Medicine 22: 939–949. Stansfeld S A, Gallacher J E, Sharp D S, Yarnell J W. (1991) Social factors
and minor psychiatric disorder in middle-aged men: a validation study and a population survey. ibid. 21: 157–167.
Figure 57: Janie Hughes, c. 1968.
Figure 58: Marion Jones, c. 1968.
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See Appendix for the list of collaborators provided by Dr Peter Elwood.
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See, for example, Strachan D P, Carrington D, Mendall M A, Ballam L, Morris J, Butland B K, Sweetnam 
P M, Elwood P C. (1999) Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic
heart disease over 13 years in the Caerphilly prospective heart disease study. British Medical Journal 318:
1035–1040. Strachan D P, Mendall M A, Carrington D, Butland B K, Yarnell J W G, Sweetnam P M, Elwood P
C. (1998) Relation of Helicobacter pylori infection to 13-year mortality and incident ischemic heart disease in the
Caerphilly prospective heart disease study. Circulation 98: 1286–1290.
Stephen came down repeatedly to Cardiff and collected
data on psychosocial factors and I think the level of
collaboration that we enlisted for that study was really
quite remarkable. Its value lies not just in what the
epidemiology unit put into it, but I listed over 40
collaborators in one of my summaries of the study, all of
whom had put a substantial amount of work into either
the ideas, the collection of data, or the analysis of the
data.133 Our policy, certainly under my direction, was to
enlist as many collaborators as possible, and to be as free
and open with our data as possible. We collaborated with
David Strachan who gave us some marvellous ideas on
chronic infection and we released stored serum samples
for that and a number of papers have come out.134 This is
the story again and again of the Caerphilly and the
Speedwell studies, and again if I may pay tribute and
express my thanks to Stephen Frankel, George Davey
Smith, Andy Ness, Yoav Ben-Shlomo, that all those data
are going over to Bristol and will continue to be worked
on and exploited, but that’s after 1990.
Dr Stephen Stansfeld: I’d like to follow up Peter
Elwood’s comments on collaboration in the Caerphilly
study. I first became involved in the Caerphilly study in
1983 when I was working with Professor Michael
Shepherd at the general practice research unit in the
Institute of Psychiatry. I was becoming interested in the
relationship between psychological disorders and
coronary heart disease and he told me, ‘Go and see
Peter Elwood in Cardiff,’ which I did and Shepherd
actually accompanied me at that time. Thus began an
involvement with the Caerphilly study that I have had
ever since. I was always impressed with the very high
standard set by the Epidemiology Unit in the collection
of data in the Caerphilly study, and as Peter has
mentioned but underplayed, his generosity in allowing
the data to be used by others. He always, I feel, had a
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real respect for the cohort, he wasn’t just going to allow
the data to be used willy nilly. He always made it quite
clear that one had to come up with very clear scientific
ideas, some clear hypotheses to test before one was
going to be allowed any access to the cohort and I think
that this was particularly so if one was going to be
measuring things like mental illness. There was a
certain amount of suspicion, I think, that had to be
overcome, perhaps understandably, before I was going
to be allowed to go out and do some psychiatric
interviews on cohort members, which I subsequently
did. But I have overwhelming gratitude to Peter and the
team for allowing me to be involved. It has allowed me
to look at all sorts of interesting things, like the
relationship between coronary heart disease and
psychological disorders. Also, at that time one of the
variables being considered as a potential risk factor for
coronary heart disease was noise exposure, and that’s
allowed me to piggy-back on to that study,135 to look at
road traffic noise exposure and psychological disorder
longitudinally, there have been very few opportunities
to do so. Altogether, I am very grateful to Peter and I
hope that there will still be opportunities for
collaboration with this wonderful team and data set.
Doll: We have plenty of other things to discuss, so let’s
go on to another subject. Dr Burr, I think you have
done some work on asthma136 that you might like to
comment on.
Dr Michael Burr: I joined the unit in 1970. Peter
Elwood was not at that time Director, Archie Cochrane
was, but Peter Elwood saw me first and advised me at
the interview to be sure to bring in the word
‘randomized’ somehow, somewhere, so I duly did and
was appointed, for which I am very grateful. And we
did some work on asthma, surveys of asthma, and
randomized trials of asthma, particularly in relation to
135 
Stansfeld S, Gallacher J, Babisch W, Shipley M. (1996) Road traffic noise and psychiatric disorder: prospective
findings from the Caerphilly study. British Medical Journal 313: 266–267. 
136
For another example of postwar developments in asthma treatment, see Reynolds L A, Tansey E M. (eds) (2001)
Childhood asthma and beyond. Wellcome Witnesses to Twentieth Century Medicine, vol. 11. London: The Wellcome
Trust Centre for the History of Medicine at UCL.
Figure 59: Receptionist takes survey details, c. 1965.
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Burr M L, Neale E, Dean B V, Verrier-Jones E R. (1980) Effect of a change to mite-free bedding on children
with mite-sensitive asthma: a controlled trial. Thorax 35: 513–514.
138
Burr M L, Eldridge B A, Borysiewica L K. (1974) Peak expiratory flow rates before and after exercise in
schoolchildren. Archives of Disease in Childhood 49: 923–926.
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Strachan D P. (1989) Hay fever, hygiene and household size. British Medical Journal 299: 1259–1260. Cookson
W O C M, Mofatt M F. (1997) Asthma: an epidemic in the absence of infection? Science 275: 41–42. 
140 
Burr M L, Butland B K, King S, Vaughan-Williams E. (1989) Changes in asthma prevalence: two surveys 15
years apart. Archives of Disease in Childhood 64: 1452–1456.
elimination of house dust mites from the bedding.137
The early trials of that were not particularly good,
looking back, and not surprisingly we didn’t get rid of
the mites, and therefore we didn’t improve the asthma.
Later on we did randomized cross-over trials, with new
bedding versus old bedding, which did show an effect,
and I have had an interest in asthma ever since. 
Elwood: That’s even briefer than the talk about aspirin.
Michael did some beautiful surveys of asthma in
schoolchildren over time,138 and I think his evidence of
the recent increase, recent doubling and more, of the
prevalence of asthma among school children is among
the best in the whole country and perhaps
internationally. He has also gone on to do studies of
asthma in different countries, so the unit made quite a
big contribution. But my disappointment is that there
are no new hypotheses to test and so although one can
continue the work, we really need some fresh thinking
on asthma and I don’t know of any. 
Burr: I think there are new hypotheses, all right. They
are coming out all the time as David Strachan can
support me in saying. I think the one I like the most is
that it’s all due to being too hygienic for our own
good,139 I think that’s quite an attractive hypothesis, but
there are plenty of others, indoor air pollution and
other things. We did a survey in 1973 of asthma in
school children, which I was able to repeat again in
1988 in the same area, using the same methods,
questionnaire and an exercise challenge test, very easy to
do, great fun to do, and over an interval of 15 years it did
demonstrate an increase, as others have shown since.140
Professor David Strachan: I guess that I am representing
the respiratory epidemiology community as much as
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anything. I think what impressed me when I first met
Michael [Burr] in 1985 was that at that stage it was clear
that people were having a great debate about how to
measure asthma. Asthma epidemiology was becoming
dominated by clinicians who had a great interest in
measuring precisely, but in a rather cumbersome manner,
the reactivity of the airways to various compounds, many
of them pharmacological. What attracted me about the
work that Michael had done was that here was a very
simple, acceptable, free-running exercise test, which was
not only measuring something that was easily applied in a
population survey, but was also measuring a natural
stimulus to asthma which was actually a relevant
challenge to the child and a relevant challenge in terms of
the burden of public health. I think the intervening
decade has vindicated that general approach of using a
simpler tool in larger numbers rather than more complex
tools in smaller numbers.141 We are seeing now with
asthma epidemiology a tendency to revert to measuring
physiological challenges as much as pharmacological
challenges, partly for ethical reasons and partly because we
feel that they can be applied in more representative
population samples. I would very much like to see a third
survey of children in south Wales to see whether asthma
has increased further over the period since 1988. I always
say there’s a prize awaiting the person who shows that
asthma is not increasing any more and decides that it is on
the decline. No one has yet published a paper to say so.
Wade: Can I just ask a question about the further
history of those children that you saw in the first survey.
Does their asthma get worse as they get older or does it
get better? Or does it not change?
Burr: We did follow them up, though we never
published the results, and I believe the questionnaires are
still in existence. They did in fact get better individually.
I am speaking now from memory, not having done a
formal analysis, but it was clear at the time they were
getting better, 12 is about the sort of age from which you
141  
See, for example, Asher M I, Keil U, Anderson H R, Beasley R, Crane J, Martinez F, Mitchell E A, Pearce N,
Sibbald B, Stewart A W, Strachan D, Weiland S K, Williams H C. (1995) International Study of Asthma and
Allergies in Childhood (ISAAC): rationale and methods. European Respiratory Journal 8: 483–491.
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history of allergic disease. British Journal of General Practice 51: 664–665.
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In 1968, the provision of free milk was abolished in secondary schools, and in 1971, Baroness Margaret
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J, Jones M, Moore F, Sweetnam P M. (1980) A randomized controlled trial of the effect of the provision of free
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entitlement to a milk supplement. Archives of Disease in Childhood 56: 831–835.
tend to improve. That was not a follow-up study, though
I have done follow-up studies since of a cohort of
children and we are actually analysing one now,142 which
was set up when I was with the Epidemiology Unit.
Wade: Why do they get better?
Burr: An interesting question. Airways get bigger with
age, but that’s probably not the only reason.
Elwood: My contact with the Ministry of Health was
Bill Berry from the iron studies, and they [MoH] asked
us later when school milk was stopped [1972] if we
would evaluate the benefit of school milk, welfare milk.
We set up two studies actually.143 Welfare milk in those
days was supplied to all pregnant women and all
children under five and to all school children, but it was
very severely curtailed, it wasn’t actually stopped, but it
was very severely curtailed [in 1972]. We set up
randomized controlled trials in both those groups. We
selected 1000 pregnant women and arranged for the
tokens to be issued to them and to all their children
under five – at Ministry of Health expense. The ‘index
child’ from that pregnancy was followed to the age of
five, half were supplied with milk tokens and half were
not, and we monitored growth in those children and we
collected a lot of further information. At the same time,
we ran a trial in school children where we selected
schools by a number of well-defined criteria to get the
most nutritionally vulnerable children and we set up a
randomized controlled trial in something like 600
children, seven to nine years of age. Half of them were
supplied with school milk and half were not. Just to
Figure 60: Janie Hughes, c. 1966.
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make a point in passing about the Department of
Health’s response to our answers, we had shown that iron
added to bread was of virtually no benefit, but it is still
added to white flour in this country. We later showed
that school milk was of benefit to the most vulnerable
children, but it was never reintroduced, so the
effectiveness of that research can be called into question.
Here I must pay tribute to Janie Hughes and to Marion
Jones, who is not here, and other members of the unit.
Those data were collected, filed and coded meticulously,
and all those records have gone over to Bristol now. One
very exciting development of that work is that the team
in Bristol is picking up a number of our surveys,
including those surveys on children, growth and
nutrition of children, and are doing further studies on
the children. The children who were seen while they
were intrauterine until the age of five are now aged 27,
and a survey is just about coming to completion.144 Early
markers of diabetes and heart disease are being sought in
those young adults and they no doubt will be surveyed
in another ten, another 20 years to see the development
of ischaemic heart disease. It is just one of the greatest
thrills that virtually all the data, thousands of stored
blood samples, serum and plasma samples, are all going
over to Bristol, and I would like to take this opportunity
to thank Stephen Frankel, George Davey Smith, Yoav
Ben Shlomo, Andy Ness, and others back in Bristol, that
they are taking over our surveys and basic studies and are
continuing that work, it’s tremendously thrilling.
Doll: We have purposely decided that the discussion
today ends in 1990, so we won’t have any extended
discussion of the great contribution that’s being made
in Bristol now by taking over the ERU studies, but it
has been nice to hear this recognition by Peter Elwood
of what is being done in Bristol now and his gratitude
to them. I am sure we all feel the same.
Hughes: As Dr Elwood said, I kept all the records, I
didn’t actually do any of the visiting of the children and
their mothers, but what I did do is that at the end of the
144 
Montgomery A A, Ben-Shlomo Y, McCarthy A, Davies D, Elwood P C, Davey Smith G. (2000) Birth size and
arterial compliance in young adults. Lancet 355: 2136.
Figure 61: Marion Jones measures
sitting height with a Holtain
stadiometer in the Caerphilly study,
c.1980.
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Dr Peter Elwood wrote: ‘The Holtain stadiometer was a highly accurate instrument for measuring standing or sitting
height, later with a digital readout. Along with other Holtain instruments  including skin-fold and bone calipers, it was
made by an engineering firm in west Wales.’ Note on draft transcript, March 2002. See Figure 61 page 86.
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transcript, 8 April 2002. See Burr M L, Fehily A M, Rogers S, Welsby E, King S, Sandham S. (1989) Diet and
reinfarction trial (DART): design, recruitment, and compliance. European Heart Journal 10: 558–567. 
study I measured every single child with a Holtain
stadiometer145 and this is my claim to fame, this is the
one thing I was trained in. I was sent to St Thomas’
Hospital to be trained how to measure the children
properly. And similarly in the milk supplementation
study in schools I measured the children with a
stadiometer, also skin-fold thickness. I was actually shown
how to do it properly. In those days we didn’t just work
Friday afternoons and Monday mornings on survey, if we
had 2000 people to see, we just worked every single day
until we had seen the whole lot, there was no let up. We
worked very hard and very long hours, and we just
continued seeing people, until we had seen the whole of
the population or the cohort, whatever it might be.
Burr: The DART study arose as part of a number of
studies on diet and heart disease. Not all of the unit
studies were in the Rhondda or in Caerphilly. For
example, we set up a cohort of 10 000 people who were
health food shoppers, a somewhat eccentric group, but
they are still being followed up in Oxford and
interesting findings are coming out of that. We also
conducted a number of small randomized controlled
trials on subjects like fish, fibre, alcohol, vitamin C,
coffee and decaffeinated coffee, looking at short-term
end-points in relation to various physiological indices
of heart disease. Then out of that we embarked on what
was a very ambitious trial, looking at men who had just
had a myocardial infarction to see whether secondary
prevention could be undertaken by means of dietary
change. In the end we enlisted 2000 men who’d just
had a myocardial infarction. They were randomized in
a factorial design, so that there were three separate
factors that they could have any combination of, or
none at all: advice to eat less saturated fat; secondly, to
eat more cereal fibre; and thirdly, what was then quite a
new idea, advice to eat oily fish.146 I should say that this
Figure 62: Cookbook issued to
subjects in the diet and reinfarction
trial (DART), prepared by Elaine
Vaughan-Williams, Senior Dietician,
no date, c. 1990.
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idea came out of a meeting that Ann Fehily (who was
then a nutritionist with the unit) had attended, and she
came back saying that people were talking about the
importance of oily fish and this seemed a rather cranky
idea, but we thought that if we were going to set up a
trial, we might as well test something new, and be a bit
original. So we set up this trial and 2000 men were
admitted to it. The advice to eat less saturated fat fell on
deaf ears, the south Wales men were addicted to their fats
and wouldn’t change. Advice to eat more cereal fibre was
taken up, but sad to say, it did them no good. In fact, to
our dismay, the results went in the wrong direction.
Mercifully they did not achieve statistical significance,
but it caused us some anxiety. But oily fish was the right
stuff to give them, because it produced a 29 per cent
reduction in all-cause mortality within two years of
starting.147 I have always felt that that was something
worth doing, as oily fish is pleasant to eat, you don’t have
to live on it, just two good meals a week is sufficient, as
long as you eat the right sort of fish, not the stuff you get
from fish and chip shops. 
Doll: I think you should tell us the 95 per cent
confidence limits of your 29 per cent reduction.148
Burr: I am sorry I don’t have them with me. In those
days that was not quite so important as it is now, but I
assure you they were quite respectable.
Wade: I think it has made quite an impact on some of
my cardiological colleagues anyway. Brian Prichard spent
a whole lecture on it. My short-term memory is badly
affected. I need whatever it is that is good for Alzheimer’s.
Burr: Excuse me, oily fish may do that as well you know!
Elwood: Aspirin is even better!
147 
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(1989) Effects of changes in fat, fish and fibre intakes on death and myocardial reinfarction: diet and reinfarction
trial (DART). Lancet ii: 757–761.
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See Fehily A M, Burr M L, Phillips K M, Deadman N M. (1983) The effect of fatty fish on plasma lipid and
lipoprotein concentrations. American Journal of Clinical Nutrition 38: 349–351. Fehily A M. (1985) Dietary fibre,
fish and blood lipids. Nutrition Bulletin 10: 36–42. Rogers S, James K S, Butland B K, Etherington M D, O’Brien
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Figure 63: Ann Fehily, c. 1980.
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For example, the Framingham Heart Study of the US Public Health Service. See Dawber T R, Meadows 
G F, Moore F E Jr. (1951) Epidemiological approaches to heart disease. American Journal of Public Health
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150
See Last J M. (1983) A Dictionary of Epidemiology. Oxford: Oxford University Press, 10.
Burr: Oily fish is good natural stuff. 
Waters: We are asked to try to say in the Witness
Seminar what was the achievement of the unit, and
obviously at face value, the achievement of the
Epidemiology Research Unit was to conduct a large
number of population studies, in a wide variety of
diseases that were all fairly common, or common enough
to be significantly represented in random samples of the
general population. The unit wasn’t the first to do that,
there were a number of other studies done earlier,149 and
the technology that was required to do these studies was
available to anyone at that time. The situation was, of
course, changing, data handling, computers and so on,
were evolving during this period of time, but I think the
achievement of the unit was not just to do this variety of
studies, but to back them up with scientific credibility.
Many people have mentioned the high response rates
that were necessary. We have also heard the examples of
the reproducibility of chest X-rays, the validity of
measurements and eliminating bias,150 and bias was one
thing I was very conscious of, at the unit, throughout the
time that I was there. Everything that was done must be
done to a very high standard, and I think it would have
been quite easy, with different personnel at the unit, to
have used the technique of random samples of the
general population, but done rather sloppy research, with
smaller numbers and lower response rates, creamed off all
sorts of areas, but in a second-rate way.
I think that the achievement of the unit really was this
very critical attitude to all the data that it collected and
particularly to the elimination of bias. This was due to
Archie’s attitude and to the inclusion of statisticians on
the unit’s staff.
Tyrrell: Can I just add that as Charles Fletcher’s arrival
Figure 64: Ann Fehily, Michael Burr and Elaine
Vaughan-Williams during the randomized controlled
dietary trials, c. 1989.
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at the unit has been brought up, that I worked with
Charles Fletcher in a small way much later and I could
see then something that he had brought from the unit
which was his great respect for first-class statistical
work, and I remember him saying to me once, ‘There’s
this young man, he’s very clever with numbers, and he’ll
actually be able to work out what all these data that we
have collected means’. This was in connection with a
bronchitis survey,151 and I had been pumping in data
along with other people, and it had just become a
mountain of data. This bright young man was Richard
Peto. So he not only appreciated his skills, but he
spotted another man with potential. 
Thomas: We ought to pay tribute to Peter Sweetnam, he
can’t be here today. He’s the statistician at the unit, he has
been at the unit from 1966 up to now, as we are finally
decommissioning the unit, and officially closing next
week. Peter [Sweetnam] has worked on virtually all the
major projects that we have been involved in. [See table
on page 38]
It has been alluded to by David Tyrrell that doctors very
often are good at collecting data and then rather slide
up to the statisticians and say, ‘Well we have got this,
can you look it?’ ‘What does it all mean?’ Well, we
haven’t been like that at the MRC but in a sense, like
many research units, I think it is always hard to get the
amount of statistical back-up that you would like for a
lot of the projects. There are often competing
researchers, collecting a variety of data, and in a sense
we are all subject to the different fashions of ways of
looking at data and though it might be very easy for us
to suggest another way of reanalysing the data, it can
involve them in a lot of work. And Peter Sweetnam has
got on with this determinedly over the years. He has
been thorough, and I think for many of us, as doctors,
we are not used, very often as clinicians, to dealing with
such errors in such detail and such exclusive definitions
151 
See Fletcher C M, Elmes P C, Fairbairn A S, Wood C H. (1959) The significance of respiratory symptoms and
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questionnaire is reproduced on pages 265–266. See also Medical Research Council. (1966) Questionnaire on
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history of chronic bronchitis. Community Health 7: 70–78.
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and so on, and statisticians can be very helpful in
getting us to think rigorously and logically about what
we are doing. Peter Sweetnam has done that and I think
all of us who have worked with him would agree. He is
co-author on around 100 papers from the unit,
including the early aspirin studies. It is interesting to
look at the early analyses, they were virtually worked
out long-hand on sheets of paper with long lines, as was
the asbestos follow-up, because some of these early
analyses were done without the benefit of the modern
computing systems and packages and so on, and it took
a lot of very detailed calculating and often, as most
statisticians complained, of tidying up our data before
they could analyse it.
Elwood: Perhaps I am anticipating, but if I may just say
here that one of the things that I find very interesting is
the totally different styles of management that Archie
and I had. Archie almost never called a unit meeting,
whereas I had a weekly unit meeting. 
Archie seemed to give tremendous encouragement to
individual people in the unit to get on with their work
and their ideas and develop them, but I always took
the view that the whole unit had combined
responsibility for everything that was done within the
unit. So the style of management was totally different,
but Archie had this marvellous ability of just coming
round occasionally and seeing me and then seeing
others at different times and he would just put his
finger on a weakness or on an opportunity that we
hadn’t already spotted. He was enormously
stimulating in that way.
Weddell: I actually differ from Peter when he said that
Archie wasn’t a good manager. I think he was a very
good manager. He wasn’t in the unit a great deal as
Janie [Hughes] has just mentioned because he was
away so much, doing so many things, but the days he
was there he used to come in and see all of us, in our
rooms, in his own time, and so if you had a problem,
you could actually talk to him, there was never any
question of queuing up to see Archie, he came round
and saw all of us.
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Pemberton: I was a contemporary of Charles Fletcher
and Archie Cochrane, but I didn’t have anything
directly to do with that unit, but we did meet at the
International Epidemiological Association (IEA)
meetings.152 I remember that Charles Fletcher, for
example, gave a paper on his bronchitis questionnaire,153
which so many people afterwards adopted in
epidemiological studies of bronchitis. We used that in
the flax byssinosis survey that Peter Elwood referred to
just now. I know Peter was glad when I introduced him
to Archie Cochrane, but when he went to south Wales
to work with Archie it was a great loss to us in the
Department of Preventive and Social Medicine at
Queen’s University, Belfast. He took to epidemiology
like a duck to water and I remember coming into the
department one morning when he told me that he had
been out knocking on doors in a street off the
Grosvenor Road, saying to the ladies who answered the
door, ‘Could I come and take some blood please?’ and
he got away with it. I was a bit alarmed when he told
me this. I said, ‘Well, Peter, you may be accused of
assault, rape and goodness knows what’ and suggested
he should take a social worker with him. 
Elwood: The study had a 97 per cent response rate.154 It
represented a sample of women on the electoral role of
Belfast, and Archie was very impressed, and I am sure that
was one of the reasons that he agreed to give me a job.
Tudor Hart: We really have to think about collective
organizations and how you enlist the support of a
population and the sort of thing that Owen [Wade] was
talking about as these sort of studies eventually became
152  
See Pemberton J. (1998) Social medicine comes on the scene in the United Kingdom, 1936–1960. 
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(www.socsocmed.org.uk/HistoryPhoto.htm) for a photograph of the 1958 IEA meeting in Dublin, provided by
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Figure 65: First meeting of the International
Corresponding Club (renamed the International
Epidemiological Association in 1959),
held at the Hotel Noordsee, Noordwijk,
The Netherlands, 1–6 September 1957.
In this selection, L to R: Back row:
(Sir) John Brotherston, Henry Makoveu,
Xavier Gellé, Charles Fletcher, John Lee,
Maurice Backett and Alice Stewart. Second
row: George Reader, Richard Doll,
R Hitchens, Lester Breslow and R F L (Bob)
Logan. Sitting:William Pickles, Joan Faulkner 
and Herman Hilliboe.
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studies, we found that when we did the pilot studies in
Glyncorrwg using Owen Wade’s methods and Archie’s
methods – public meetings and explanations and
answering these really very sensible questions about
‘Why me and not him?’ – we found that nobody else
would do it. None of the other GPRF practices thought
this was a sensible way to go about things and they
thought that miners and mining communities were a
special environment and nobody else could do this, and
that’s not so. So it isn’t only a matter of these anecdotes.
I think the truth is that the most telling anecdotes are
really very characteristic about what it is that motivates
people to take part in studies. I wanted to end up with
what didn’t happen, but could have happened, from
this foundation which was laid in the 1960s. The
Rhondda Fach had a population of around 10 000 at
that time, and the repeated studies, particularly where
the samples were large and overlapped, meant that you
were accumulating a more and more complex profile of
all sorts of different social and clinical problems and
you were accumulating them over time. And had the
unit staff persisted with that, we could have ended up
with a population that was very much more completely
described, where all the different studies would have fed
into one another and been multidimensional, and it
could have linked up with clinical care and it could
have linked up with a periphery of excellence, of clinical
excellence. That never happened and the studies moved
out of the Rhondda Fach over to Caerphilly and I do
suspect, because at the time I was there fatigue was
beginning to set in in the population, that researchers
were beginning to find that they were getting lower
responses, as people repeatedly found themselves in the
samples. So the answer was to move house and start
with a new population, and I don’t think that would
Figure 66: Eleventh scientific meeting of the
International Epidemiological Association, Helsinki,
Finland, August 1987. L to R: Professor John
Pemberton, Dr Joan Faulkner (Lady Doll) and
Professor Sir Richard Doll attended the first
meeting in 1957.
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have been necessary if we’d found a way to link up
clinical care, primary care, in the Rhondda Fach with
research studies. I think a failing that Archie had, and
that really was common to practically everybody
associated with the unit at that time, was a feeling that
there was a completely unbridgeable gulf between the
data requirements for epidemiology and the data
requirements even for very good clinical medicine. In
view of the appallingly low quality of clinical medicine
when you were seeing people at two- to five-minute
intervals in the Rhondda it was just unthinkable that
this could be incorporated into the research design, but
I don’t think it was unthinkable, and I think we ought
to be starting to think like that now.
Dr Andy Ness: One point. The story of the shillings.
D’Arcy Hart describes how the MRC sent shillings
[half crowns, 2s.6d., 121/2p] on the train to the miners
in, I think it was, the 1937 survey.156
Wade: Can I say that I agree very much with what Julian
[Tudor Hart] said, and I can’t remember ever paying any
miners. We worked up enthusiasm for the surveys. The
older man would bring in the younger man, that’s what
I remember, because we had taken a lot of trouble about
the survey publicity that we did in these areas. 
One other comment that I would like to make about
the interviews of these patients. We really learnt an
awful lot. I remember John Gilson, I think it was up in
Whitehaven, or perhaps up there on the coast in north-
west England, one of the pits that goes right under the
sea and we, Gilson and Philip Hugh-Jones, somebody
else and I, all had to interview the people before they
were X-rayed. They would have a short ten-minute
interview. One of the interesting things was that three
of us, when we asked the question about whether they
had ever worn a gas mask underground, we only had
about 1 per cent who told us that they had worn a
mask, but John Gilson had about 8 or 9 per cent in his
lot, and the reason for it was that John had worked in
156
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the RAF during the war, was interested in gas masks
and obviously he put over this question in a slightly
different way from us. He said, ‘Have you ever worn a
gas mask?’ and there was obviously something in the
way he said it or the influence he had. So he got chaps
that would say, ‘Oh yes, I did wear one for a day, last
Christmas time’ or something like that. He got positive
results, while we got negative results. I think the
accuracy of such questions are very interesting, from the
point of view of survey work.157
Weddell: Tudor Hart was mentioning the factor of
survey fatigue and this particularly affected the
Rhondda, and I am sure someone else is going to tell
this story, but there was a Mr Jones who came up for
the fifth time in a survey and he saw Archie because he
was one of the refusals, and he said, ‘How is it that my
name has been drawn so many times?’ and Archie said,
‘Well we put all the names in a hat, and we shake them
up very, very well, and then draw out a certain
percentage at random’. ‘Oh I see,’ said Mr Jones, ‘A
bloody funny hat!’
Strachan: I am interested in asking a question of those
who were working with the unit in those relatively early
days as to whether there was a concept of a career in
epidemiology? This is a question that has really posed a
lot of problems over the last 20 years; whom do we wish
to recruit as epidemiologists, how do we encourage them
to acquire a set of skills, and is there a career structure
that they can pass through? I would be interested to hear
the perspective of those working for the unit, and
perhaps people from the MRC who were interested in
overseeing the units, whether they feel there was a career
structure, whether the unit offered stepping stones to a
career and what the concept was at this time of the
epidemiologist in training for the 1970s and 1980s?
Waters: I was thinking of that very point when I was
considering this meeting and my recollection is that I
enjoyed the work there and thought that it was
important. I didn’t have any particular view about
Figure 67: Marion Jones does an
ECG in the Caerphilly study, c. 1989.
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where it was leading me; I just stayed on, for over five
years, because I found it stimulating and exciting. I was
not aware of any career structure in epidemiology and
was surprisingly unconcerned. 
Doll: Professor Pemberton, would you like to
comment on that? Or can I tempt you to comment on
something else?
Pemberton: In the International Epidemiological
Association (IEA), we met a lot of these people each year,
and that sort of mixing and meeting of people helped
them to transfer these ideas and to inspire each other.158
Dr Shaun Murphy: Could I ask the general question
about the fact that obviously during the war years and
the immediate postwar years, the MRC emphasis on
occupational health research was a very important
directional influence, but into the 1960s, the 1970s and
the 1980s, to what extent was government policy and
MRC policy influencing the choice of subjects for
surveys?159 Peter Elwood has mentioned the
Department of Health’s interest in the milk studies and
the iron studies, but were most of the projects that were
undertaken the result of an individual’s research
interests, or were there examples of the Government,
government bodies or the MRC influencing the choice
of subjects?
Elwood: I would say it was very unusual for a statutory
body of any kind to influence research helpfully. I think
one of the things we all set ourselves was to watch the
literature, to go to meetings, and to pick up ideas that
were not only worth researching but feasible, and these
were difficult criteria to apply. Usually government
bodies saw questions that were either not worth
answering or were not feasible to answer. I often refer to
those two areas of work, the iron deficiency and the
school milk, but I always add the outcome of them, that
iron is still added to your white flour, and most of our
deprived children do not get school milk although they
158
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would benefit from it. The Ministry of Health, or
whatever department, paid no attention to the results.160
Doll: I can’t resist following up the lead given by Peter
with an experience of my own. Following the
Rothschild recommendations when so much money
was taken away from the MRC and given to the
Department of Health for commissioning research, I
was phoned by the Chief Scientific Officer of the
Department of Health, ‘Would I be interested in
having under this commissioning system a cancer
epidemiology unit?’ Well I had quite a lot of support for
my department, but I thought a little more support
wouldn’t harm so I said, ‘Well, yes, all right if you give
us the money’. So they gave me quite a lot of money,
and then that was that, they didn’t say anything about
doing any work. The whole time I had that unit, I had
two requests from the Department of Health to do
work, one of them was so obvious that I had been doing
it already for the past two years, and nearly had the
answer, and the other was impossible to do. After some
time, because the Department of Health refused to give
career appointments to scientists, I succeeded in getting
the unit switched from the Department to the Imperial
Cancer Research Fund. But I think some other people
may wish to provide some personal experiences in
response to the question that we were asked.
Booth: Well, as somebody who sat on the Medical
Research Council in the post-Rothschild years I can tell
you exactly what happened at MRC level. There was, if
I remember, a biennial meeting, maybe annual, but
what happened was that the chief chap at the
Department of Health, who in those days was Sir
Patrick Nairne, came to a meeting of the MRC and they
had a list of things they had been provided with by the
MRC, which the MRC was already doing. They went
down to the meeting and said, ‘Right, under the money
paid over by the Department of Health, we’ll have this,
we’ll have that, and this, that and the other’.161 It was
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already happening, it wasn’t the Department of Health
making a plea for certain things to be done, it was the
Department of Health choosing to fund what the MRC
was already doing and saying, ‘We’ll put it under the
budget we support’. Now there are two very
distinguished MRC administrators [Faulkner and
Howarth] behind me who might wish to comment on
that. Knowing them, I don’t suppose either will wish to,
but the pressure on them to speak is considerable.
Faulkner: I remember one or two things that were
suggested by a group of medical officers from the
Department of Health when we had a meeting with
them to discuss commissioning research. One was that
they said beds were being used a lot in the National
Health Service to look after people disabled by
disseminated sclerosis, multiple sclerosis, and would we
do research on that, please. And so we told them that
we already had a unit in Newcastle that was devoting
most of its time to research on that subject162 and also
that people all over the world were hoping for a Nobel
Prize by solving the problem of multiple sclerosis, so we
couldn’t really think of anything else to do. The other
was research on incontinence, which was also a great
problem. And they said we had to set up a committee,
I don’t remember what the outcome was, but we set up
a committee on research on sphincters. Do you
remember any more about that, Sheila?
Howarth: No, I don’t think it went much beyond having
a couple of conferences on the subject. We had various
recurring chestnuts, didn’t we? Tonsillectomy was one. It
was a great expense to the NHS and the health
departments, so would the MRC do a trial to decide
whether tonsillectomy in children was worthwhile? Low
back pain was another, wasn’t it? And how to stop
children smoking, that was another one. Those are just
three I can think of off the cuff, and they were recurrent.163
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Booth: If I could just comment, because the only man
I knew who took seriously the MRC’s consideration of
incontinence was Tom Meade at Northwick Park and
Tom Meade for my money is an epidemiologist who
managed to put mathematical certainty on to events
that I would never even have dreamed of thinking
about in that sense, he really is quite remarkable. What
he did over low back pain was to set up a study in which
he compared the success at dealing with low back pain
of the chiropractors in the local neighbourhood and he
compared them with what the doctors in the hospital
were doing.164 If I remember rightly, the chiropractors
came off best. 
Tyrrell: They were the physiotherapists doing the
physical therapies that the doctors had prescribed, as
against the chiropractors using their methods. 
May I raise another possible example of this pressure
from government? It was the use of vitamin C in the
prevention and treatment of colds. In that example
there was a mixture of forces on the Common Cold
Unit.165 One was the literature, both newspaper
publication, and the publicizing of a double Nobel
Prize winner from California,166 who said that vitamin C
would cure colds and cancer as well. And there were also
then questions asked in the House [of Commons] about
why weren’t we issuing vitamin C to everybody in the
country? We did limited trials that showed no effect, and
I got a letter from the said Nobel Prize winner saying
that we hadn’t proved it beyond doubt, we’d used too
small numbers. I just wondered whether Peter [Elwood]
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was subjected to any of this sort of pressure when he set
up a clinically based study in a natural population? 
Elwood: We actually ran two trials, one on the
amelioration of the symptoms of a cold and the other
on the prevention of cold during two winters. We
actually set those up as piggy back research. I’ve already
mentioned the study of 1000 pregnant women and
their infants up to the age of five [the milk study].167
That was an intensely boring study because the nurses
made the same measurements again and again and
again, so we added in a lot of other research projects. We
did work on sleep and we did work on vitamin C in the
mothers just to keep the interest up and to hopefully
improve the quality of the data. We were using a gram
of vitamin C a day throughout the winter in one trial,
and in the other trial a gram once they had their first
sniff [of a cold] in the other trial, telling them to take a
gram a day to see how long the symptoms lasted.
Neither trial showed any effect at all.168 But that wasn’t a
response to any request from any official body, that was
just our reading of the literature and perhaps the papers. 
Tyrrell: Maybe I can come in there, because Tom
Meade did take on a 1000-, or was it 800-person study
based in Harrow and in Salisbury, which showed very
clearly that there was no measurable effect of a large
dose vitamin C and the possibility of statistical error
was much reduced by the larger numbers.169
Doll: Well, if we think over all the things we have heard
this afternoon and what we have known ourselves
beforehand, what conclusions can we come to about the
main contributions of the ERU and what criticisms do
we have of its work? In what way did it fail to achieve the
objectives for which it was set up that would be of use to
167
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other people in the future? I think it would be helpful in
the closing minutes of this discussion to see if we can
draw anything out in relation to those two points.
Tudor Hart: Well, I am taking aspirin and eating oily
fish twice a week, so I will still be around in five years’
time, when you can have another of these meetings
with the survivors of this cohort, if the Going for Gold
project170 takes off in the south Wales valleys, which is
modelled entirely on what Richard [Doll] has just said,
lessons from ERU and the PRU. You can’t get primary
care doctors any more in south Wales valleys. Primary
care doctors are small business men, that’s what they
have to be, and anyone who has set up a small business
in the south Wales valleys now, prospectively, would
need their head tested, so we don’t have any volunteers.
So at last we could start taking primary care as seriously
as we have always taken secondary care, so we could have
the integrated research and periphery of excellence that
you have in clinical trials in hospitals, where you have
centres of excellence and research. You would have the
excellent data sets, but they would be applying to the
whole population and you could start approaching things
like they seem to be doing in Iceland, making the human
genome available ultimately for the benefit of the human
race and immediately for the benefit of shareholders. All
sorts of extraordinary possibilities open up. It looks as
though it actually might happen, because part 1 of that
salaried service for GPs is having Welsh Office
endorsement – the British Medical Association (BMA) is
not opposed to it – for the valleys, not for fox-hunting
practices, but for the valleys that they don’t want to go to;
they want them off their consciences. The rest of the
bundle, the research part, meets some desperate needs of
the universities serving the valley areas that need to prove
to the medical school that you don’t have to be a doctor
to do research, in fact it might even be an advantage not
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to be a doctor because you don’t have to go through the
process of corrective learning to lose all the vanities of
doctors. So I think it is going to happen and it is entirely
based on these lessons, positive and negative, that Archie
and company and Peter set in motion, and if it happens
of course the Caerphilly population is going to be one
component of it and another component – if the press
isn’t here and it can’t get into print soon enough for it to
matter – Dr Sengupta’s practice in Ferndale, which was
the birthplace of the Rhondda Fach studies. It’s quite
likely that the first, or one of the first, places that we’ll be
able to get our salaried doctors of the Going for Gold
scheme operating in will be exactly there, which will have
tremendous symbolic significance and the sort of people
who take decisions about the real money are mainly
thinking in symbolic terms. That is about as far as I can
get. I am serious, I think if this comes off that will be
about the time, in about five years, to see whether we can
actually make this happen, but it has got extraordinarily
wide backing from a remarkably diverse range of people,
including quite establishment sort of people.
Thomas: Looking back to the period, I see one of the big
contributions made by Professor Cochrane, and
Professor Elwood later, is actually looking at a population
and defining illness there and the extent of the illness. I
am sure this is very important to general practice, because
in the early debate about high blood pressure they’d been
looking at hospital populations. In glaucoma they were
looking at people who were presenting at eye out-
patients, and so actually getting out there and seeing
what was in the community has actually created a very
valid view of why general practice research is so
important and, as Aneurin Bevan pointed out, how
much pathology is out there in the population that
people weren’t presenting to the medical practitioners
because it was just too expensive for them to get
treatment. The PRU and ERU have contributed to
general practice research and our knowledge of disease. 
Secondly, I think there are practical lessons. We did
collect a vast amount of data, and it is always difficult in
any unit to keep in step with the statistical analysis and
the use of it, and it is good that sometimes this data can
be reused and re-presented later on. Some people make
Figure 68: Hugh Thomas measured for standing
height by Marion Jones, 1978.
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accusations of ‘data dredging’ and so on, but if the data
is there and has the answers to questions then being
asked, it is perfectly valid to go back and use it. I looked
in fact at some of Peter Elwood’s data from the byssinosis
survey in Northern Ireland, he actually looked at rope
workers, but didn’t present it in a published form. I wrote
it up virtually 20 years later and published it in a hygiene
journal, because it was relevant to African countries that
have a rope industry.171 An important thing is to try to
use the data effectively and have the statistical back-up
when you have got it and statisticians are perhaps a more
difficult breed to get hold of now, but constant dialogue
with them was very important. I think the hours that the
early fieldworkers worked, that if any of them were to
decide to start suing the unit for having worked so long,
they might have a case, but that wasn’t the attitude then.
There was a real sense of, ‘There’s a problem or there’s a
survey that we are going to do’ and a real pride in their
work. We’re beholden to all their families as well, because
there was a family price to pay for many of them who
were out for such long hours all the time doing it. But it
was through that leadership and that small team
enterprise really, and I think perhaps a fourth lesson is
when you are evaluating a unit, you can’t always evaluate
just on papers, on the analysis of the research profile and
the impact of the publications and so on, there is also the
evaluation of the people who are training there, coming
on, being influenced. The unit touched many people and
there are famous people right across the world who’ve
been inspired through working in the unit, albeit for
brief attachments. If we think in terms of value for
money, there was a lot of good work in the ERU and also
future work that will take place from it in terms of some
of the local genetic studies, and from the long term
follow-up of the different populations. These are such
high-quality data they will be used well into the next
millennium, and that has sort of added to the value the
units (PRU and ERU, later EU) have given.
Waters: Probably the main contribution that the unit
had is to the natural history of the disease, or prognosis,
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and it is because of such studies that the unit became
interested in screening for disease, something that I
don’t think we have mentioned up to now this
afternoon. I wonder if I am right in thinking, was it the
interest in screening and whether it was effective that
broadened Archie Cochrane’s interest in health services
research and ‘effectiveness and efficiency’?
Elwood: I would like to comment and confess, because
you [Doll] ask what are the failures of the unit. Well, I
have thought a lot about why the unit was closed. It
closed on my retirement and a small team was kept on
and is finishing this month [March 1999]. But I would
like to acknowledge that I think I failed the unit. Archie
was an enormously high-profile figure. Somebody
referred to his attendance at clinical meetings where he
was enormously stimulating to a point of irritation, he
made a lot of enemies, but he challenged clinicians.172 I
was not like that at all, I was very much a hands-on
epidemiologist, out with the team, not going round the
world, not collecting honorary degrees, I couldn’t have
kept up what Archie Cochrane did, but I do believe, if
I may say and not be thought too modest, I think the
quality of the data while I was director was very, very
high indeed, and again I pay tribute to the team who
worked with me and kept up a high response rate, very
careful data, very careful coding, and storage of the
data. I think the benefit of the unit has been immense
but is going to continue because Stephen Frankel and
his team have got all the data, all the samples, and are
going to continue the work. I was hands on, I was out
in the field, I wasn’t going round meetings, boosting up
the unit and so on, and I feel in some ways I let the unit
down because it closed on my retirement.
Wade: In rather similar thinking to yours, Dr Elwood, I
don’t think they set up the Pneumoconiosis Research Unit
the right way. I think it was too isolated, and should have
been established in close association with the Welsh
National School of Medicine, but it wasn’t. It was out at
Llandough Hospital and was very separate and Charles
Fletcher, although I was very fond of Charles and he did
172
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Figure 69: Peter Elwood photographed in front of 
an Ordnance Survey map of Wales in the
Caerphilly study, c.1989.
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a tremendous amount for the unit, but he didn’t really
understand this Welsh community at all. One of the
consequences was that we didn’t get the support that the
unit deserved and should have had from people like Jethro
Gough, a pathologist.173 He was one of the first people to
show convincingly that coal dust really did damage
people’s lungs, and he did it by conducting a post mortem
on all the trimmers who had died. The trimmers were the
chaps who worked in the ships at Cardiff docks, and
when they poured in their truckfuls of coal they stood
round with great sheets of steel and bounced the coal into
the four corners of the hold, otherwise there was the
danger that a ship could tip over if all the coal went in one
side only. It was Jethro Gough who convincingly showed
that coal dust was toxic to people. Up until then it was
always thought that it was the silicosis and the hard
headers, the boys who cut the rock through to the
coalface, who got silicosis. It was thought that they were
the ones who were really in danger. 
One of the consequences of the fact that the PRU was
set up in isolation was that later on when it came to the
time of closing it, it should have expanded 15 years
earlier into other problems of occupational health,
besides just the dust diseases. Let me say that it was
because I knew that that Pneumoconiosis Unit was
shutting down and there were so few occupational
health units in universities, that I was able to persuade
Robert Hunter, Vice-Chancellor of Birmingham
University, to produce the money so that we could get
Malcolm Harrington appointed, and to establish the
Department of Occupational Health there.
Booth: Can I just say that I think what Owen Wade has
just said is highly arguable. I don’t want to say that I
totally disagree with everything that he said. There are a
lot of questions here. The question of the isolation of the
MRC units have been of great advantage for some units
and I think the Central Middlesex Hospital [London] is a
very good example of that, it worked extremely well there.
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I think that the PRU when it was set up owed a great deal
to Jethro Gough, a pathologist who had advised the south
Wales trades unions. The miners’ trades unions and Jethro
Gough convinced the Government and the MRC that
something had to be done and that dust was not just
silicosis but it was a big problem for coal miners.174
Wade: I’d agree with that but the trouble was that
Jethro didn’t really collaborate, he and Charles Fletcher
didn’t get on. I thought it was a great pity, this.175
Faulkner: I thought it was strange that Owen Wade said
that Charles didn’t get on with the local Welsh people
and didn’t understand people, but I have heard him
address a meeting of Welsh miners and trade unionists
in a brilliant manner and they gave him some sort of
gold medal, but I can’t remember exactly what it was.
They were devoted to him.
Booth: I agree.
Doll: We heard one of the values of these seminars was
to get contradictory statements made for the recording
in history, so its has been interesting to have them. I
have spoken too much and I don’t want therefore to
summarize my own views of what I think contributed
to what went wrong in so far as anything did go wrong.
I’d like other people to do it. 
Tyrrell: I would like to think that the unit would be
regarded as an example, particularly in the years that
174 
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Peter [Elwood] has been describing, of having a
well-studied, well-understood cohort of people
followed over a period of time. At times, I used to think
of the Common Cold Unit as a resource like the
Daresbury Synchrotron.176 Such places can be a ‘central
facility’ to which people with extra technical skills and
understandings of pathology, chemistry, and so on,
could come to answer different questions. They could
use the corpus of understanding of the patients and
their society to do a study to answer questions which on
their own neither group could ever do. Probably the
epidemiologists would not develop the high-technology
unless they were in a high technology centre. Bringing
the two together would, I think, be the way in which
things should be done in the future. The other
advantage of a cohort, I believe, is that cohorts followed
up over a long period of time later yield information
that you weren’t thinking of originally. I am thinking
perhaps of David Barker looking at cohorts who had
been studied as babies decades before.177 I would hope
that people would continue to see the central
importance of very well-studied groups of people in
practically any problem in pathology and medicine.
Davey Smith: One short comment, following on from
Peter’s comment about the unit being shut, is that in
the UK there is not now any similar outfit carrying out
epidemiological studies on general population
samples.178 Many of the studies currently being carried
out are in very special populations, civil servants for
example, and the generalizability of the findings you
then can make to other populations is in doubt. Also
there is no central resource teaching field epidemiology
that people go through to learn how to do field studies
in the UK. From my short one-and-a-half-year
connection with the unit in the 1980s, it was incredibly
valuable to be able to go with people who could show
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you how to do field epidemiology and I was rather
surprised when I went to the London School of Hygiene
and Tropical Medicine and did the then Rolls Royce
Master’s degree in epidemiology, after having worked
with the unit, that the basic aspects of fieldwork just
weren’t covered in those sorts of courses. The best way of
learning fieldwork is by being involved in those sorts of
studies and understanding it in that way. Perhaps
symptomatic of that is also the shift of epidemiology
into something that is attached to the evidence-based
medicine movement, which of course is very important,
but maybe leaves this space, which the unit and similar
places occupied, of work with representative population
samples. There’s no obvious replacement for the unit in
Britain at the moment.
Strachan: The decision by the MRC to close the
Epidemiology Unit begs a question of why the MRC
wants to have an epidemiology unit or epidemiology
units and I think you could come up with several
answers to that question. One would be that there is a
role for a community laboratory in which people with
particular tests or particular investigational tools can
apply them to a relatively representative sample of the
general population, find out normality and
abnormality, find out about prediction, find out a little
bit about relationships over time and test a few
aetiological hypotheses. So there is in a sense the model
which was set by Framingham179 and which has been to
some extent followed with Caerphilly. Secondly, there is
the role of hypothesis generation to ‘fly the flag’ for
cause being as important as mechanism. Thirdly, there
is the role of training and developing skills and (I would
argue) creating some sort of career for people to become
card-carrying epidemiologists. Those are three aspects
which it seems to me, having heard the discussion, the
MRC unit fulfilled in small ways over its period in
office, but the question is whether the MRC views any
of those three as being worthy of continued support in
the future. That is a question that the MRC has to
address, not just retrospectively in relation to the
decision to close the unit in Cardiff, but also perhaps in
179  
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its decision about the continuing support for
epidemiology in relation to the other two units which
are being reviewed at this moment. So I would like to
put in a plea for some creative thinking about why it is
we might need an MRC-supported epidemiology unit,
as distinct, of course, from substantial programmes of
investigation which the MRC would normally fund as
projects and research programmes in their own right.
Weddell: I shall be very brief. I think one of the great
benefits of siting the unit in Cardiff is that the
populations both in the Rhondda Fach and Caerphilly
are relatively stable and so you can do long-term studies
of these populations. If you tried to do this in London,
it would sink without trace, you couldn’t do it. You do
need relatively stable populations.
Doll: There’s one study that the unit carried out in
1979, it was a correlation study which was initially set
up to look at socioeconomic factors in relation to
mortality from ischaemic heart disease in particular, but
also mortality very widely, and this study came up with
two findings. One was that in developed countries the
infant mortality rate was inversely related to the number
of doctors per 1000 of the population, a finding that I
know intrigued Archie and which he often spoke about.
It was statistically highly significant, but he never got a
satisfactory explanation as to what it was due to. The
other finding was an inverse relationship between
alcohol consumption, or rather wine consumption, in
this particular study, and the mortality from ischaemic
heart disease.180 I think we haven’t discussed that study,
because we now have an opportunity for putting its
findings to effective use, and I would therefore like to
thank all the speakers very much for their contribution,
close the meeting and tell you that wine awaits.
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Archie Cochrane
In 1974 I retired to a desk in the
attic at 4 Richmond Road and
Peter Elwood became Director of
the unit. It was largely as a result
of his kindness that I stayed on.
He was very encouraging, hoping
that I would continue with two
main lines of research: the 
20-year follow-up studies of the
various populations on which we
had done cross-sectional surveys
in the 1950s and the
investigation of factors associated
with mortality in 18 developed
countries. For my part, I
arranged for Peter to receive
enough money from the
Abbotshill Trust, with which I
had a close association, to employ
an additional statistician for
three years. I had not succeeded
in persuading the MRC that 
an epidemiological unit 
needed as many statisticians 
as epidemiologists, with
programmers to support them...
Then came a dreadful day in
1977. It followed a routine
MRC review of the unit that had
not gone particularly well. There
was something of a cloud over the
place. Knowing a little about the
review body, it was not difficult
to suspect a degree of unhelpful
personal bias in some of its
reporting. Eventually Peter
Elwood gained the necessary
permission to show me the 
report, and to my horror it
recommended that I should cease
to work there. The committee felt
that my presence was having a
deleterious effect on the
unit...The next few days were
dreadful. I had, as far as I
remember, a lot of silly ideas. I
also drank too much. I
considered selling Rhoose Farm
House and buying a flat in
Cardiff or Galashiels...Slowly the
clouds lifted. The MRC finally
ruled that I could continue
working at 4 Richmond Road. I
am very grateful to some
unknown friends who gave me
support at such a critical time. I
am particularly grateful to all
members of the unit who signed
a letter supporting the view that
I should be allowed to stay on.181
Peter Elwood
When I was appointed Director,
I remember somebody said that I
had fire in my belly, and that
was one of the strands of
thinking that allowed me to
become Director of the unit after
Archie Cochrane. Who could
follow Archie Cochrane?
Certainly the whole style of the
unit changed very, very
markedly, but I think one of the
benefits was the on-going budget,
the rolling budget. In the early
days money was very free and I
was asked if I needed any more
staff, or could I do with some
more money? I think we did
things very, very efficiently,
because while we were doing the
Caerphilly study I was also
running studies on lead, we were
also doing the final follow-up of
subjects in relation to byssinosis,
and Janie and Marion would
work on Caerphilly for three days
a week and the other two days
would be in Bolton and
Oldham, or up in the valleys
taking blood for lead studies. I
think the cost of the various
studies was very much less than if
funding had been for the
complete study on its own. We
made very efficient use of time
and resources. I think also that
the unit attracted enthusiasts.
Fieldworkers are rather a
speciality, and to have a love of
going out and meeting people
and accepting the challenge of
getting a high-response rate
demands a certain kind of person
and we seemed to get those
people. We also could give them a
career, and a career structure; the
medical and the non-medical
people, and the support staff, they
all had careers structures within
the MRC and permanent posts
most of them. This was very
beneficial to the development of
an area of research, rather than
just a one-off project. There was
continuity, and I knew that when
we followed up Caerphilly, we
wouldn’t have to start recruiting
another set of staff for phase two
and phase three. We would have
the same people going back, who
knew the area and were known
by the men. That was a
tremendous advantage.
John Yarnell
When I came to the unit it was
rather interesting that Archie
was sharing the same room as
Peter Elwood. It was rather
amusing at the time, as Archie
was President of the Faculty of
Community Medicine as well.
Now Peter Elwood had just been
appointed as unit Director
[1974], Peter had a telephone
with an intercom system there
and Archie used to sit at the
other end of the table in his old
room, sharing this room with
Peter Elwood, and he used the
wall phone there. The MRC
secretariat paid a visit and I
think they saw this arrangement
and they had 50 fits and they
tried to expel Archie from the
unit. We drafted a letter,
181
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Figure 70: Archie
Cochrane,
c. 1970s.
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petitioned everybody to sign to
request that Archie should be
allowed to stay because he was
not interfering with Peter
Elwood’s work and he was
contributing his own expertise to
the unit. They [MRC] did let
him stay but on the proviso that
he moved upstairs to the attic. So
Archie went up to the attic at
Richmond Road and carried on
his work on the Rhondda follow-
ups with Fred Moore, and others,
who had mainly worked for
Archie in the past. I should say
that Fred Moore was an
extremely valuable fieldworker.
He was a trained nurse and did
all the ECGs meticulously for the
Caerphilly survey, at least for
phases 1 and 2. He retired finally
after that, well into his seventies
I think. After this they [ECGs]
were done by Marion Jones,
another invaluable fieldworker.
Hugh Thomas
Working with Archie Cochrane
when he was writing his
biography there [at the ERU], it
did always strike me, I am
afraid, at how unfortunate a
relationship he had with Jethro
Gough. You could not mention
that chap’s name without Archie
almost having a convulsion, but
also there was his real sense of
disappointment that the research
did leave the MRC and go to the
Coal Board and I just tried to
listen dispassionately to him
when he was talking about it.
But in a sense, you can reflect
historically, I suppose, that if
Archie Cochrane had stayed
entirely in the area of dust
disease, we might have missed an
awful lot of his other work in
health services research and
general epidemiology that he did
in the Rhondda. So I think that,
in a sense, his disappointment
was actually turned to a very
good advantage.182
John Yarnell
One of the first surveys of
urinary incontinence that had
been carried out in a population
sample183 was done in the
Caerphilly district and
surrounding villages. We went
up further towards the Rhondda,
but not right into the valley. The
Rhondda was a special coal-
mining community and that was
why Archie used it so much,
because of course they were
exposed to coal dust and he was
interested in pneumoconiosis and
then tuberculosis.
Peter Elwood
It became increasingly difficult
[to get posts approved], but I did
manage to get a nutritionist,
Ann Fehily, who put a superb
amount of very high-quality
work into Caerphilly, and that
was a new post. I also got John
Gallacher, with very great
difficulty. Now he’s a very, very
bright original thinker and he
put a marvellous slant on
psychosocial factors into
Caerphilly and later on cognitive
function. He also set up a study
of stress management within
patients with angina, then the
MRC pulled the plug on that.
But it certainly became
increasingly difficult to get more
staff, but in the early years it was
very, very easy, and I was asked
whether I would like more staff
and in the early days I said no I
don’t think I would want to cope
with a bigger team. But later, I
can think of one or two people
that I would love to have
appointed or to have offered an
appointment to. And the MRC
were just not willing at all.
Peter Elwood
Caerphilly was launched in
1979, and the first phase took
until 1983, it took four years to
see the men. John Yarnell chose
the sample, using the electoral
register, and some of the doctors
lists, but we wanted to get a
complete sample of men within a
Figure 71:
John Yarnell
during the
Caerphilly study,
c.1980.
Population-based Research in South Wales
112
184 
See note 96.
185 
Miller G J, Miller N E. (1982) Dietary fat, HDL, cholesterol, and coronary disease: one interpretation. Lancet
ii: 1270–1271.
certain age range, 45–59 years of
age, so a questionnaire was sent
out, asking a few general medical
questions, and asking the age of
the respondent, and that was a
key factor in identifying this
particular age group within the
community, and letters were sent
out to virtually every male on the
electoral roll, in order to pick the
sample, and get a complete
sample between those age groups.
We set up the study in church
halls, the YMCA and in doctors
surgeries, moving around the
town, and seeing people in the
different areas. We had one
dedicated person who visited the
men and tried to persuade them
to come to the clinic, and in the
clinic we had six stations as we
called them, where different tests
were done. We piloted all this,
timed everything and tried to
envisage delays in the procedure
so that the men went through as
smoothly as possible. The record
keeping and so on really
developed ad hoc as we went
along, and one of the very, very
big mistakes we made was that
we used numbers going up from
1001 upwards and then we
discovered later that Speedwell,
the study in Bristol, had done the
same, and so there was an
overlap in the numbers, and that
was bitterly disappointing. I had
always suggested within the unit
that each research topic had a
unique number, and for instance
our study on school children was,
if I remember rightly, 32s, 33s,
and 34s, and those numbers
came first and then 01, 02, 03,
for the different subjects. Janie
and I developed this system and
if we picked up a questionnaire
we were able immediately to say
which study it came from. But
nobody thought much of that
when Caerphilly was being set
up, and we just used straight
numbers, and then we got into a
terrible situation where
Caerphilly and Speedwell had
been stored together and it has
been very, very difficult to
unscramble the two sets.
Peter Sweetnam
Selwyn St Leger was the official
statistician to the Caerphilly
study when it initially started
up. John Yarnell had done a
variety of studies in Caerphilly,
and this was essentially just
another one. His initial study
was the wide age range study of
700-odd men aged 30 to 69
years. My memory is that it was
a unit review in the early 1980s,
which said, ‘Well, that’s an
interesting piece of work, but it’s
nothing like big enough, make it
larger’. Hence it was expanded
into the size that it became
[2500]. It was about then that I
probably started getting
involved, I guess partly because
Peter’s aspirin work had finished.
I think the paper on the second
aspirin trial in the Lancet184 was
some two-thirds of the way
through the first phase in
Caerphilly. I think that would be
about the date of my first
involvement with the study. My
involvement with aspirin
finished about this stage, and by
then the cervical cytology had
outrun its course. I think we had
got about as much out of it as we
thought we were ever going to. 
My work was almost always in
tandem, particularly once
Caerphilly got up and running
and I got involved with that, but
even before that, there was
always more than enough to do.
In the first few years, there
certainly wouldn’t have been
from within the unit, which is
why Hubert Campbell got 
me involved with the
gastroenterologists at the Heath
[Hospital] and others as well.
But after that there were Peter
Elwood’s aspirin trials for which
I did the analysis. There was
always cervical cytology, which
in one sense was entirely my
pigeon. It wasn’t really an
epidemiology Unit project,
although Archie was very
interested, Peter and Michael
Burr didn’t want to know. I was
interested in learning to handle
these large volumes of data and
learning how to use the
computer. It was very useful from
that end, but it was certainly
extremely timeconsuming. 
David Bainton
I came back to Cardiff , I felt that
had been my stomping ground
and I had good connections. We
set up a partnership and I
managed to get some money from
ICI. Because we asked patients to
fast, to come fasted, it was a two-
stage observation. They would
come to the clinic usually in an
evening, and then we asked them
to fast and come back for the
blood sample [the following
morning], and we then had to
give them breakfast, and
persuading the health authority,
and justifying the packets of
cornflakes and toast and so on.
Yes, we provided patients with
breakfast after they had given
their blood samples. And so we got
bits of money, and also we were
sending samples to Portsmouth for
various platelet function tests, so
there was a Red Star carriage
charge every week. I got soft
money for that. So we put a
package together based on the
HDL hypothesis and you know,
Caerphilly as well, but the trouble
is Framingham had already got
the data but never analysed it. Of
course, within a very short time of
the Lancet publishing George
Miller’s hypothesis,185 they could
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certainly publish cross-sectional
data very quickly, and then they
went back and looked at the
incidence data. Anyway, there
were various clinicians who got
to hear about this ostensibly
unselected population and
wanted to ask whether there were
opportunities for them to do some
work. I would say,‘Well, we
could slot this into Speedwell.’ 186
There was a Canadian
gastroenterologist, who was
interested in gallstones. What
interested him in particular was
the question, ‘What was the
normal bowel habit?’ So we
included that question and I
said, ‘Perhaps we could do our
measurements first?’ being a bit
uncertain about quite how
patients would respond to
questions about their bowel
habits. He appeared in a white
coat and he was the last one to see
them. So we slotted those questions
in like that. And then we did the
initial recruitment phase and
several follow-ups. Ian Baker
joined me in sharing the clinical
work and we trained the clerk and
the nurses in survey matters, trying
to minimize bias and so on.
John Yarnell
The Caerphilly Prospective Study
really started out of this work in
women187 in that we went back
to these women to ask them for
blood and we had this fairly
elaborate theoretical structure
looking for the determinants of
HDL cholesterol, both dietary
and physical determinants. We
thought that it would be a good
idea to do this in men as well. I
had some encouragement and
some disencouragement from
other people. Peter Elwood was
quite keen. David Bainton had
actually just moved to Bristol
and there had been the screening
clinic. I am sure you know all
about the beginning of the
Speedwell study and I knew the
chap who had actually run the
original Speedwell clinic and I
mentioned him to David, who
had been away doing the MSc at
the London School of Hygiene. I
knew that David had previously
been working with Archie, and
he’d got this move to Bristol to
start his work there and being at
that time much more interested
in epidemiology set up this
Speedwell clinic, following and
doing a much better job than the
medical officer who had set it up
in the first place. David was a
friend of George Miller, who
started up the work on HDL
with his brother Norman Miller,
and they were set up really to do
another cohort study to look at
whether HDL was truly an
independent risk factor. That’s
what David set up his study to do
and I started this small cross-
sectional study in Caerphilly,
encouraged by Peter Elwood to
look at the determinants of HDL
cholesterol and look at a number
of lifestyle and physiological
factors. I got interested in
hormones although David wasn’t
especially. The work of Gerald
Phillips188 in the USA looked as
though it should be followed up,
so we did some pilot studies in
the unit, measuring a small
group of volunteers, staff and
their friends, on five occasions to
see what the biological
variability of plasma testosterone,
oestrogen and cortisol actually
were, and whether they were
stable enough to get away with
doing single measurements. We
thought we could possibly add
this to David’s work in
Speedwell, but David felt he was
taking enough blood, so he didn’t
want to take any more, and we
wanted to make special effort on
Figure 72: Mavis Prentice, a field survey assistant in the Caerphilly study,
serves breakfast to a subject who has just given a blood sample, c. 1989.
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the hormones. So I did this cross-
sectional study189 in a wide age
range, which we hadn’t looked at
very much, but the men were 30
right up to 70 years of age.
Encouraged by Peter Elwood, we
decided to continue to form a
Caerphilly cohort as well,
looking at all the extra things
that they weren’t looking at in
Speedwell, achieving a sample of
similar size to that in Speedwell.
Peter Sweetnam played a key role
in the design of the original
Caerphilly and Speedwell
studies. One of the other things
that we were quite interested in
doing was measuring
subfractions of HDL and we
worked with Colin Bolton who
collaborated with Norman
Miller in setting up the method
to do that in Southmead
Hospital, Bristol. So it started
from a cross-sectional study and
grew into a cohort study when it
seemed that we would get a lot of
extra information. 
Janie Hughes
These men [from the Caerphilly
cohort studies], now 20 years
later, look on us as friends, and
they have even been known to
ring up just to chat. We are still
seeing them, monitoring their
progress, still doing tests on them,
so I think we have established a
really good rapport with them. I
am following up some men from
another study that was done in
south Wales, some of it was
Bristol and Gloucester, but mostly
south Wales, and my response has
only been about 50 per cent,
whereas I could guarantee that if
I sent out a similar questionnaire
to the Caerphilly cohort men, my
response would be about 85 
per cent.
Janie Hughes
There were two units, the
Pneumoconiosis Research Unit
and the Epidemiological
Research Unit, which became the
Epidemiology Unit in the 1970s.
Then ‘Epidemiological’ was
dropped and it became
‘Epidemiology’. Dr Elwood took
over as Director in 1974. I think
it was probably then that things
began to change and you really
had to justify why you wanted to
do particular areas of research
and your proposal was sent out to
referees, as is the norm nowadays.
Except that the MRC was still
the grant-giving body as such,
the money still came entirely
from the MRC. If you look at the
history of the unit, people who
stayed, stayed for an awful long
time, because we were basically a
really, really happy family unit.
Peter Elwood
Archie was always very anxious
that field epidemiology played a
large part in the activities of the
faculty [Faculty of Community
Medicine, now of Public Health
Medicine], and the original
documents setting out the aims
or mission statements or
whatever it was at the beginning
[in 1960], talked about statistics
and field epidemiology being the
basis of epidemiology. Only lip
service was paid to that later,
and all the training that the
faculty introduced was [directed]
towards community medicine,
public health medicine, and the
unit lost out very badly. In fact
that was very noticeable, because
a number of splendid people in
the unit, like David Bainton,
had great difficulty in getting
their theses approved for their
Part II Membership, and the
view was taken that it hadn’t a
public health aspect. He
[Bainton] looked at temperature
and cardiovascular disease. He
wrote a splendid piece. There
were one or two others who got
into the same difficulties. 
Peter Elwood
I think perhaps it was me who
didn’t make a bid to [make
training and career management]
play a bigger part in this. But we
used to get students visiting, and
Cambridge used to send down
their students, two days initially,
and they stayed overnight, and
we showed them the field studies
going on and a view of the
studies in progress. Several other
groups used to send down people,
and, of course, we still put a slot
in the local teaching and
training. But possibly if Archie
had continued as Director we
would have had a much bigger
part to play within the Faculty
and within the College of
Medicine in Cardiff, we would
still have been a significant part.
But I just enjoyed fieldwork and
testing hypotheses so much that I
wasn’t terribly interested in
lecturing and training and so on.
Let me say that most of the people
who came to us and took up 
the training post of junior
epidemiologist did extremely
well, and it was almost a unique
training in fieldwork, because we
were so heavily involved in that,
and practically nothing else.
Janie Hughes
I wouldn’t say it was tension
[between the clinical staff and
the administrative staff ], there
was just a bit of a divide. It
wasn’t tension. I thought it was
normal in a unit like that, that
there were scientific staff and
others, but I think looking back
it was probably down to
Professor Cochrane’s leadership.
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He was a bit of a snob and we
were the workers, and there was
the scientists and the two didn’t
mix really. But that was my
impression, but I think I
probably was proved wrong later
on. When he came back to work
with us after he retired, some of
the younger people, like Andy
Beswick and Kim Neale, shared
a room with him and he was an
entirely different person. He
seemed to love their company
and they did The Times
crossword together. Had I been
wrong about him? I think it was
probably because he wasn’t
Director any more and the unit
wasn’t his concern and so
probably it was because of the
type of leadership he had that
there was ‘them and us’. That’s
our way of putting it. I mean it
wasn’t just my own personal view
a lot of us thought this. Every
Friday there was a scientific staff
meeting and we weren’t invited,
so we never really were au fait
with what was going on, we
didn’t know what studies other
people were doing that we weren’t
involved in, which in hindsight I
think was a bad thing. And it
wasn’t until Dr Elwood took over
that we began to be invited.
Perhaps not straightaway, but
when he realized how we felt we
began to be invited to the
meetings. They were called
scientific staff meetings, then they
were just called staff meetings.
And these continued right up
until the time he retired, when
we all used to meet in the
conference room every Friday
morning, whether there was
anything to discuss or not, it was
just to meet and to get together
and know what other people
were about, what they were
doing. They were used as sort of
rehearsals for papers that people
were going to give at conferences.
I think it helped both the speaker
and the audience, as more often
than not the audience had been
part of the study that was being
presented at conferences, and we
had worked on these studies, so it
was nice to see it being put
together and talked about or
given as a paper. And when there
were 30-odd of us, we weren’t
always aware of what other
scientific staff were proposing, so
it was nice to keep up to date.
Peter Sweetnam 
I can’t actually put a date on it
[statisticians’ involvement in the
design stage of projects]. I think
things slowly developed.
Certainly when Peter [Elwood]
took over the unit in 1974, he
introduced a weekly staff meeting
at which somebody would give a
presentation, either of some
analyses or some results, or a
proposed piece of work etc., so
that to some extent everybody got
a little bit involved in the design
of these things. I think actually
over time we found that people
tended to get a little bit overly
critical and then others shied
away from presenting things,
because they didn’t want to get
cut to bits, which tended to
happen. And I think probably
after that, it then later evolved
more into the people who were
involved with a particular
proposed project, literally sitting
down and discussing it. But I
suppose what also happened as
well was that the size of the
projects got larger and larger.
There were some exceptions, even
in the 1960s, some of Peter’s
anaemia studies are quite large
numbers of individuals, but
some of those were never even put
on punch cards. The smaller ones
were, but there were one or two
that I think weren’t. They might
have been on edge punch cards.
It’s very difficult, I think to date
changes in things, because the
changes were usually gradual,
rather than incremental,
although certainly there was an
incremental change, I think
when Peter took over. He
actually worked very hard at
trying to decide how he was
going to manage this unit and he
talked a lot with a chap called
Tony Johnson who was a lab
manager from down in west
Wales, who was very interested in
the theory of management 
of organizations, and he
introduced, in particular, these
weekly staff meetings. We had
staff meetings under Archie, but
my memory is that they were
much less regular and they were
much more to do with routine
things. There must occasionally
have been presentations of
planned bits of research and also
results, but my memory is very
hazy about these things, much
less so for things like the arrival
of the Monroe  Epic190 and what
you could and couldn’t do with
it, than for the way the unit was
managed. In a sense, it’s probably
partly me, but it’s also partly the
statistician’s role, in that he
didn’t really manage the research
(that was essentially the
epidemiologist’s job) and the
statistician was there as 
adviser and essentially a
calculating machine.
Selwyn St Leger
I think that we would have a
staff meeting on a Friday
morning, where, after dealing
with the housekeeping matters,
most of the time was spent
discussing research proposals and
ideas, batting them around,
perhaps chucking them out as
rubbish. We would have quite
vociferous discussions, various
camps would form and argue
their points. And after that very
often a research proposal or idea
would arise. So Mike Burr might
come and say he was interested in
asthma and mites (as he was). All
of us batted those ideas around,
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and then obviously the person who
was leading on that day would go
away with whoever was linking
in, and work out proposals. They
[these ideas] would still come back
and be batted around.
Peter Elwood191
But the question of continuing
disability from industrial
byssinosis remained with me, and
so about ten years later I went
back to the north of Ireland, got
the survival rate of all the men
and women in the study, and
worked out the mortality in the
different departments. I showed
that there was no excess mortality,
even in the men who were exposed
to the heaviest dust levels,
provided we allowed for smoking
and so on. I wrote a paper
arguing that byssinosis was an
acute condition, and although it
led to men having to leave the
industry, it did not cause
permanent disability.192 Schilling
clashed with me quite severely
over that, but he remained a
friend. I found a lot of these men
felt very strongly about their
research, but one was able to keep
friends with them, and that
added to the delight of medical
research. There was a lot of
controversy, but it was usually
with friends. About ten years
further on, I took the opportunity
of looking at people who had
worked in the flax industry, and
we set up a similar study in the
cotton area (Bolton and
Oldham). We took random
samples of people in towns in
Northern Ireland where flax had
been a major employer. We
selected a large sample, I think it
was about 2000 people, our
estimate was that half of them
would have worked in the flax
industry, and half would not. We
did exactly the same in Bolton
and Oldham, and half of them it
turned out had worked in cotton
and half had not. And we looked
at respiratory symptoms and
respiratory function in some detail
and we published two papers
showing, I think, quite
conclusively that whether or not
there had been byssinosis, whether
or not the subjects had worked in
flax or in cotton, there was no
residual disability.193 There was a
massive effect of smoking on
respiratory function, but when we
allowed for that there was no
evidence of any respiratory
disablement from textile dusts.
Again, that led to controversy, but
I think it did establish a very
important fact, which sadly was of
relatively little importance, because
the flax industry died in Northern
Ireland and the cotton industry
died in Lancashire. So it was a
very, very satisfying series of studies
over a period of about 25 years,
but of little ultimate consequence
in this country. Whether or not
other countries take account of it or
not, I don’t know. The results were
so conclusive when we had finished
that series of three studies, the
prevalence study, the mortality
study, and then the retrospective
case control as it were, it really
established that byssinosis was still
a condition that caused acute
disablement, could lead to people
having to leave the industry, but
was not a cause of permanent
disability. It did lead to very, very
great change in the attitude of
companies towards compensation.
They were able to stand up to them
and say there is no permanent
disablement. The size of
compensation awards and the
number of compensation awards
fell away to almost nothing.
Peter Elwood 
In the early days of the MRC
unit we were the sharp end and
we were the reason for
headquarters existing. Somebody
has made that very point to me,
that the work that we did
secured the future of the whole
organization, and so the whole
focus was on facilitating and
encouraging units. Then the
board system was set up.194 I am
not a politician, I don’t
understand a lot, but my
thinking is that the universities
became more and more jealous of
MRC units, with their stable
funding and secure careers, and
people in the universities who
were in research had to find their
own money and had no stability,
or at least not the same career
stability. And the MRC boards
came in and were very, very
aggressive in the early days and
the review process was certainly
very, very threatening. This was
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a total change and it led to
changes in headquarters, which
changed from being our
representatives in negotiations
with other bodies to become the
executives of the boards. They
came down to see us to put into
effect decisions that had been
taken by the boards and the whole
atmosphere changed over a very
short period of time. The review
processes also became very, very
threatening and initially very
hostile. I submitted my first report
on our first five years under the
board system [c. 1980], and I was
asked to appear before the board.
One man, whom I won’t name,
attacked me most aggressively, hit
the table, and almost shouted at
me, because we had used a
method that he disapproved of in
one of our studies. I was told
afterwards that because of his
performance, it was decided that
no Director would ever be called
to give account in front of a board
again. That was judged to be so
discourteous, and it was certainly
so threatening and so hostile. But
that was the general atmosphere of
the board and we never felt that
we had friends at headquarters
after the boards came in. 
Peter Elwood
Certainly the foundation of
epidemiology in those early years
was the cross-sectional survey and
I can remember lectures I
received, and lectures I gave,
focused on case-control study,
leading onto cross-sectional
surveys. Intervention trials were
rarely talked about in
epidemiology. There were drug
trials, and a few prospective
studies, such as Framingham, but
these stood out as unique.
Epidemiologists didn’t tend to
think in those terms, I think the
value of the long-term prospective
study was being slowly established
and like the mustard seed it grew,
but it wasn’t the thinking in those
days. I remember that my original
department in Belfast set up one
prospective study which was to
run for a year to follow cholesterol
level and blood pressure in, as I
remember it, about 500 men and
this was referred to as a rather
unusual prospective study. The
men were to be seen several times,
rather unusual.
Janie Hughes
Fieldwork has changed
enormously because people
distrust you nowadays, whereas,
perhaps even 20 years ago,
working in the Rhondda, in
particular, was easy because
everybody left their keys in their
door and you just turned the key
and shouted, ‘Can I come in?’
and they would say ‘Yes’, without
even knowing who you were. In
the early days, I think I am right
in saying this, we didn’t even
write to the people and say we
were coming, we just cold-called,
which we are not in favour of
doing at present. We always
announce our arrival by sending
a letter. Nowadays in our studies
we keep in touch with the
population by sending them
newsletters and keeping them up
to date with what’s going on. I
don’t think we did anything like
that in the early days of studies in
the Rhondda. I think in the 
X-ray study of the miners, for
instance, notices were put up in
workmen’s halls, but perhaps it
might have helped had we
thought of putting an advert in
the local press, or putting notices
in doctors’ surgeries. We mightn’t
even thank them, you know as a
community, for what
contribution they had made to
our studies. So they probably
might have ended up rather
disgruntled and not wanting to
cooperate in more studies.
Years ago people knew their
neighbours, they knew lots about
them, they knew the people across
the road, they knew the people
down the road. Nowadays no one
wants to tell you anything about
anybody, because they are always
afraid of being accused of
revealing things to agencies like
the DSS, and so it’s a closed shop.
You can rarely get any
information from neighbours
these days. You cannot call at the
corner shop, or the post office,
which is what I used to do a lot,
to learn about people’s
movements, that’s out now. So
now you have to rely on health
authorities or ONS [Office for
National Statistics], if you have
flagged people, rather than by
word of mouth with neighbours.
Valleys people stay valleys
people, but in the big towns like
Cardiff and even Caerphilly,
they do move and change. I am a
valleys person, so I suppose I am
a bit biased, but valleys people
are communities and they care
about what goes on around them
and they are very friendly, they
are very warm, on the whole,
whereas town people are cold,
distant. Cardiff particularly is
very cosmopolitan with lots of
flat dwellers and you are not even
knocking on a door, you are
buzzing on an intercom at the
bottom of the block of flats, so you
don’t get tremendous satisfaction
from home visiting as we did
years ago. And sometimes you can
travel quite a distance and it’s an
absolute waste of time.
David Bainton
I thought we could try to
evaluate some of the components
of stroke care and I found a
speech therapist who was
prepared to concede that there
might be some adverse
consequences of speech therapy, so
it became much easier to say, ‘Oh
let’s do a trial, let’s do a
randomized trial’. You appreciate
that at the worst, it was neutral,
in ethical terms. It was difficult to
get a balanced question. We very
tentatively ran a pilot, wrote a
protocol and we ran it for six
months, without additional
resources. We examined the
question – ‘What is the
contribution of a professional
speech therapist over and above a
lay volunteer who is expressing
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the same commitment and
enthusiasm, without the
particular skills of the speech
therapist?’ – and we randomized
patients. The subjects had to
have a sufficient degree of
dysphasia. We applied for a
grant, using our pilot data to
furnish the application and we
got a three-year grant from the
Department of Health, which
effectively paid for a full-time
speech therapist to manage the
study and also act as a therapist
when required. I came back to
the unit to help and got Peter
Sweetnam to help as well,
because I wanted to make sure,
both for comment on the protocol
(which I think he passed), and
some power calculations, all the
things you are supposed to do.
What this illustrated was the
dictum that ‘There’s nothing that
makes a common disease so rare
as starting to set up a
randomized trial.’  We got about
160 patients, I think it was, but
by the time they were broken
down into age, sex, level of
dysphasia, intervention or
control, there were quite small
numbers. But what was quite
clear was that, you know,
volunteers were as good as – or
actually they were better, but not
statistically significantly better –
than speech therapists. This
raised, as always, lots of other
questions. That was really my
first major study and what I
found is that you acted almost as
a source of advice sometimes, and
people would go off and do their
own study and you weren’t
involved at all. Other times you
would actually make various
suggestions and almost help them
write a protocol and maybe work
with them. Other times there
were studies that were initiated
just from within the Department
of Community Medicine.
John Yarnell
Yes, there were discussions about
the size [of Caerphilly] and I
think we had to balance this with
the very intensive fieldwork
which was very time consuming.
I think both Tom Meade and
Gerry Shaper [of the British
Regional Heart Study] 195 had
suggested that it should be larger
and based on a fresh sample. We
thought we would lose an awful
lot of momentum to start again
somewhere else. Peter Sweetnam
did some calculations and we felt
that we had just about got enough
size and power to be satisfactory.
One of the ideas was that at some
stage things could possibly be tested
out in the sister study in Speedwell
or visa versa, so for some things we
were going to rely on the combined
cohorts whose total is close to 5000
men. But practically speaking, we
just hadn’t got the resources or the
funding to do a larger sample
with what we had. We did feel,
and I particularly felt, that we
could possibly overload it, ask too
much of the men, but I was
interested in getting as much as
we possibly could out of the study
scientifically. The second time
round I think that in terms of
what we were asking the men, we
probably asked them quite a lot,
two clinic attendances, the first
visit a minimum of one and a
half hours and the second visit
included anything up to about
80 to 100 ml of blood which I
don’t think anybody else has ever
asked for. We did take the 
advice of one of our consultant
haematologists, Dave Hutton,
who was working with us. He felt
that for most people it was quite
safe to have that amount taken.
Selwyn St Leger
This is where I have views that
many would find unacceptable.
This is again looking back to this
theme of mine about change
promotion. I have now in my
mind and in my writing drawn
a distinction between what I call
science and change-promoting
research. Now science has a
number of characteristics, one of
which is that it is circular in the
sense that it is scientist-to-
scientist. The scientist decides
what the issue is, largely what it
is going to be, the peers decide
whether the funding is going to
be given and on the quality of
the scientist and all that. Now
change-promoting research,
which I think all of R&D should
come into, is actually externally
referential – NHS priorities as
specified by managers who decide
largely what the research issues are
although they are informed by the
knowledge of researchers. The
criterion of good work is not
whether it has got published and
gained brownie points, but
whether it has brought about
change or improvement. I won’t
go into all the details of that, that
is in my book,196 but what I am
saying is that if you have got
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fundamental scientific research,
nobody has found a better way,
including myself, of organizing it
than the sort of MRC-type
model, where you have got to give
people quite a lot of freedom and
leeway to get on with things, you
may as well give them resources,
but essentially it is the scientists
themselves that are largely
deciding what are the issues to be
researched. When we comes to
health services-type research, to
which I would also put
epidemiology, I think while they
are not treating it as science in
that sense, it’s no less rigorous an
activity, and it still has many of
the trappings of science. The
methods are the same. I think
when you look at it in that
context one is saying, ‘Why? What
for?’ Now it may be that when
you are at the level where
aetiologic epidemiology is closer to
traditional science, but even that
needs a bit of oversight, because
an awful lot of money goes into
very large epidemiological studies
and one wants to ask how they are
going to inform future decisions or
future research that leads to
something practical. So I no
longer believe in the idea of a unit
of people given plenty of resources
being left to get on with it.
I don’t think the MRC will be
able to sort that [epidemiology in
the 21st century] out for itself,
because it is in the culture of
science, most of its study, all of its
senior people on the scientific side
and all these would call
themselves scientists, and most of
them are. I can only say – well
again I will be provocative – if
you consider something like the
research assessment exercise
(RAE), which is a driving force
in universities in terms of their
agenda and what they value, if
you want to change it, as I do, to
work that is actually for the most
part useful in the health service.
I am not talking about the pure
sciences again, I am talking
about the disciplines which do
have a practical application.
Well, you might ask, ‘Why don’t
we go for a single stream of
funding?’ At the moment the
funding you can get is relatively
small, but some funding [is
available] from NHS R&D, and
that is the one thing which
actually has an agenda, and you
can get the prestigious larger beer
from the MRC, for example, or
the Social Science Research
Council.197 My feeling would be
that we actually take firstly, from
the HEFC (Higher Education
Funding Council) that
proportion of their monies which
is meant for medicine, then take
from the MRC that proportion of
its money which is meant for
applied or directed research, and
put that in with the NHS R&D
and manage all of them through
the NHS R&D structure.
Instead of having RAE, in a
sense, directing the funding,
what you would do is to fund
slightly differently. There’s lots of
pure science in the medical
schools. Funding would be
through the R&D stream, in a
sense, of rolling projects, which
would come with the
infrastructure built in, not built
on top of the existing
infrastructure, so that would
include the RAE component. I
don’t think it will happen in any
short period of time and the
reason I say that is that I don’t
think the MRC is capable of
thinking along those lines, of
things that are of interest to the
NHS, linking with management
interest. For example the
concordat we have at the
moment [between the
Department of Health and the
Medical Research Council]
basically permits the MRC to do
its thing and the health service
will sort of step out of the way
and let them get on with it. Now
that’s not sensible.
Janie Hughes
I was very loath to move from the
middle of town [Richmond
Road] to Llandough Hospital [in
1990] for several reasons, but
one of them was that it was
further for me to travel and
another was it was going to be
different, because in Richmond
Road [where the unit had been
since 1962] we had been in a
three-storey house and we were
like little separate departments
and in Llandough Hospital, we
were going to be all in one
corridor and I just couldn’t
envisage that working. As it
happened, I was proved entirely
wrong and it became an even
nicer place to work in. It was just
absolutely pleasant; it was
wonderful. There were little
factions every now and then, that
disturbed the happiness, but on
the whole I am sure we were
quite unique. The building [in
Richmond Road] was owned by
the Welsh National School of
Medicine and I think they gave
it to us for a pittance which the
MRC readily agreed to pay, but
then the Welsh School of
Medicine became the College of
Medicine and I think they
became a bit desperate for
accommodation and money and
they decided to sell the building.
They gave us about two years’
notice and we had to look for
somewhere else. Dr Elwood hit
on the idea of coming back to
where the unit had originated,
the pneumoconiosis block of
Llandough Hospital, so that’s how
we came to be in this particular
suite of rooms now. A lot of
conversion had to be done,
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because most of these rooms
weren’t used as offices, they were
laboratories, hence the hundreds
of power points. There were
laboratory worktops all around
the place that had to be ripped
out. Extensive alteration had to
be done and the MRC agreed to
pay. The rent for this place was
quite hefty as well, so we were
very fortunate. I didn’t want to
come and in fact I didn’t pack
my bags until the afternoon
before we were due to move, I
was going to stick it out as a
sitting tenant. We got yearly visits
from a subcommittee.  I think I
am right in saying this, that they
had decided in 1990 that this
was just a temporary move for
the next five years and we were to
wind down. In fact they were
quite brutal in that they stopped
what we considered quite a few
extremely good studies and that
was a disaster – DART2,198 that
was one of them. And the stress
management substudy 199 of
DART2, and that was a really,
really well thought-out study and
everybody was terribly upset by
this. As I say they were quite
brutal, and they sort of said,
‘Stop within three months’,
something like that. But we
knew that there were about four
or five of us who were due to
retire or be made redundant in
March 1997, and three more
were to stay on until March
1999, so we knew exactly what
the issue was. That didn’t make
it any easier, but I can honestly
say that morale didn’t get low. We
had heard lots of tales about
morale in the Pneumoconiosis
Unit where there were 90-odd
people working and they
marched on Downing Street to
no avail, and morale got really,
really low and people got terribly
bitter,200 but it wasn’t like that in
the unit. Possibly because some of
us who were due to ‘retire’ were
coming to the end of our working
lives anyway and it didn’t matter
too much. Of course, to people
like Dr Elwood, you mustn’t
speak the word ‘retire’ – it’s a
dirty word. [AN: Put 10p in the
box.] Yes. Every time you say it,
it is a swear word.
Janie Hughes
We knew five years before we [the
EU] finished, it was called
ERCS (Early Retirement
Compensation Scheme). The
unit was closing when I was
coming up to 60 years of age. So
they were making us redundant,
but it was called early retirement
and we were given a package.
Janie Hughes
Most of the training was on the
job, but I did have some specific
training. I went to St Thomas’ to
learn how to do anthropometric
measuring properly and also I was
privileged to work for other units,
in that I was recruited to work for
the UKCCCR (United Kingdom
Figure 73:The Epidemiology Unit’s 25th anniversary at the University Hospital, Cardiff, 1985. A bust of Archie
Cochrane, brought by Peter Elwood, is in the foreground, as he was too ill to attend the celebration dinner.
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Coordinating Committee on
Cancer Research) on three studies,
– a breast cancer study, a testicular
tumour study [20 years ago now]
and most recently, a child
leukaemia study [1992].201 So I
went to lots of training days for
that: how to interview parents of
children who were terminally ill;
how to interview them in clinic
situations; how to interview in
their home situation; and how to
treat sensitive data properly. I went
on lots of courses, and I was often
on away-days to Leeds or Oxford.
Stewart Kilpatrick
But I think on the whole, the
Welsh people benefited from the
research work done, certainly the
miners did, there’s no doubt about
that at all. And I think as you
probably know even now there’s a
new scheme for the compensation
of ex-miners who have bronchitis
and emphysema and I am one of
the assessors for that, so I know
quite a lot about it, and that was
all really based on a lot of the
work that was done mostly in the
Pneumoconiosis Unit, but mostly
under Archie Cochrane, so I think
the Welsh people have benefited
from the presence there.
Educationally, there’s no doubt
that the medical students have
benefited from both these units
and the research that they have
done. And I was Dean 
of Clinical Studies in the
University of Wales College of
Medicine for 16 years, so I have
had quite a lot to do with the
education of medical students and
the choosing of them at that time.
At the same time I was Professor
of Chest Diseases, so I really had
rather a busy professional life. 
Selwyn St Leger
We used to discuss lots and lots of
things at Archie’s court up in the
roof, there was a good group of
us, and that was the time when
Brenner had been looking at
mortality and unemployment
and other people were trying to
explain mortality patterns in
other ways. We were just
speculating, ‘Well, look,  if
provision of health services and
all the rest of it is so effective,
shouldn’t we find some
correlation between service
provision levels and mortality,
perhaps in different countries?’
That led us to think of doing an
ecological study – of course we
didn’t use the word ecological
study in those days, we called it a
correlational study. Archie, Fred
and myself took this forward,
and we decided what we would
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Chart 2: Relationship between ischaemic heart disease mortality-rate in men aged 55–64 years
and wine consumption. See note 180.
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want, but not all of it was easily
available, such as the economic
information, and this is where
Archie came into his own. He
had contacts and he managed to
get quite a lot of international
information, which would be
readily available now, but in
those days it wasn’t. Fred put the
information onto big pieces of
paper listing 18 countries, with
all the variables along the top,
such as ischaemic heart disease in
different age groups. I am not sure
if I transcribed the data myself,
but we got a nice little database
onto the computer. This led to the
paper.202 We regarded that as
great fun and didn’t take it
terribly seriously. What it did
show was no particular link with
health indices and, as you might
expect, a very strong link with
indices of wealth of the nation,
such as gross national product. It
also showed a curious little
anomaly. If one standardized for
everything else and then plotted
the standardized residuals against
provision of doctors per head for
infant mortality, we found that
infant mortality increased with
doctors per head. We duly sent the
paper off to Hubert Campbell,
who accepted it and said that he
would publish it, and when it
was too late, he had dealt with
the proofs himself, he was being a
bit naughty I think, because
when it was too late, I noticed
that they had taken this lovely
graph out of the paper. I was
furious with Hubert, but it was
too late, so we managed to
persuade, I think it was the
Lancet to publish the graph.203
We sent a letter into the Lancet
with this graph in it, ‘The
anomaly that wouldn’t go away’.
And then we forgot all about it. 
We decided that the next thing
we wanted to look at was
ischaemic heart disease. Being
sceptics, does it really relate to
saturated fat intake and all the
other things that people look at?
We were using the same 18
countries and ischaemic heart
disease in various age groups, but
we also managed to get hold of
alcohol consumption and this is
where Archie was particularly
good with his contacts again. He
managed to get the data broken
down by beer, wine and spirits, in
terms of ethanol equivalents. We
had a fantastic time with this, we
put it into our regression and
looked at it every which way, and
every which way I looked at it, I
found a strong association with
total alcohol and an equally
strong association with wine
consumption and very little with
beer or spirits. After looking at
various combinations of our data
and bearing confounding in
mind, we could not make this go
away. So we were delighted by 
this news. We didn’t believe it 
was a cause–effect relationship,
although we wished it were true,
because Archie in particular was
a great wine drinker in those days
and I have been ever since. And so
we wrote this up. In fact I
remember I actually did the
drafting of both those papers. I
think Archie wanted me to get the
experience of writing publi-
cations, but also I had done the
analysis, so it was in my mind just
how it was structured. But I
remember what he did in the
second paper,204 I remember
sitting one afternoon just writing
it up, it was in more or less the
final form. Archie added one
thing that would almost be a
sacrilege if anybody found out
what was causing the beneficial
effects, because basically the wine’s
all very well packaged as it is. And
then he added, ‘We are sorry we
cannot advise our friends whether
or not it is best to have red, white,
or rosé ’. That went off to the
Lancet and caused quite a bit of
interest. In fact I got invited,
shortly after, to do an editorial
based on that, and on the basis of
that I wrote a whole string of
editorials during the time of –
was it Ian Munro’s editorship? –
which was very enjoyable, and of
course they were all anonymous in
those days. We didn’t take it any
further. We had a bit of
speculation round the table. And
remember Peter was teetotal. To
be fair to Peter he never shoved his
views on others, in terms of what
it means in terms of a research
question. At this stage we were
seriously discussing with Peter and
others, whether we should do some
sort of clinical trial, or something,
of alcohol. I think Michael Burr
suggested that we did something
with monks and nuns. We came
to the conclusion that really it was
just far too tenuous. This was just
an example of a correlation
analysis that crops up something.
Of course that’s how history proves
you did it wrong. When I last
checked on that paper, I think we
got about 250-odd citations. It
has gone throughout the medical
literature – it’s in the general stuff,
it’s in the biochemical stuff – it’s
always the paper that is cited as
the foundation of what we
thought of  as a red herring.
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Peter Elwood
We also set up a study in seven
year-old children to look at the
effect of school milk and we
selected schools in a deprived
area, and we did this by
standard criteria, which were
indices of deprivation. We went
to areas in south Wales with high
indices of deprivation. We
selected from all the schools in the
defined areas, we selected
children from families of four or
more children, and social class 3
manual or lower, so that we were
getting a  group of deprived
children. We supplied half of
them with school milk for two
years and we monitored that and
paid surprise visits to the school
to check who was actually getting
the milk. The teachers were all
intrigued by this study and
cooperation was really very high
indeed. And then we analysed
growth over that two-year period
and produced a very nice
gradient where the children in
social class 3 showed virtually no
change in growth, they grew, but
there was no difference between
the ones given the milk and those
not given the milk, and when we
went down the social class to the
unemployed, the nonclassifiable,
then we found quite a difference,
still just a few millimetres, but a
sizeable difference in growth. If
we multiplied that up by the
number of years that the children
might have received school milk,
it was a worthwhile increment.
We showed that school milk did
have an appreciable and, we felt,
worthwhile effect on the growth
of the most vulnerable children;
the Department of Health paid
no attention to it and school
milk was not reinstated.205
1976–78 School milk supplementation study
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Peter Elwood
Lead in petrol was a very, very
hot issue. A group was set up and
led by a politician and doctor
from Wales, an extraordinary,
exceedingly forceful character,
who dedicated himself to the
Campaign for Lead-free Air
(CLEAR). I became more and
more angry at the bad
epidemiological methods that
were being used in journals and
articles. I wrote one or two letters
to him, pointing out that the
data he was quoting and the
comparisons that he was making
were totally invalid. I wrote to
him a number of times. But I felt
this was an area in which we
should make a contribution, so I
set up one or two studies to look
at lead. 
The Welsh Office was interested
and asked us to look at water
lead. Some of the areas in Wales
have a very acid surface water
and old lead pipes. One or two
studies had shown that the lead
levels in the water were really
quite high, higher than the WHO
recommendation. We went to
north Wales and did a number of
surveys of water lead and blood
lead and estimated that the
contribution that water was
making to blood lead levels was
quite substantial. Whereas with
air lead, no matter where we went
we couldn’t get estimates of the
contribution to blood lead from
air higher than about 10 per cent.
Now there were uncertainties in
this. Food lead was obviously a
very important source and food
handling wasn’t nearly as careful
as it is now. I suspect that a
damaged conveyor belt might be
repaired with lead solder, whereas
now they wouldn’t dare have lead
solder anywhere near food
handling. I suspect that the fall in
lead levels which has been shown
quite conclusively in many studies
over the years206 has been largely
due to a reduction in water lead
and in food lead. We certainly
showed that the lowering of water
lead was important and was
effective. On two occasions we
were alerted to the fact that the
Welsh water authority was going
to change the pipes to an estate or
to a village, and so we went and
got blood lead levels and then we
followed the blood lead levels
following the change, the removal
of the lead pipes and the putting
in of copper pipes, and we showed
very nicely the fall in blood levels
and we showed the sort of half life
of blood lead from those studies.207
We also selected a town in East
Anglia that had a lot of lead pipes,
but had hard water, and we
showed that there was a very
substantial difference in both
water lead levels in the hard-water
area and the soft-water area and
very substantial difference in
blood lead levels. The relationship
between lead in the water and
blood was the same, but one was
higher up the curve than the other
in soft water.208
The other study which got the
headlines for a short period of
time was comparing areas with
heavy traffic and areas with very
little traffic and estimating water
lead, blood lead, and lead in the
dust. We also did children in
those days and dust lead was a
very important source. We used
to swab the children’s hands and
measure the amount of lead and
1976–82 Environmental lead studies
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relate that to blood lead. But the
most delightful studies were the
traffic-less islands. We chose three
areas in Wales with different
levels of traffic, from a rural area
to a very heavily polluted area.
The heavily polluted area was
Port Talbot, where there’s a
motorway which is elevated
above houses. Along this
motorway we chose houses on the
main road and houses with the
motorway over above and we did
lead sampling, lead air sampling
and confirmed that the lead
levels were very, very high, and
air lead levels were very high. So
we took blood from those women,
from Beaufort at the top of one of
the valleys, where there’s quite
high traffic, from Porth where
there’s a one-way system and very
heavy traffic. But then we went
to three islands. I got a colleague
in Ireland and another colleague
to do the surveys on Tory Island
off the north coast of Ireland, a
rather isolated community, and
this we were told had no petrol
traffic at all, never had and there
was never likely to be any petrol
traffic. My colleague was
appalled to see a petrol driven
van sitting some little distance
from the harbour and made
enquiries about it. Now
remember it was an Irish island,
an Irish community, and about
two years previously the local
authority had given a petrol-
driven van to the islanders
because there were two
communities on the island and,
the school was at one end of the
island and, on wet days, the van
would collect the children from
the other community. The
islanders had been told that
petrol was put in at the back of
the vehicle, and water in at the
front, but they had forgotten to
tell them that you also put in oil
from time to time to lubricate the
engine. So the van ran very
happily for some time and then it
seized up, and they just left it
where it had ceased and never
bothered with it again. With
that background we felt we could
call it a traffic-less island. We
took blood from every adult,
swept every house to get lead in
dust, and measured air lead, we
had one or two air samplers on
the island. We then went to
Arran Island off the west coast of
Ireland, and again my colleague
was appalled to see a petrol-
driven Hillman car on the island
and he made enquiries. And he
found that the district nurse on
the island had brought a car
over, sometime previously, and
every time she went to the
mainland, at most once a month,
but probably not even that often,
she took her petrol can and
collected two gallons of petrol,
put it into the car, drove the car
until the petrol ran out, and then
just left it wherever it was, until
she next went to the mainland.
So again we felt that we could
call it a traffic-less island. The
third island was truly traffic-less,
and that was Sark in the
Channel Islands. We asked the
doctor living on the island if he
would take blood for us and he
got permission from the
Monsignor. There used to be a
Dame of Sark, and one of the
laws of the island of Sark is that
only the Dame or the Monsignor
is allowed to have a bitch, others
can have dogs, and no one is
allowed any mechanically driven
vehicle of any kind, lawnmower
included. So we truly did have a
traffic-less, vehicle-less island,
and we got blood from them.
Well it was delightful that study,
but we found that the lead levels
were almost identical to the areas
in Wales. There was very little
difference between them. Tory
had a terrible problem of
alcoholism there and it may be
that alcoholics do raise their
blood lead for whatever reason,
because they used to seal wine
with lead in some way, but really
there was very little difference.209
But I reckon that all the work
that we did on lead was good
epidemiology. I think that
instead of doing all those studies,
we should have done one really
big study. There was one much
bigger study, a survey of health in
Wales in connection with health
promotion. The Welsh Office had
funded a group to do a study
right across Wales, with about
2000 people examined in
relation to heart disease, one of
the heart prevention projects.
Well we asked the team for a
sample of blood from every
person, so I got 2000 or 3000
samples of blood and we looked at
that, and the one paper that we
published was on blood lead and
blood pressure. That was quite an
issue and we entered into that
debate as to whether or not lead is
related to blood pressure.210 The
most curious publication of all
that we got out of that was blood
lead and platelet function. Blood
lead is negatively related to platelet
function, so we published a
paper,211 tongue in cheek, and I
think it actually asks the question
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at the end ‘Does this mean that
people exposed to lead have a lower
risk of ischaemic heart disease?’ 
The studies on lead I think
were good epidemiology, they
weren’t very big, I think we lost
out in that way, but they
achieved virtually nothing. I
think CLEAR was scientifically
scandalous in the way they
distorted data.
Janie Hughes
It was lovely working in north
Wales, because you just explained
to the parents that there was a
little worry about lead in the air
and they were more than anxious
to cooperate, even though it was
to take a venous blood sample
from a tiny infant. I took my
daughter’s little dancing doll, the
music was from Dr Zhivago,
and it went round and round
and round, and the kids were
mesmerized by this doll, and I
would try and distract them
while the parents usually held the
arm and Dr Elwood took the
blood. So the parent was fully
aware of what was going on. 
MRC Epidemiology Unit
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John Yarnell
The Caerphilly Prospective Study
really started out of my work in
women in that we went back to
these women to ask them for
blood and we had this fairly
elaborate theoretical structure
looking for the determinants of
HDL cholesterol, both dietary
and physical determinants. We
thought that it would be a good
idea to do this in men as well. I
knew and Peter Elwood knew
that probably we should
concentrate on ischaemic heart
disease. We had the example of
Speedwell as being set up by
David Bainton as a prospective
study.212 We knew that it was not
possible to do everything within
that, so I think it was a strategy
formulated in the unit itself to
develop the Caerphilly study,
which was genuine team work
with the Director, Peter Elwood,
and Peter Sweetnam insisting
that we concentrate on 45 to 59
year olds to try to maximize the
cost-effectiveness of the exercise. I
suppose I was prepared to do a lot
of the donkey work as well – two
evening clinics a week, which we
used to do out of normal working
hours, because in the 45 to 59
years olds there was still a fairly
high level of employment,
although a proportion of men
had retired or been forced to
retire early. We also did a single
morning clinic to which we
invited everybody to have their
fasting blood sample taken in the
middle of the week. Peter Elwood
and others helped on a very
practical level with the morning
clinics. I think a lot of the
staffing arrangements were
geared towards the Caerphilly
study and as it went on Peter
Elwood became even more
enthusiastic. He was still doing
some aspirin work then. Towards
the end of the baseline
examination it became fairly
obvious that we ought to carry on
with the cycle of work and we did
make an unsuccessful bid the
second time round to get funding
from the British Heart
Foundation. One of the things,
however, that we had got funding
for, or unofficial funding for,
because he was very keen to do it,
was for tests of platelet
aggregation. I met Serge Renaud
the first time on the same
platform as Tom Meade talking
about platelet studies. He had
done a lot of cross-sectional work
and was very convinced that his
methods would be convertible to
large-scale epidemiological studies.
So he invited me over to his unit
in Lyon and had this mobile
laboratory which he wasn’t using
at the time, and he really jumped
at the chance of bringing it to
Caerphilly to use in our study.
After some discussions with Peter,
the two Peters if you like, we
decided to do a pilot phase in the
grounds of the Caerphilly Miners’
Hospital and we got a group of
volunteers plus the reproducibility
group, we called back about 200
people from the first phase of the
study to see whether these tests
would be reproducible in terms of
single measurements for an
epidemiological study over a
period of time. Serge brought one
technician with him. She worked
for about four or five months in
parallel with our two technicians
to get the thing up and running.
In the pilot phase we found that
these tests did seem robust enough
or precise enough to characterize
individuals with a single
measurement. So that was the
cornerstone of phase 2. We did
have some interest from Stan
Hepsinsall in Nottingham, in
doing additional tests on the
platelet active markers etc., but
unfortunately we weren’t able to
get the funding for all of that. We
were able to do some more platelet
function tests in phase 3 of the
study, but during phase 2 we went
to some trouble to reconstruct the
cohort by inviting people who had
moved into the area, or somehow
we had missed the first time, and
this provided us with a new
baseline of the second phase of the
study and so it carried on with
fresh tests being added at various
stages. I think in phase 2 and
perhaps more particularly at phase
3 we realized that this might go
on for some time and we began
being interested in looking at
stroke as an outcome, and we
persuaded David Bainton and
Ian Baker to put stroke into the
Speedwell study at that stage,
which was working on its own
regular three-year cycle.
Peter Elwood
John Yarnell made the first
contact with Serge Renaud, who
had taken a similar path to me,
had an interest in platelets, an
interest in aspirin and so on, but
he had determined to do platelet
aggregation studies and so he had
persuaded INSERM, the
counterpart of the MRC in
France, to give him money to
equip a caravan with platelet
equipment which he towed
around France and the south of
England, doing platelet tests.213
He had two platelet
aggregometers (that were slightly
modified O’Brien models). He
had two of everything – two
centrifuges, two platelet counters,
1979–ongoing  Caerphilly cohort study
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including two coffee-making
machines – in this caravan. It
was delightful the way it was laid
out, extremely efficient, in that
the subject came into the caravan,
a bed was lowered across the door
(it was the only way he could do
it), the man lay on the bench,
gave his blood, was then thanked
and let go, and immediately the
platelet work started, so it was
done while the blood was
absolutely fresh. Renaud, bless
him, agreed to lend us his caravan
for however long it took to do all
the men in Caerphilly. 
I was terribly apprehensive. I
thought that if we parked this
outside men’s houses that it
would be vandalized in no time,
but we compromised, we set it up
in Caerphilly Miners’ Hospital,
who were marvellous. They put
in hard-standing and steps for
us, a cable into it for current,
and Andrew Beswick, who has
been an absolute brick in the
unit, spent four years of his life
doing nothing but platelet
aggregation. We asked the men to
come early in the morning and
give a sample of fasting blood,
and Andrew found that he could
only do six in a morning. It’s
quite a complicated test. We did
aggregation of three agonists. We
had to wait then for cases of MI
[myocardial infarction] to occur,
and we waited, I think, five
years and then worked on an
analysis, and we found no
evidence of prediction at all. We
really went to town on this, the
standard measures of
aggregation, pen records, I think
it was about 12 different
measurements on these traces and
then as a final attempt, I gave
them to one of the girls, and I
said, ‘Look, treat these as
wallpaper, sort them into
different patterns, tell me at the
end how you describe these
patterns’. I think she had about
ten patterns from no effect at all,
to a crazy curve. We played
around with this, but still there
was absolutely no prediction. We
published a paper in Heart,214
and I can tell you with
amusement that in recent days,
two people have quoted that
paper as showing platelet
function is predictive of
ischaemic heart disease. There
was one very, very scrappy
prediction which I was uneasy
about, but if we took the very
early heart attacks, there was a
vague suggestion that one of the
tests might predict. So that was
phase 1. We then heard about
two new tests of platelet function,
so five years later in the next
phase, we put in those two tests.
One was a method of looking at
aggregation in whole blood, the
original test requires platelet-rich
plasma, and you have to spin the
blood, remove the red and white
cells, and then count the
platelets. There’s quite a lot of
manipulation of the sample and
its plasma, and we felt that that
was not very realistic. So when
this test, devised by Rod
Flower,215 came along on whole
blood, we thought, ‘This will be
it’. So we did that test on every
man and that again took
Andrew Beswick another four
years of his life and John O’Brien
meanwhile had devised a 
very, very simple test.216 The
background physiology of
platelets is that if platelets are
damaged or exposed to ADP
[adenosine diphosphate], then
they are activated. But if you
block that response with aspirin,
you can still get them to
aggregate if you expose them to
high shear and in atheroma some
of the platelets are exposed to
high shear forces in the blood
vessels and so that might be a
separate method of activation.
John O’Brien took a whole-blood
sample, just the residue in the
syringe, stuck it in a little filter
holder, sucked the blood through
at a pressure which meant that
they were going through the filter
at high shear and then he did a
platelet count on the whole blood
and on the blood that came
through. There was a second
measure which made the test
very, very attractive, you simply
sucked the blood through and
counted the number of drops,
which gives an indication of
platelet activity. Again it took, I
think, ten years after those two
tests, and just within the last few
weeks, I have analysed the data
and the whole-blood test shows
no trend, but when we divided
the men into fifths by their
whole-blood platelet test, there
was a suggestive trend with
stroke, but  not significant. But
the fifth of men with the most
active platelets on the whole-
blood test, have a significantly
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reduced risk of stroke. It’s only
one subgroup, but the risk we
showed is about 0.5 and is
statistically significant. So that
has thrown us, the association’s
with stroke, and it’s the wrong
way round, and I am just
writing it up at the moment for
publication.217
Peter Elwood
In those days a sample of 2500
wasn’t particularly small. We
would have liked it to be bigger,
but I was so insistent that the
Caerphilly study should be
intensive, that we should
collaborate with as large a
number of collaborators as
possible and add in as many
variables as possible. For
instance, at a later stage we
added in lead, we added in
arthritis with Silman, and we
added other things, such as
homocysteine with Dr Job Ubbink
and antioxidants with Strain 
and Thurnham.218 It was a very
intensive study, so rather than
recruit large numbers, we were
prepared to go on for a long time.
You see it was a very stable area.
Some of the cohort studies in
London and places like that got
into trouble trying to follow up
people. Initially we had thought of
ten years, but I don’t think we had
thought of that as an absolute end
to the study. Now with regard to
women, we were aware of the
opportunity that we were missing,
not looking at men and women,
and so towards the end of the
study we added in 250 women,
and sadly nothing to my
knowledge has ever been published
about those women. When we
started to analyse them, and I took
a personal interest in those 250
women and looked at a number of
things in them, but Peter
Sweetnam pointed out that the
drift by the laboratory estimations,
there was always a drift over time
and the women came in at the
end, so we would either have to
compare the women with the last
250 men in Caerphilly or we
would have to indulge in some
rather dubious standardization
process, with the drift and the
changes in the laboratories. So
sadly we found it difficult. 
Figure 76:
Speedwell
team, c. 1989.
From left: Janet
Lloyd, Roma
Worner, Ian
Baker, David
Bainton, Eileen
Coleman.
Figure 75: Speedwell team, c. 1989. From left, seated: Roma Worner, Eileen
Coleman, Janet Lloyd. Standing: Ian Baker, Peter Elwood, David Bainton.
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Professor Sir William Asscher 
Kt FRCP (b. 1931) was Professor of Medicine at
the University of Cardiff from 1976 to 1987 and
Director of the Institute of Nephrology in Cardiff
from 1970 to 1987. In 1988 he became Dean (later
Principal) of St George’s Hospital Medical School,
London, until his retirement in 1996. He was
Chairman of the Committee on the Review of
Medicines of the Department of Health from 1985
to 1987 and Chairman of the Committee on Safety
of Medicines from 1987 to 1993. 
Dr David Bainton 
MRCP (1941–2002) was a member of the scientific
staff of the MRC Epidemiological Research Unit
(South Wales) from 1970 to 1973, leaving to take
an MSc at the London School of Hygiene and
Tropical Medicine, moving to the Avon Area Health
Authority and later the Gwent Health Authority.
He was Senior Lecturer at the Centre for Applied
Public Health Medicine, Cardiff, at the University
of Wales College of Medicine from 1989 to 2001
and Honorary Consultant in Public Health
Medicine at Gwent Health Authority from 1994
until his retirement in 2001.
Anthony Barber 
(Lord Barber of Wentbridge from 1974) PC TD DL
(b. 1920) was Minister of Health and member of the
Cabinet from 1963 to 1964, later Chairman of
Standard Chartered Bank plc from 1974 to 1987.
Professor David Barker 
FRCP FRCOG FRS has been Director of the
Medical Research Council Environmental
Epidemiology Unit at the University of
Southampton since 1984.
Dr Evan Bedford 
CBE FRCP (1898–1978) joined the Middlesex
Hospital in 1926, where he later became Consultant
Physician, later also at the National Heart and
Connaught Hospitals. He was Chairman of the
Council of the British Heart Foundation and editor
of the British Heart Journal. See Somerville W.
(1984) Davis Evan Bedford. Munk’s Roll 7: 28–30.
Dr Bill Berry 
Was Chief Chief Medical Officer (Nutrition) in the
Department of Health from about 1960 to 
perhaps 1980. Information from Dr Peter Elwood.
Sir Christopher Booth 
Kt FRCP (b. 1924) trained as a gastroenterologist
and was Professor of Medicine at the Royal
Postgraduate Medical School, Hammersmith
Hospital, London, from 1966 to 1977 and
Director of the Medical Research Council’s Clinical
Research Centre, Northwick Park Hospital,
Harrow, from 1978 to 1988, and Harveian
Librarian at the Royal College of Physicians from
1989 to 1997. He was the first Convenor of the
Wellcome Trust’s History of Twentieth Century
Medicine Group from 1990 to 1996. 
Professor Gustav Born
FRCP FRS was Vandervell Professor Emeritus 
of Pharmacology at King’s College, London, 
from 1978 to 1986, later Emeritus.
Dr Michael Burr 
FFPHM (b. 1937) was in general practice from
1962 to 1966 and in public health until he was
appointed a member of scientific staff at the
Epidemiology Unit in 1970. He was Consultant
Epidemiologist to the unit from 1979 and honorary
consultant to the health authority until he joined
the University of Wales College of Medicine in
Cardiff in 1993.
Dr Jeffrey Chapman 
(1923–2000) was a medical member of the
scientific staff at the Pneumoconiosis Research Unit,
leaving to become a medical officer of a whaling
ship, the leader of one of the National Coal Board
medical teams working on pneumoconiosis and 
a member of the Medical Research Council
headquarters staff dealing with occupational
medicine from 1959 to 1980. See Cochrane A L
with Max Blythe. (1989) One Man’s Medicine: An
autobiography of Archie Cochrane. London: British
Medical Journal for the Memoir Club, 160.
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Professor Eric Cheeseman 
(1912–1987) was Professor of Medical Statistics,
Queen’s University of Belfast, from 1961to 1977,
later Emeritus. He had been a staff member of the
Statistical Committee of the MRC from 1929 to
1939, and Research Statistician with the Statistical
Research Unit of the MRC from 1946 to 1948.
Professor Archie Cochrane 
CBE MBE FRCP FFCM (1909–1988), medical
scientist and epidemiologist, whose independent
wealth supported his studies in interwar Berlin,
Vienna and The Hague, and a year in a field
ambulance unit supporting the International
Brigade in the Spanish Civil War before returning
to complete his medical studies at University
College Hospital, London. He qualified in 1938
before joining the Royal Army Medical Corps, was
captured in 1941 and a prisoner of war in Salonica,
where he conducted his first clinical trial. Following
the war his work for a Diploma in Public Health at
the London School of Hygiene and Tropical
Medicine was supported by a Rockefeller fellowship.
He was appointed to the Medical Research
Council’s Pneumoconiosis Research Unit in 1948. 
In 1960 he was appointed David Davies Professor of
Tuberculosis and Diseases of the Chest at the Welsh
National School of Medicine, Cardiff, becoming
Director of the Epidemiological Research Unit in
Cardiff in 1961 until his retirement in 1974. See
also Cochrane A L. (1976) The development of
epidemiology in MRC Units in Wales (1945–1975):
a personal view. Journal of the Royal College of
Physicians 10: 316–320. (1988) Obituary: A L
Cochrane. British Medical Journal 297: 63 (signed
ALC), 355, 419, 614, 1704. His papers are available
for study at the Cochrane Archive, Llandough
Hospital, Penarth, Cardiff.
Dr R H L (Dick) Cohen 
CB MRCS (1907–1998) was on the staff of the
MRC from 1948, serving as Deputy Chief Medical
Officer from 1957 to 1962, when he was seconded
to the Ministry of Health as Principal Medical
Officer from 1962, Deputy Chief Medical Officer to
Sir George Godber from 1967, and finally as the first
Chief Scientist to the Department from 1972 until
his retirement in 1973. See Wilson J M G. (1998)
Richard Cohen: First Chief Scientist at the DHSS.
Journal of the Royal Society of Medicine 91: 222–224.
Professor Sir Richard Doll 
Kt CH OBE FRCP FRS (b. 1912) was Director 
of the MRC Statistical Research Unit from 1961 
to 1969 and subsequently Regius Professor of
Medicine at the University of Oxford from 1969 
to 1979, later Emeritus. He was Chairman of the
Adverse Reaction Subcommittee, Committee on
Safety of Medicines, from 1970 to 1977 and has
been Honorary Consultant, MRC/Cancer 
Research UK/BHF Clinical Trial Service Unit 
and Epidemiology Studies Unit, Radcliffe Infirmary,
Oxford, since 1983.
Dr Peter Elwood 
FRCP (b. 1930) was a member of the scientific staff
of the Epidemiological Research Unit (South Wales)
from 1963 and its Director from 1974 until its
closure in 1995. He qualified in medicine at
Queen’s University, Belfast, in 1954 and worked
with John Pemberton from 1958 to 1963. He was
to retire in 1995 but has ignored the advice and still
works almost full time, supported by Janie Hughes
and Janet Pickering, a statistician in the unit from
1977 to 1982. He holds Honorary Professorships 
in the Department of Epidemiology, Statistics and
Public Health Medicine in the University of Wales
College of Medicine and the Department of Social
Medicine in the Univeristy of Bristol, and is a
Visiting Professor in the Department of Science 
at the University of Ulster.
Dai Dan Evans 
was General Secretary of the South Wales area
National Union of Mineworkers in the 1950s and
1960s. Information from Dr Julian Tudor Hart, 
18 April 2002.
Dr Joan Faulkner (Lady Doll) 
(1914–2001) qualified in 1937, took the Diploma
in Public Health in 1942, and joined the MRC staff
in 1943 as research assistant to Dr Philip D’Arcy
Hart. She joined headquarters staff in 1945 and
retired as Senior Principal Medical Officer in 1979. 
Professor Charles Fletcher 
CBE FRCP (1911–1995) directed the MRC
Pneumoconiosis Research Unit from 1945 to
1952 and was Secretary of the MRC Committee
on Bronchial Research from 1954 to 1976. He
was Professor of Clinical Epidemiology at the
Royal Postgraduate Medical School,
Hammersmith Hospital, London, from 1973 
to 1976, later Emeritus, and Physician to
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Hammersmith Hospital from 1952 to 1976. See
also a videotape interview with Professor Charles
Fletcher by Max Blythe, held at the Royal College
of Physicians of London. See note 9.
Dr Harold ‘Bill’ Foreman 
FRCP (1898–1980) was physician-superintendent of
Sully Hospital, a sanitorium that became a centre for
cardiothoracic medicine in south Wales. He had been
a prisoner of war with Archie Cochrane and was
instrumental in the relocation of Archie’s
epidemiology and medical statistics course to Sully
Hospital from Richmond Road, Cardiff in 1962. See
Robson K. (1984) Harold Mason Foreman. Munk’s
Roll 7: 189–190. See also See note 20, 176–178.
Dr John Gallacher 
AfBPsS, CPsychol (b. 1956) was a member of the
MRC Epidemiology Unit from 1977 until 1997
when he became a lecturer in epidemiology in the
University of Wales College of Medicine, Cardiff.
He introduced psychosocial questionnaires,
audiometry and noise exposure into Phase II of the
Caerphilly study and a series of tests of cognitive
function into Phase III and IV. He continues to
work with Peter Elwood on these data and is
organizing the cognitive tests for Phase V. 
Dr John Gilson 
CBE FRCP (1912–1989) served at the RAF
Physiological Laboratory in Farnborough during
the Second World War because of his interest in
respiratory physiology, where he developed oxygen
masks that improved air flow. He joined the MRC
Pneumoconiosis Research Unit in 1946, becoming
Director in 1952 until his retirement in 1976. See
Kilpatrick G S. (1994) John Carey Gilson. Munk’s
Roll 9: 197.
Dr Philip D’Arcy Hart 
CBE FRCP (b. 1900) trained in medicine at
University College Hospital, London, where he
became a Consultant Physician. Interested in
developing a career in medical research, and
encouraged by Sir Thomas Lewis, he became a
member of the MRC’s staff, and in 1937 undertook
the survey he here describes (see page 3). In 1948
he became the Director of the MRC Tuberculosis
Research Unit until his retirement in 1965, to
become a grant-holder of the MRC in the
laboratories of the National Institute for Medical
Research, London.
Dr Julian Tudor Hart 
(b. 1927) was first an epidemiologist working in the
Epidemiology Research Unit in 1961, before
moving to general practice in 1961 until 1988. See
Mullan F. (1995) Interview with Julian Tudor Hart,
February 1995. Primary Care Oral History Project,
1995–98. Modern Manuscripts Collection,
National Library of Medicine, Bethesda, MD, USA.
Dr Tudor Hart’s practice records from 1965 to
1992 are held as CMAC/GP/13 in Archives and
Manuscripts, Wellcome Library, London.
Mr Nick Henderson 
MRCVS FIPR (b. 1926) was a veterinary surgeon and
is Executive Director of the European Aspirin
Foundation. He is a Liveryman of the Society of
Apothecaries.
Professor Ian Higgins 
Was one of the three original scientific staff
appointed to the Epidemiological Research 
Unit in 1961. 
Sir Austin Bradford Hill 
Kt FRS (1897–1991) was Professor of Medical
Statistics at the London School of Hygiene and
Tropical Medicine from 1945 until his retirement in
1961. His series of 17 articles in the Lancet in 1937
introduced the medical researcher to the use of
statistics (reprinted as Principles of Medical Statistics.
London: The Lancet, 1937). He was made an
Honorary Fellow of the Royal College of Physicians
in 1963. See Doll R. (1994) Austin Bradford Hill.
Biographical Memoirs of Fellows of the Royal Society
40: 129–140.
Sir Harold Himsworth 
KCB FRCP FRS (1905–1993), a distinguished
clinical scientist, was Professor of Medicine and
Director of the Medical Unit at University College
Hospital, London, from 1939 to 1949 and
Secretary of the MRC from 1949 until his
retirement in 1968. See Black D A K, Gray J.
(1995) Sir Harold Percival Himsworth KCB.
Biographical Memoirs of Fellows of the Royal Society
41: 201–218. Gray J, Booth C. (1994) Sir Harold
Himsworth. Munk’s Roll 9: 238–241.
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Dr Sheila Howarth (Lady McMichael)
FRCP (1920–2000) joined the staff of the
headquarters office of the MRC in 1964. She
retired as Principal Medical Officer in 1980, having
held responsibilities at office level for much of the
MRC clinical research programme, including the
Clinical Research Centre. She had previously
(1943–1945) been engaged in research, mainly on
the cardiovascular system, at the British
Postgraduate Medical Federation, University
College London, and the Institute of Cardiology.
Mrs Janie Hughes 
(b. 1944) joined the MRC Epidemiological
Research Unit in April 1964 and has worked under
the directorship of both Archie Cochrane and Peter
Elwood. She has been involved in most of the major
studies mentioned in the transcript and still assists
Professor Peter Elwood as he continues to work well
into retirement.
Dr Philip Hugh-Jones 
(b. 1917) was Consulting Physician and Director of
the Chest Unit at King’s College Hospital, London,
and Consulting Physician and part-time Director of
the MRC Clinical Pulmonary Physiology Research
Unit at Hammersmith Hospital, London, from 1964
to 1967 when it was taken over by the University of
London. He had been on the scientific staff of the
MRC Pneumoconiosis Unit from 1945 to 1955.
Professor Edward H Kass 
(1917–90), physician, medical researcher and a
world expert in infectious diseases. He was William
Ellery Channing Professor of Medicine at Harvard
Medical School, Founder and Director of the
Channing Laboratory. His interest in bacteriuria 
led to questions about its possible relationship to
hypertension and he collaborated with Bill Miall
and Ken Stuart and his son Steven, from Barbados
first in Jamaica and later in the Rhondda Valley,
south Wales, which he described as ‘twelve years
preceptorship in epidemiologic methods and
approaches to the study of chronic diseases’. 
See Kass A M. (1996) ‘A Brief History of the
Channing Laboratory,’ talk given on 31 October
1996. (www.channing.harvard.edu/kass.htm, 
visited 4 February 2002).
Professor Stewart Kilpatrick 
OBE FRCP (b. 1925) was Registrar at the
Pneumoconiosis Research Unit in south Wales from
1952 to 1955. He followed Archie Cochrane as David
Davies Professor of Tuberculosis and Chest Diseases at
the University of Wales College of Medicine, Cardiff,
from 1971 and was Dean of Clinical Studies and later
Vice-Provost from 1987 until his retirement in 1990
and Consultant Physician for the South Glamorgan
Area Health Authority from 1963 to 1990 .
Sir Thomas Lewis 
CBE FRCP FRS (1881–1945), Welsh cardiologist
and clinical scientist, directed the first of the
MRC’s research units, the Department of Clinical
Research, established at University College
Hospital Medical School, London, from 1919 until
his retirement in 1945. He was awarded one of the
first Beit Fellowships in 1910. See Drury A N,
Grant R T. (1945–48) Sir Thomas Lewis. Obituary
Notices of Fellows of the Royal Society 5: 179–202.
A collection of his papers, CMAC/PP/LEW, is held
in Manuscripts and Archives, Wellcome Library.
Professor Thomas Meade 
FRCP FRS (b. 1936) has been Director of the
MRC Epidemiology and Medical Care Unit since
1970, first at Northwick Park Hospital then at the
Wolfson Institute of Preventive Medicine in 1992.
He is also Honorary Consultant in Epidemiology at
St Bartholomew’s Hospital, London, and
Northwick Park Hospital, Harrow.
Sir Edward Mellanby 
FRS (1884–1955) was Secretary of the Medical
Research Council (MRC) from 1933 to 1949.
Dr William Miall 
(b. 1917) was a member of the scientific staff of 
the MRC’s Pneumoconiosis Research Unit from
1951 to 1961, when he joined the MRC’s
Epidemiological Research Unit until appointed
Director of the MRC Epidemiology Unit in Jamaica
from 1962 to 1970; a consultant in epidemiology
and member of the scientific staff in the
Epidemiology and Medical Care Unit at 
Northwick Park Hospital, Harrow, from 
1971 to 1983.
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Mr Fred Moore
(b. 1915) was a member from 1950 to 1985 
of the Pneumoconiosis Research Unit, moving 
to the Empidemiological Research Unit, later the
Epidemiology Unit.
Dr Ian Munro
FRCP (1923–1997) was editor of the Lancet from
1976 to 1988. He had joined the staff of the Lancet
in 1951 and was deputy editor from 1965. 
Dr Shaun Murphy 
(b. 1951) has been Departmental Manager of the
Department of Social Medicine at the University 
of Bristol since 1993 and writes on the history of
social medicine.
The Rt Hon Sir Patrick Nairne 
GCB MC (b. 1921) had a Civil Service career from
1947 to 1981 serving in the Admiralty, the Ministry
of Defence and the Cabinet Office. He was
Permanent Secretary of the Department of Health
and Social Security from 1975 until 1981.
Dr Andy Ness 
(b. 1962) has been a Senior Lecturer in
Epidemiology at the University of Bristol since
1997. From 1993 to 1997 he held a Wellcome
Training Fellowship in Epidemiology at the
University of Cambridge, and was senior registrar 
in public health medicine at Cambridge in 1997.
Dr Peter Oldham 
Was a statistician at the Epidemiological Research
Unit, trained by Sir Austin Bradford Hill. 
See Oldham P D. (1968) Measurement in 
Medicine: The interpretation of numerical data.
London: English Universities Press.
Professor Linus Pauling 
(1901–1994) advocated the use of large doses of
vitamin C to cure cancer and other diseases. He
received the Nobel Prize for Chemistry in 1954 for
his work on the chemical bond and its application
to the structure of complex substances, such as
proteins and antibodies, and was awarded the 
1962 Nobel Peace Prize for his campaign against 
nuclear weapons. 
Professor Anthony Seaton 
CBE FRCP FRCPE FMedSci (b. 1938) has been
Professor of Environmental and Occupational
Medicine at Aberdeen University since 1988. He
was Director of the Institute of Occupational
Medicine, Edinburgh, from 1978 to 1990; Editor
of Thorax from 1977 to 1982; Chairman of the
Department of Environment Expert Panel on Air
Quality Standards from 1991 to 2002; President of
the British Thoracic Society in 1999; and a member
of the Department of Health Committee on
Medical Aspects of Air Pollution.
Professor Sir Stanley Peart 
FRS FRCP (b. 1922) was Professor of Medicine,
University of London, at St Mary’s Hospital
Medical School, from 1957 to 1987, later Emeritus.
He was a Trustee of the Wellcome Trust from 1975,
and Deputy Chairman from 1991 until 1994.
Professor John Pemberton 
FRCP (b. 1912) was Professor of Social and
Preventive Medicine at Queen’s University, Belfast,
from 1958 to 1976, later Emeritus, and Consultant
in Social and Preventive Medicine at the Royal
Victoria Hospital, Belfast. He was a founder
member and first treasurer of the Society for Social
Medicine in 1957 and co-founder of the
International Epidemiological Association in the
same year. He confirmed the existence of byssinosis
in flax workers in Northern Ireland in 1963. See
also Pemberton J. (1998) Social medicine comes on
the scene in the United Kingdom, 1936–1960.
Journal of Public Health Medicine 20: 149–153.
idem (2002) Origins and early history of the Society
for Social Medicine in the UK and Ireland. Journal
of Epidemiology and Community Health 56:
342–346, photograph on page 345. McPherson K,
Dunnell K. (2002) Society for Social Medicine
1977–1992. Journal of Epidemiology and
Community Health 56: 347–348.
Professor Sir Richard Peto 
FRS (b. 1943) has been Professor of Medical
Statistics and Epidemiology at the University 
of Oxford since 1992. He was an MRC Research
Officer from 1967 to 1969 before moving to the
University of Oxford in 1969, as Lecturer from
1972 and Reader in Cancer Studies from 1975.
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Sir George Pickering 
FRS (1904–1980) was Regius Professor of Medicine
in Oxford in the Department of Clinical Research
from 1956 until his retirement in 1969. He was a
member of the MRC and its Clinical Research
Board from 1954 to 1958. A collection 
of his papers, CMAC/PP/GWP, is held by Archives
and Manuscripts, Wellcome Library.
Sir Robert Platt 
(Lord Platt of Grindleford from 1967) Bt FRCP
(1900–1978) was Professor of Medicine at the
University of Manchester from 1945 to 1965 and
President of the Royal College of Physicians from
1957 to 1962. See his autobiography, Private and
Controversial. London: Cassell, 1972.
Dr John Fraser Roberts 
CBE FRCP FRCPsych FRS (1899–1987), a pioneer
in medical genetics, studied animal breeding at
Edinburgh, and later qualified in medicine in 1936.
He was Director of the MRC Clinical Genetics
Research Unit at the Institute of Child Health,
London, and Honorary Consultant in Medical
Genetics at the Hospital for Sick Children, Great
Ormond Street, London, from 1957 until his
retirement in 1964. He had been Director of the
Burden Mental Research Department at the Stoke
Park Colony, Bristol, from 1933 to 1957 and
Consultant in Medical Genetics at the Royal
Eastern Counties Hospital, Colchester, from 1946
to 1980 and was associated with the Eugenics
Society for 37 years. See Polani P E. (1989) John
Alexander Fraser Roberts. Munk’s Roll 8: 416–420.
Professor Richard Selwyn Francis Schilling 
CBE FRCP (1911–1997) was Professor of
Occupational Health at the London School of
Hygiene and Tropical Medicine from 1960 until his
retirement in 1976, later Emeritus, and Director of
the Rockefeller Unit of Occupational Health (later
Institute) from 1956. He had been Secretary of the
Industrial Health Research Board of the MRC from
1942 to 1946 at the time of Charles Fletcher’s
appointment. See his autobiography, Schilling R.
(1998) A Challenging Life: Sixty years in occupational
health. London: Canning. See also Schilling R.
(1997) Obituary: Richard Selwyn Francis Schilling.
British Medical Journal 315: 1546.
Professor Gerry Shaper 
FRCP FRCPath (b. 1927) qualified in Cape Town,
South Africa, joining the Department of Medicine
at Makerere University Medical School, Kampala,
Uganda, in 1957, moving to the MRC Social
Medicine Unit at the London School of Hygiene
and Tropical Medicine in 1970 and in 1975 to the
Department of Epidemiology and Public Health as
Professor of Clinical Epidemiology at the Royal Free
Hospital School of Medicine, London, until his
retirement in 1992, later Emeritus.
Professor Michael Shepherd 
CBE FRCP FRCPsych was Professor of
Epidemiological Psychiatry at the Institute of
Psychiatry, University of London, and Hon.
Physician at the Bethlem Royal and Maudsley
Hospitals, King’s College Hospital, London, from
1965 to 1988, later Emeritus.
Professor George Davey Smith 
FSPHM (b. 1959) has been Professor of Clinical
Epidemiology in the Department of Social
Medicine at the University of Bristol since 1994.
He had a part-time attachment at the MRC
Epidemiology Unit from 1986 to 1987 and has
collaborated closely with them since.
Professor Stephen Stansfeld 
MBBS PhD MRCP MRCPsych (b. 1951) has been
Professor of Psychiatry at St Bartholomew’s and the
Royal London School of Medicine and Dentistry,
Queen Mary and Westfield College, since 1999. He
was a Wellcome Trust Research Training Fellow at
the Institute of Psychiatry, London, at the time of
his first involvement with the Caerphilly study.
More recently, he has been Senior Lecturer in Social
and Community Psychiatry, Reader and 
Co-Director of the Whitehall II study at University
College London. See Marmot M G, Davey Smith
G, Stansfeld S A, Patel C, North F, Head J, White
I, Brunner E, Feeney A. (1991) Health inequalities
among British Civil Servants: The Whitehall II
study. Lancet 337: 1387–1393.
Dr Antony Selwyn St Leger 
FFCM (b. 1948) has been a consultant and senior
lecturer in public health medicine at the University
of Manchester since 1980. He was at the MRC
Epidemiology Unit (South Wales) from 1974 
to 1980.
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Dr Alice Stewart 
FRCP (1906–2002) worked on MRC-funded
projects for Dr Leslie Witts during the war, including
a study of pneumoconiosis, 1945–46, became a
lecturer in the Nuffied  Department of Social
Medicine at the University of Oxford in 1946, 
a reader in 1949 and head of the Social Medicine
Unit until her retirement in 1974. Her work on
radiation risks and childhood cancer put her at odds
with the medical establishment. With the statistician,
George Kneale, she established in 1953 what became
the Oxford Survey of Childhood Cancer, one result
was that pregnant women were no longer sent for X-
rays. In 1974 she started her collaboration with
Thomas Mancuso on the health of nuclear workers in
the USA, which led to congressional investigations in
1978–79. She was awarded the Livelihood Award, 
the alternative Nobel, in 1986 and the Ramazzini
Prize for epidemiology in 1992, and was  one of the
founders of the British Journal of Industrial Medicine.
See Anonymous. (2002) Obituaries: Dr Alice Stewart.
The Times (27 June 2002). See also note 40.
Professor David Strachan 
FRCP FMedSci (b. 1957) has been Professor of
Epidemiology at St George’s Hospital Medical
School, London, since 1997. Although he never
worked at the MRC Epidemiology Unit he recently
collaborated closely with the unit on studies of the
relationship between several chronic infections and
coronary heart disease in the Caerphilly cohort. He
also has major research interests in the epidemiology
of asthma and allergy. He was a Wellcome Research
Training Fellow in Clinical Epidemiology at the
Department of Community Medicine at the
University of Edinburgh from 1985 to 1987.
Mr Peter Sweetnam 
(b. 1941) was a statistician at the Epidemiological
Research Unit (South Wales) from 1966 until the
final cessation of MRC funding in 1999.
Dr Hugh F Thomas 
(b. 1952) was a research officer at the MRC
Epidemiology Unit, Cardiff, from 1976 to 1981
and after medical training from 1995 to 1999. 
He has been Honorary Archivist of the Cochrane
Archive, Llandough Hospital, Penarth, South
Glamorgan, since 1998. He is now in general
practice in Eastbourne. See Thomas H F. (1999)
Medical research in the Rhondda valleys.
Postgraduate Medical Journal 75: 257–259.
Ms Mary Thomas (Mrs Hart)
(b. 1940) was a fieldworker at the Medical Research
Council Pneumoconiosis Research Unit from 1960
to 1962, and later for the MRC Medical
Epidemiology and Medical Care Unit. Dr Julian
Tudor Hart: ‘When Mary was working for the
MRC, which she did for most of our working lives,
there was a time when she was the head of our
research unit: she was running the team, organizing
everything, a very responsible job, and doing it very
well indeed. She had got a fearsome reputation in
Tom Meade’s unit. Her starting hourly rate of pay
was less than the street crossing lady outside the
school.’ Interview with Julian Tudor Hart
conducted by Andy Ness on 14 June 2000.
Dr David Tyrrell 
CBE FRCP FRCPath FRS (b. 1925), physician and
virologist, was previously Director of the MRC
Common Cold Unit, Salisbury, from 1982 to 1990
and Deputy Director of the Clinical Research
Centre, Harrow. He served as a Trustee of the
Nuffield Foundation from 1977 to 1992 and on
committees concerned with clinical research ethics,
genetic manipulation, use of dangerous pathogens,
AIDS and BSE.
Professor Martin Vessey 
CBE FRCPE FRCGP FRCP FMedSci FRS 
(b. 1936) was Professor of Public Health, formerly
Social and Community Medicine, at the University
of Oxford from 1974 until his retirement in 2000,
later Emeritus. He had been a Scientific Officer in
the Department of Statistics at Rothamsted
Experimental Station from 1960 to 1965, a
member of the Scientific Staff at the MRC
Statistical Research Unit from 1966 to 1969 and
Lecturer in Epidemiology at the University of
Oxford from 1969 to 1974. 
Professor Owen Wade 
CBE FRCP (b. 1921) was a clinical assistant at the
Pneumoconiosis Research Unit from 1948 to 1951,
when he moved to the University of Birmingham as
Lecturer, later Senior Lecturer in Medicine until his
appointment as Whitla Professor of Therapeutics
and Pharmacology at Queen’s University, Belfast,
from 1957 to 1971, returning to Birmingham as
Professor of Therapeutics and Clinical
Pharmacology from 1971 to 1986. See his
autobiography, When I Dropped the Knife. Bishop
Auckland: Pentland Press, 1996.
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Dr Christopher Wagner 
(1923–2000), a pathologist educated in South
Africa, was a member of the scientific staff of the
Pneumoconiosis Unit, Llandough Hospital,
Penarth, Cardiff, from 1962 to 1988. His 1960
paper on ‘diffuse pleural mesothelioma and asbestos
exposure in the North Western Cape province’
implicated exposure to blue asbestos and the
development of a particular type of cancer. See
Anonymous. (2000) Christopher Wagner. The
Daily Telegraph (12 July 2000), 27. McConnochie
K. (2000) Chris Wagner. The Guardian
(1 July 2000), 22.
Professor Estlin Waters 
(b. 1934) born in Toronto, Canada, was Senior
House Officer at the Pneumoconiosis Research
Unit, Llandough Hospital, Penarth, Cardiff, 
from 1960, joining the Epidemiology Research 
Unit in 1965 until moving to the University 
of Southampton on his appointment as Senior
Lecturer in 1970, Reader in 1975 and Professor of
Community Medicine from 1976 to 1990. He was
Professorial Fellow until his retirement in 1994,
later Emeritus. He was on the Council of the
International Epidemiological Association from
1971 to 1977 and 1981 to 1984, serving as
Membership Secretary and General Secretary from
1974 to 1977.
Dr Jean Weddell 
(b. 1928) qualified in 1953 and spent five years in
South Korea and Jordan working on tuberculosis
control. She had been a student on Archie
Cochrane’s tuberculosis and chest diseases course at
Sully Hospital and became a member of the MRC
scientific staff, joining of the Epidemiology Research
Unit (South Wales) from 1966 to 1970. She took
part in the development of computerized
information systems for child health, cancer
registration, perinatal care and a register of those with
learning difficulties as well as the higher specialist
training of registrars in public health medicine.
Dr Martin Wright 
FRCP (1912–2001), the inventor of the peak flow
meter, was a bioengineer who joined the Medical
Research Council Pneumoconiosis Research Unit at
Llandough Hospital, Penarth, South Glamorgan in
1949. He moved in 1957 to the National Institute
for Medical Research, Mill Hill, London, to work
solely on instrument development, then in 1969 to
the MRC’s Clinical Research Centre at Northwick
Park Hospital, Harrow. He developed, among other
equipment, the Wright respirometer, the continuous
infusion pump now universally used in terminal
and postoperative care, an infant apnoea monitor
and the standard breath alcohol detector. The MRC
holds the patents on all his inventions. See
Anonymous. (2001) Martin Wright. The Times (23
March 2001), 25. Wright C M. (2001) Basil Martin
Wright. British Medical Journal 322: 1308.
Mrs Sheila Wright (neé Smith)
(b. 1919) was the Medical Research Council’s
Publications Officer from 1950 to 1952, when she
edited one of the PRU’s reports, and from 1970 to
1980 as a Grants Committee Secretary.
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Diagnosis of ischaemic stroke 
Tony Bayer, Llandough Hospital; Shah Ebrahim,
University of Bristol. 
Haemostatic factors
John O’Brien, Mike Etherington, St Mary’s
Hospital, Portsmouth; Gordon Lowe, University 
of Glasgow; Philip Whitehead, Ceridwen Spence,
Frenchay Hospital; Serge Renaud, INSERM, Lyon,
France; John Martin, Philip Bath, Wellcome
Research Laboratories, Beckenham, Kent; John
Giddings, Arthur Bloom, University Hospital
Cardiff; David Hutton, Cardiff Royal Infirmary;
Rod Flower, University of Bath; Professor Stan
Heptinstall, University of Nottingham. 
Lipids
Professor Tom Hayes, Keith Davies, University
Hospital, Cardiff; Dolores Price, Caerphilly and
District Miner’s Hospital; Colin Bolton, Bristol;
Norman Miller, St Thomas’ Hospital, London; Paul
Durrington, J Mackness, University of Manchester. 
Hormones
Diane Riad-Fahmy, Tenovus Institute, Cardiff;
Vincent Marks, University of Guildford. 
Biochemistry 
Job Ubbink, University of Pretoria, South Africa;
Sean Strain and David Thurnham, University of
Ulster; Neal Benewitz, USA; John Yudkin,
Whittington Hospital, London. 
Epidemiology Unit’s collaborators during the Caerphilly Study, 1979–99
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Bacterial and other antibodies
David Strachan, St George’s Hospital Medical
School, London. 
Trace elements
Hartmut Ising, Berlin; Colin Toothill, 
University of Leeds. 
Psycho-social factors
Stephen Stansfeld, St Bartholomew’s and the 
Royal London School of Medicine and Dentistry,
Queen Mary and Westfield College; Teresa Yeung,
University of Wisconsin, USA. 
Hearing loss
Stuart Gatehouse, MRC Hearing Institute,
Nottingham; Adrian Davies, University 
Hospital, Cardiff. 
Cognitive function
Carole Brayne, Felicia Huppert, University 
of Cambridge; Professor Keith Wesnes, University
of Reading; Brian Stollery, Pat Rabbitt, University
of Manchester.
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‘miners’ phthisis’, 3
Mines Department, 3, 4, 26, see also Department of
Mines
Ministry of Defence, 30
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aspirin, action on, 74, 128
blood lead and, 125–126
function tests, 53–54, 55, 127–129
in ischaemic heart disease, 54, 74, 127–128
see also aspirin
PMF, see progressive massive fibrosis
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